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Action of Pungent and Non-pungent Vanilloids on the Emetic Reflex and 
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Submitted by Wan Pui Chu Christina 
for the degree of Master of Philosophy 
at The Chinese University of Hong Kong in June 2004 
The recent discovery of the broad-spectrum anti-emetic potential of the 
tachykinin NKi receptor antagonists underscores the importance of substance P in 
“ the emetic reflex. Vanilloids are capable of modulating substance P, glutamate, and 
CGRP functioning via TRPVl receptors. They are also broad-inhibitory anti-emetic 
drugs. However, pungent vanilloids are associated with irritancy and hypothermia 
and may induce transient emesis before conferring long lasting anti-emetic protection. 
The present studies used a range of pungent and non-pungent vanilloids to 
investigate the possibility of dissociating pungency and anti-emesis from emesis and 
other actions such as hypothermia and grooming. 
.Intracerebroventricularly (i.c.v.) administered resiniferatoxin (0.1-10 nmol), 
capsaicin (30-100 nmol), and PPAHV (10 nmol) initially induced transient emesis 
(p<0.05) and subsequently antagonized emesis to intragastric copper sulphate (120 
mg/kg) in Suncus murinus (p<0.05). Hypothermia was also elicited (resiniferatoxin: 
0.3-10 nmol; capsaicin: 10-100 nmol; PPAHV: 3-10 nmol; p<0.05). Only 
resiniferatoxin (1-3 nmol; p<0.05) evoked genital grooming. The TRPVl antagonist 
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capsazepine (300 nmol, i.e.v.) failed to inhibit any of the resiniferatoxin-induced 
responses (p>0.05). Capsazepine administered alone had transient hypothermic effect 
(p<0.05). Olvanil (10-600 nmol) was anti-emetic against copper sulphate (p<0.05) 
but did not produce emesis or hypothermia that were significantly different from the 
vehicle DMSO (p>0.05). PPAHV and olvanil increased locomotor activity (p<0.05) 
but without obvious dose-relationship. 
Subcutaneous injection of resiniferatoxin (100 nmol/kg) elicited significant 
emesis (p<0.01), hypothermia (p<0.001), and genital grooming (p<0.01). None of 
these responses were antagonized by capsazepine (30-100 |imol/kg, s.c.) or 
ruthenium red (0.3-3 }imol/kg, s.c.), although there was a non-significant trend for 
the antagonists to block resiniferatoxin-induced genital grooming. Ruthenium red (3 
|amol/kg) significantly reduced the latency to resiniferatoxin-induced emesis 
" (p<0.05). Capsazepine (100 |imol/kg) and ruthenium red (0.3 |imol/kg, s.c.) also had 
intrinsic effects to enhance locomotor activity (p<0.05). 
In conclusion, centrally administered resiniferatoxin produced emesis, 
hypothermia, genital grooming, and anti-emesis via a capsazepine-insensitive 
mechanism; peripherally administered resiniferatoxin induced similar effects but 
emesis was probably mediated via a ruthenium red-sensitive mechanism. The 
effective dose ranges for resiniferatoxin, capsaicin, and PPAHV to produce the 
different effects overlapped one another. However, olvanil had a more favourable 
profile to inhibit emesis without causing significant hypothermia or initial emesis. It 
remains to be determined whether other non-pungent vanilloids may be useful anti-
emetics in man. 
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Abbreviations: NKi, neurokinin-1; CGRP，calcitonin-gene related peptide; TRPVl, 
vanilloid receptor; PPAHV, phorbol 12-phenylacetate 13-acetate 20-homovanillate; 




近年使用NKi受體拮抗劑作為廣譜止呕藥物的趨勢突顯了 substance P 
在控制卩區吐中扮演著重要的角色。Vanilloids能透過激活TRPV1受體而調節 





在駒鼯中，大腦第一側腦室注射的resiniferatoxin (0.1-10 nmol), capsaicin 
(30-100 nmol ) ,和PPAHV (0.1-10 nmol)起初均誘發卩區吐（p<0.05)’及後便阻斷 
•• 
了 copper sulphate (120 mg/kg)所引致的卩區吐（p<0.05)�動物的體溫同時也下降 
(resiniferatoxin: 0.3-10 nmol; capsaicin: 10-100 nmol; PPAHV 3-10 nmol; 
p<0.05)o 只有 resiniferatoxin (1-3 nmol)能誘發生殖器甜犢(p<0.05)�TRPVl 受 





皮下注射的 resiniferatoxin (100 nmol/kg)誘發 了啯吐(p<0.01)、低溫 
( p O . O O l ) �以及生殖器甜犢 ( p O . O l ) �這些反應均未能有效地被 c a p s a z e p i n e 
(30-100 i^mol/kg)和 ruthenium red (0.3-3 ^mol/kg)所抑制(p>0.05),但這些抗拮 
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劑能對 r e s i n i f e r a t o x i n所致的生殖器甜犢有未達統計學意義的阻斷。 
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Chapter 1 - Introduction 
Chapter 1 Introduction 
Such epithets, like pepper, 
Give zest to what you write; 
And, if you strew them sparely, 
They whet the appetite: 
But if you lay them on too thick, 
You spoil the matter quite! 
——Lewis Carroll (1832-1898) 
British author 
1.1 Introduction to the Vanilloid Receptor 
"Sin chile, no creen que estan comiendo!" (Without chili, they don't think 
they are eating!), thus commented the century Spaniard, Bartolome de las Casas， 
on the foods of the Native Mexicans. Chili pepper {Capsicum annum) is the source of 
.. capsaicin, the first vanilloid to be isolated and studied. From jalapeno-flavoured 
salsas to grilled poblano rellenos to Caribbean habanero marinades, chili peppers are 
as diverse in their culinary practices as they are in their degree of hotness. Besides 
serving as dietary condiments, chili peppers have been exploited for medicinal 
purposes since antiquity. Native Americans rubbed their gums with pepper pods to 
relieve toothache and ancient Chinese used pepper extracts as the anesthetic during 
castration of the Emperor's eunuchs (Szallasi & Blumberg, 1999). 
Capsaicin was rekindled as an object of pharmacological pursuit by the early 
pioneering works of the Hungarian pharmacologist Nicholas Jancso (1903-1966). 
The existence of the vanilloid receptor, via which capsaicin exerts its effects, was, 
however, not confirmed until fairly recently, thanks to the aid of a distant cousin 
resiniferatoxin, a vanilloid extracted from the cactus Euphorbius resinifera, which 
mimics the actions of capsaicin but at a much enhanced potency (Szallasi & 
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Blumberg, 1989). The development of capsazepine as the first vanilloid receptor 
antagonist (Bevan et al, 1992) also helped accelerate the understanding of the 
vanilloid receptor. The term "vanilloid" was originally coined to highlight the 
common vanillyl (3-hydroxy 4-methoxyphenyl) group shared by capsaicin and 
resiniferatoxin that was initially, albeit erroneously, taken to be essential for 
biological activity. It is now known that compounds bearing no resemblance to the 
vanillyl moiety can also activate the receptor. Nonetheless, the term remains, though 
with improved knowledge of the vanilloid receptor, attempts were made to rectify the 
historical error. 
1.1.1 Properties of the VRl Channel 
Heralding a new era in vanilloid research, Caterina and coworkers (Caterina 
et al., 1997; Tominaga et al, 1998) succeeded in the cloning of the vanilloid 
receptor, which they named VRl, from rat dorsal root ganglion cDNA in 1997. 
Orthologues of this receptor have now been cloned from human (Hayes et al.，2000), 
the guinea pig (Savidge et al, 2002), and the rabbit (Gawa et al., 2004). VRl is a 
ligand-gated cation channel with a notable preference for calcium ions (Caterina et 
al, 1997). Patch-clamp studies with VRl demonstrate a robust inward current that 
diminishes upon repeated capsaicin application (Caterina et al’’ 1997). Noxious heat 
(>43�C) and low pH (<6) can directly open the channel (Tominaga et al, 1998). At 
pH levels that are below neutrality but not acidic enough to activate the channel (i.e. 
pH 6-7.4), responses to both capsaicin and noxious heat are substantially augmented 
(Tominaga et al, 1998). In addition, protons lower the temperature threshold for 
VRl activation, such that at mildly acidic conditions, even physiological 
2 
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temperatures are sufficient to activate the receptor (Tominaga et al, 1998). It is now 
shown that receptor phosphorylation by Ca^^-calmodulin dependent kinase II 
(CaMKII) is a prerequisite for capsaicin binding and activation, although acid-
induced activation was CaMKII-independent (Jung et al., 2004). 
Protein topology of VRl revealed six transmembrane domains, with a re-
entrant pore between domains five and six, and three repeating ankyrin domains at 
the N-teraiinal (Benham et al, 2002). This structural organization resembles the TRP 
(transient receptor potential) receptor family of store-operated calcium channels. 
Hence, VRl was included into the TRP superfamily and the new terminology 
TRPVl emerged (Benham et al, 2002; Montell et al., 2002b). The six-membered 
TRP superfamily of cation channels is putatively responsible for maintaining calcium 
homeostasis, although there is by far no evidence implicating TRPVl to function as 
, such (Caterina et al, 1997). At least two protein paralogues of VRl, or vanilloid 
receptor-like proteins, known as VRL-1 (Caterina et al., 1999) and VRL-2 
(Gunthorpe et al，2002), have also been cloned. According to the TRP nomenclature, 
these proteins are now termed TRPV2 and TRPV4 respectively (Montell et al., 
2002a). TRPV2 and TRPV4 do not respond to capsaicin, but instead to heat and 
osmotic stimuli respectively (Gunthorpe et al, 2002). Other subfamilies of TRP with 
closer resemblance to TRPV include the TRPC and TRPM channels (see Figure 1.1) 
while the subfamilies TRPP, TRPML, and TRPN are more distantly related 
(Gunthorpe et al., 2002). The heterogeneity of TRP proteins parallels their divergent 
roles in assorted sensory processes, which range from vasorelaxation to vision to 
male fertility (Montell et al., 2002a). 
The common consensus is that the binding domain for capsaicin exists 
intracellularly (Jung et al., 1999) and is probably distinct from the recognition sites 
3 
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Figure 1.1 Receptor family tree of the TRP superfamily of non-voltage gated cation 
channels. Adapted from Montell et al, (2002). 
for acid and heat (Jung et al, 1999; Welch et al, 2000). The recognition site for 
protons is thought to be extracellular and it has been suggested that the enhancing 
effect of protons on heat-evoked TRPVl activation and the direct action of protons 
themselves to activate TRPVl are mediated through distinct recognition sites (Jordt 
et al, 2000). The ligand binding site for capsaicin has been partially localized to the 
intracellular loop between helices S2 and S3 (Jordt & Julius，2002) while studies 
with resiniferatoxin extended this model to include the S4 transmembrane domain 
(Chou et al, 2004). Key residues have now been identified in transmembrane regions 
S3 and S4 that confer vanilloid sensitivity (Gawa et al., 2004). Point mutations that 
4 
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confer capsaicin and RTX sensitivity also result in a gain of sensitivity to other 
vanilloid agonists (Gawa et al.，2004) and mutations that alter capsaicin sensitivity 
can do so without affecting sensitivity to acid or heat (Welch et al., 2000). 
The vanilloid receptor is highly expressed by a subset of primary sensory 
neurons originating from the dorsal root, trigeminal, and nodose ganglia (Szallasi & 
Blumberg, 1999). These capsaicin-sensitive neurons mostly give rise to nociceptors-
expressing, peptidergic C- and A6-fibres. Collectively, they form a pathway for pain 
perception by transmiting nociceptive information from the periphery to the central 
nervous system (Szallasi & Blumberg, 1999). Recent evidence proposed glutamate 
as the central neurotransmitter in this pathway, as capsaicin evokes glutamate release 
from rat hypothalamic and brain stem slices (Morgado_Valle & Feldman，2004; 
Sasamura et al., 1998). At the peripheral terminals of these capsaicin-sensitive 
neurons, neuropeptides such as calcitonin gene-related peptide (CGRP) and 
substance P are released during inflammation and partake in the neurogenic 
component of the inflammatory cascade. 
Intense TRPVl immunostaining is found throughout the spinal cord and 
caudal brainstem, including the dorsal horn (Tominaga et al, 1998). Brain areas with 
high TRPVl immunopositivity include the nucleus tractus solitarius, area postrema, 
locus ceruleus, preoptic area of the hypothalamus, all cortical areas, parts of the 
limbic system e.g. hippocampus and amygdala, reticular formation, substantia nigra, 
cerebellum, certain thalamic nuclei, and inferior olive (Mezey et al., 2000; Szabo et 
al, 2002). With the role of TRPVl in pain perception having been reasonably well 
elucidated, the wider distribution of this receptor in the brain places it in a broader 
perspective and opens up new possibilities of TRPVl involvement in other functions 
5 
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such as motor coordination, autonomic control, memeory, and thermal regulation 
(Mezey et al, 2000). 
1.1.2 Explaining the Unexplained: Desensitization and Pungency 
Current clinical indications for capsaicin therapy include relief of chronic 
pain and amelioration of urinary incontinence (Szallasi，2001). The majority of the 
therapeutic potentials of vanilloids arise as a consequence of receptor desensitization. 
Desensitization is the rapid diminution of activity of the receptor after repeated or 
prolonged excitation (Caterina et al, 1997). Upon capsaicin binding, the TRPVl 
channel pore opens to allow calcium entry, causing cell membrane depolarization. 
Action potentials are fired when depolarization reaches activation threshold, leading 
to neurotransmitter release (Sasamura & Kuraishi，1999). The capsaicin-sensitive 
neuron subsequently becomes unresponsive, not simply to a second vanilloid 
challenge, but also to other noxious, pain-inducing stimuli, thus conferring an 
analgesic action. Capsaicin creams for relief of neuropathic pain associated with 
diabetes mellitus are commercially available (Szallasi，2001). Also, intravesical 
capsaicin, which reduced the sensitivity of C-fibers innervating the urinary bladder, is 
beneficial in treating urinary incontinence, a condition exemplified by increased C-
fiber activity of the bladder (Szallasi, 2001). 
The phenomenon of desensitization may help explain the bell-shaped releases 
of CGRP (Wardle et al, 1997) and substance P (Lever & Malcangio, 2002) from 
spinal cord slices. According to a popular model for explaining desensitization (Liu 
& Simon，1996), agonist binding switches the conformation of the TRPVl channel 
from a closed state to an open state. The open state then flips back to the closed state 
6 
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for reactivation via a transitive (desensitized) state. Desensitization reflects the rate 
of recovery of the channel from this transitive state. Alternatively, desensitization has 
been attributed to a blockage of voltage-gated calcium channels in consequence to 
increased intracellular calcium (Docherty et al, 1991). In addition, increasing 
knowledge of the role of protein phosphorylation in the regulation of TRPVl 
sensitivity has identified calcineurin-mediated dephosphorylation of TRPVl as a 
possible key regulator of receptor desensitization (Jung et al, 2004). Lastly, a 
functional view of desensitization is the depletion of neuropeptides (Szolcsanyi et al, 
1990) and receptor downregulation (Szallasi, 1995) and internalization (Lao et al, 
2003), underlining the persistent desensitization or even functional loss of some 
responses (Szallasi et al, 1989). (See Figure 1.2) 
Originally, the distinguishing feature of vanilloids that singled them out as a 
. separate class of pharmacologically active compounds is their pungency, defined as 
the burning sensation one experiences after ingesting hot peppers. Possibly evolved 
as a chemical defense for organisms to deter predators, pungency arises from the 
stimulation of primary nociceptors (Jung et al, 2004). Mushrooms, plants, and 
certain insects are rich in sources of pungent substances (Szallasi & Blumberg， 
1999). Pungency is conventionally measured in terms of Scoville Units (Szallasi & 
Blumberg, 1999). A pepper with 1,000 Scoville Units means that its alcoholic extract 
needs to be diluted 1,000 times for it to cease to be hot-tasting on the human tongue. 
The Mexican habanero, boasting a good 350,000 Scoville Units, is the hottest pepper 
in the world (Szallasi & Blumberg, 1999). The standard laboratory procedure for 
assessing pungency is the eye-wiping assay (Szallasi & Blumberg, 1989), although 
the human tongue is still sometimes preferred (Szallasi et al, 1999a). The eye-
wiping assay consists of counting the number of wipes the animals exhibit after 
7 
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TRPVl 
廬 鑫 Desensitized 
墨 墨 ⑴ 滋 State 
\ .^"'felntefnalization >产：： � 
^ y • Voltage-gated 
TRPVl Ca2+ Channel 
Figure 1.2 Possible pathways for vanilloid receptor desensitization. (1) Desensitization 
may reflect a transitional stage between the closed state and the open state of the 
TRPVl channel. (2,3) Increased intracellular calcium leads to release followed by 
depletion of neurotransmitters and the inhibition of voltage-gated calcium channels. (4) 
Activation of calcineurin by calcium leads to dephosphorylation of the vanilloid 
receptor. (5) Activation of TRPVl results in receptor internalization and 
downregulation. 
8 
Chapter 1 - Introduction 
dripping solutions of the tested substance onto their eyes (Szallasi & Blumberg, 
1989). 
In the clinic, pungency becomes a problem. Initial application of capsaicin 
causes a painful burning sensation which many find intolerable, rendering clinical 
experience with capsaicin creams somewhat disappointing (Szallasi, 2001). This 
adverse effect of capsaicin could reach a level so severe as to prompt patients with 
urinary incontinence to withdraw from treatment (Szallasi, 2001). A temporary 
aggravation of urinary incontinence might also occur during the initial stages of 
capsaicin therapy (Szallasi, 2001). Resiniferatoxin, having an improved pungency to 
desensitization ratio, was found to be superior to capsaicin as a clinical drug; at 
therapeutic concentrations, resiniferatoxin was only reported to produce mild 
discomfort (Szallasi, 2001). Resiniferatoxin is often regarded as the "ultrapotent" 
analogue of capsaicin, although this "ultrapotency" was later realized to be assay-
specific. Despite being somewhat equi-pungent to capsaicin, resiniferatoxin is 1，000 
times more potent to desensitize the rat urinary bladder (Maggi et al.’ 1990). The 
relative potency of resiniferatoxin to capsaicin assessed by various assays is 
presented in Table 1.1. 
Notwithstanding the superiority of resiniferatoxin over capsaicin, the urgency 
for newer analgesic compounds devoid of side effects prevails. So far, progress has 
been made in the development of non-pungent vanilloids such as olvanil (Dray et al., 
1990a) and SDZ 249,665 (Urban et al., 2000), which are structural analogues of 
capsaicin, as well as phorbol 12-phenylacetate 13-acetate 20-homovanillate 
(PPAHV) (Appendino et al., 1996), which is an analogue of resiniferatoxin. These 
agents are effective analgesics in several models of pain but are inactive in the eye-
wiping assay (Appendino et al, 1996; Brand et al, 1987). Olvanil has the added 
9 
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advantage of oral activity (Brand et al., 1987), SDZ 249,665 does not induce 
bronchoconstriction or blood pressure changes sometimes seen with systemic 
capsaicin (Urban et al., 2000), and PPAHV purportedly lacks the hypothermia 
response (Appendino et al., 1996). 
Response Relative Potency 
Specific binding 1 100,000 
Desensitization of neurogenic inflammation in rat^ 20,000 
Inhibition of electrically-induced twitching in rat vas deferens; 10,000 
Hypothermia^ 7,000 
Desensitization of rat urinary bladder^ 1,000 
Induction of neurogenic inflammation^ 1,000 
Increase in tail-flick latency� 1，000 
Channel activation"^ 500 
Calcium uptake' 300 
“ Bradycardia^ 60 
Contraction of rabbit iris sphincter muscle， 10 
CGRP release from rat dorsal spinal cord^ 10 
Contraction of rat urinary bladder^ 1 
Excitation of rabbit ear afferents^ 1 
Eye-wiping response in rat� 1 
Activation of pulmonary chemoreceptors^ RTX inactive 
Desensitization of pulmonary chemoreceptors^ Capsaicin inactive 
Table 1.1 Potency of resiniferatoxin (RTX) relative to capsaicin in various assay 
systems. References: \ACS et al, 1996), ^(Szallasi & Blumberg，1989), ^(Maggi et 
al.’ 1990)，4(0h et aL, 1996), ^(Wang & Hakanson，1992), ^(Wardle et al, 1997), 
7(Szolcsanyi et al, 1990). 
Nonetheless, the synthesis of these compounds shed little light on the 
structural determinants of pungency. While the vanilloid family is forever expanding, 
the structure activity requirements for TRPVl binding and activation are growing all 
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the more puzzling, especially after the introduction of compounds lacking the 
vanillyl functionality, such as the pungent isovelleral (Szallasi et al.，1996a) and the 
non-pungent scutigeral (Szallasi et al, 1999a). Both of these compounds are 
naturally occurring and structurally dissimilar to either capsaicin or resiniferatoxin. 
One hypothesis is that the lipophilicity of the compound, rather than a specific 
structural functionality, is the main determinant of pungency (lida et al, 2003). This 
theory contends that lipophilic, non-pungent compounds get trapped within the 
lipophilic compartments of cells, preventing them from accessing free nerve endings 
(lida et al, 2003). These compounds, however, are still capable of producing pain if 
exposed directly to sensory terminals. From an electrophysiology perspective, non-
pungent compounds are thought to activate the receptor with much slower activation 
kinetics than pungent ones do, such that they inhibit the generation of action 
potentials, i.e. achieve desensitization, before they could excite the receptor (Liu et 
al., 1997). Still, the possibility that a yet uncharacterized subtype of the vanilloid 
receptor is responsible for mediating pungency cannot be ruled out (Liu et al., 1998). 
Unfortunately, despite the successful cloning of TRPVl, no receptor subtypes have 
yet been identified or classified. However, few would disagree that subtypes of the 
vanilloid receptor do in" fact exist. Vanilloids exhibit cooperative binding in central 
tissues (sensory g^gl ia , spinal cord) while they bind non-cooperatively to peripheral 
tissues (urinary bladder, airways) (Szallasi, 1994) and resiniferatoxin and capsaicin 
showed differential preferences for binding and for inducing calcium uptake and 
distinct patterns of desensitization (Acs et al., 1997; Acs et al.’ 1996). 
Electrophysiology studies with different vanilloid agonists revealed different current 
kinetics, extent of desensitization, and calcium dependence among them (Liu et al., 
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1997; Liu & Simon，1998; Liu & Simon，1996; Liu et al, 1998). It is perhaps just a 
matter of time when systematic classification can be achieved. 
1.2 The Quest for the Endogenous Ligand: Activation versus Modulation 
1.2.1 Anandamide and the Cannabinoid System 
With the receptor sequenced and cloned, agonists synthesized and studied, 
the next step for scientists was to search for the endogenous ligand(s) for the 
receptor. Arachidonoyl-ethanolamide, or anandamide, is a generally accepted 
candidate. Recent reports showed that anandamide binds to (Ross et al, 2001) and 
activates TRPVl (Roberts et al, 2002; Zygmunt et al, 1999). Anandamide is 
produced on demand from the hydrolysis of phospholipids and is inactivated by 
either reuptake into the cell via the anandamide membrane transporter (AMT) or 
enzymatic hydrolysis into arachidonic acid and ethanolamide by fatty acid amide 
hydrolase (FAAH) (Szallasi & Di Marzo, 2000). Anandamide release can be evoked 
by the application of capsaicin to neuronal cultures (Ahluwalia et al, 2003b). The 
first indication of anandamide, an identified endogenous cannabinoid CBi receptor 
agonist, as the endogenous ligand for the vanilloid receptor is its chemical similarity 
to the vanilloid olvanil (Di Marzo et al, 1998). Olvanil, on the other hand, also 
displays an affinity for the CBi receptor (Di Marzo et al, 1998) and is an inhibitor of 
AMT (Beltramo & Piomelli，1999)，thus being capable of prolonging the action of 
anandamide in addition to directly acting on the cannabinoid system. The reverse 
also holds true: the AMT inhibitor AM404 was also found to activate the vanilloid 
receptor (Zygmunt et al, 2000) and to have a higher affinity for TRPVl than for 
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AMT (De Petrocellis et al., 2000). The activation of TRPVl by anandamide and 
AM404 are both inhibited by the TRPVl antagonist capsazepine (Roberts et al., 
2002). 
The CBi receptor and TRPVl are highly co-expressed on a subpopulation of 
primary sensory neurons (Ahluwalia et al, 2000). These two receptor systems 
perform opposite roles, with TRPVl mediating excitation and CBi mediating 
inhibition of nociceptive responses. This seemingly paradoxical fact that anandamide 
acts concomitantly as the endogenous ligand for two opposing systems unveils an 
intricate interplay between them. Anandamide has a 5-10 fold lower affinity for 
TRPVl than for CBi (Ralevic et al, 2002). At low concentrations, it produces CBi-
mediated inhibition of neuropeptide release while at high concentrations, it releases 
neuropeptides via TRPVl stimulation (Ahluwalia et al, 2003a). In the presence of a 
“ CBi receptor antagonist, both anandamide- (Ahluwalia et al, 2003a) and capsaicin-
(Lever & Malcangio, 2002) induced peptide release were augmented, depicting a 
tonic, CBi-mediated inhibitory effect on TRPVl activation. 
The cross talk between CBi and TRPVl is likely to be attained through 
intracellular signaling mechanisms (see Figure 1.3). Intriguingly, CBi activation can 
lead to either an enhanced or an abrogated activation of TRPVl, depending on the 
coupling system being activated (Hermann et al, 2003). Forskolin, a protein kinase 
A (PKA) activator, and 8-Br-cAMP, a cAMP analogue that activates PBCA, both 
potentiate anandamide activation of TRPVl (De Petrocellis et al, 2001). This 
forskolin potentiation is enhanced in the presence of the CBi antagonist SR141716A 
(Ahluwalia et al, 2003a). Receptor phosphorylation by PKA or protein kinase C 
(PKC) sensitizes TRPVl to capsaicin and anandamide as well as to heat and protons 
by increasing the channel open probability (De Petrocellis et al, 2001; Premkumar & 
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Figure 1.3 Diagram illustrating modulation of TRPVl sensitivity by intracellular 
events. Activation of the cannabinoid CBj receptor leads to (1) reduced cAMP 
production, hence reduced protein kinase A (PKA)-mediated phosphorylation of 
TRPVl, or alternatively, (2) the hydrolysis of PIP2 by phospholipase C (PLC) to 
produce IP3 and DAG. DAG results in the stimulation of protein kinase C (PKC)-
mediated phosphorylation of TRPVl. (3) PIP2 itself allosterically inhibits TRPVl. (4) 
‘ Inflammatory mediators such as bradykinin (BK), prostaglandin (PgE), and nerve 
growth factor (NGF) potentiate TRPVl via PKC activation. (5) Anandamide (AEA) is 
transported into the cell via the anandamide membrane transporter (AMT) and directly 
activates TRPVl. Hydrolysis of AEA by fatty acid amide hydrolase (FAAH) leads to 
production of arachidonic acid (AA). (6) AA can be oxygenated to generate HPETE 
and leukotrienes (LTB4) which are TRPVl agonists. Modified from Ross (2003). 
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Ahem, 2000; Vellani et al, 2001). Stimulation of the CBi receptor reduces adenylate 
cyclase activity, thereby decreasing cAMP-dependent PKA activity (Hermann et al, 
2003). Repeated application of anandamide evokes progressively larger currents, an 
effect attributed to PKC activation by anandamide (Premkumar & Ahem，2000). In 
fact, activation of PKC alone is sufficient to induce TRPVl activity in the absence of 
other agonists (Premkumar & Ahem，2000). ‘ 
If the adenylate cyclase system is not concomitantly activated, then CBi 
stimulation potentiates TRPVl activation (Hermann et aL, 2003). In this scenario, 
the CBi receptor initiates the phospholipase C (PLC) signaling cascade that 
commences with PLC-catalyzed PIP2 hydrolysis to yield IP3 and DAG, one 
consequence of which is PKC activation. Moreover, PIP2 itself exerts an inhibitory 
allosteric control over TRPVl (Chuang et al, 2001; Hermann et al, 2003), which 
- gets removed upon PLC activation. PI-PLC, the recombinant PLC, enhances TRPVl 
channel activity and capsaicin-induced responses (Chuang et al, 2001) while a PI-
PLC inhibitor reduces these responses (Hermann et al, 2003). These observations 
allow one to anticipate that regulation of PKA and PKC activity are pivotal in 
balancing CBi and TRPVl activation by anandamide. 
1.2.2 Inflammatory Mediators and Lipid Metabolites 
The regulation of TRPVl plasticity by intracellular events unearths yet more 
possibilities for TRPVl modulation, especially under pathophysiological situations. 
Tissue damage generates an array of endogenous mediators that heighten pain 
responses to noxious stimuli (Di Marzo et al, 2002). TRPVl was long recognized to 
be involved in inflammatory hyperalgesia. The dependence of TRPVl sensitivity on 
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phosphorylation provides another gateway through which inflammatory mediators 
can alter its functionality. Except for bradykinin, neither serotonin nor prostaglandin 
E2 applied alone could induce TRPVl activity; but when all three were added in 
combination, a TRPVl-induced current was generated (Vyklicky et al, 1998). These 
agents, again in combination, also potentiated proton-induced currents (Kress et al, 
1997). Bradykinin alone activates TRPVl in a PKC-dependent manner (Premkumar 
& Ahem, 2000) and augments the TRPVl response to protons and capsaicin 
(Chuang et al, 2001). The pro-algesic agent nerve growth factor (NGF) also 
analogously reduces the temperature threshold for TRPVl activation (Chuang et al, 
2001). Bradykinin and NGF, via the BK2 and the tyrosine kinase receptors 
respectively, both stimulate the PLC system. In addition, ATP released during tissue 
injury is known to cause pain through ionotropic purinoceptors. This effect 
“ notwithstanding, ATP was found to sensitize TRPVl to capsaicin, heat, and protons 
(Kwak et al., 2000; Tominaga et al, 2001), despite incongruities regarding the 
involved mechanisms. Some authors maintained participation of metabotropic P2Y1 
receptors coupled to PKC pathways (Tominaga et al., 2001) while some believed in 
direct interaction of ATP with the TRPVl channel without involvement of 
phosphorylation (Kwak et al, 2000). The polymodal nature of TRPVl renders it 
difficult to classify which activators are true agonists and which are merely 
modulators that alter its sensitivity to a primary agonist. It has been hypothesized that 
temperature is the key agonist and that other agents simply lower the temperature 
threshold for activation to physiological temperatures (Tominaga et a/., 1998). 
Currently, there is an expanding interest in the role of lipid metabolites as the 
endogenous ligands for TRPVl. Since anandamide has a rather low affinity for 
TRPVl, some have doubted whether it is possible to reach such high concentrations 
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of anandamide in physiological situations. However, the low intrinsic efficacy of 
anandamide does not undermine its candidacy for the "endovanilloid", but rather, 
may contribute to the differential roles it plays under homeostatic and 
pathophysiological conditions (Ross, 2003). Lipid derivatives of arachidonic acid 
(AA) are found to be agonists at TRPVl with enhanced potency than anandamide, 
one of them being N-arachidonoyl-dopamine (NADA). Fitting in with the 
cannabinoid-vanilloid cross-talk story, NAD A is also an agonist at CBi receptors and 
an inhibitor of A M I and FAAH (Bisogno et al, 2000). NADA occurs in abundance 
in brain areas with the highest TRPVl receptor density and activates TRPVl with 
potency and efficacy similar to those of capsaicin (Huang et al, 2002). NADA-
induced calcium uptake is abolished by the TRPVl antagonist iodo-resiniferatoxin, 
and pre-exposure to NADA results in a reduced response to capsaicin (Huang et al， 
‘ 2002). NADA also releases substance P and CGRP from rat dorsal spinal cord slices, 
effects that were antagonized by capsazepine and capsaicin pretreatment (Huang et 
al, 2002). Similar to anandamide, repeated applications of NADA at short intervals 
potentiate its own response in a PKC-dependent manner (Premkumar et al., 2004). 
Various lipoxygenase products of AA, but not cyclooxygenase products, also have 
activities on TRPVl, with 12-hydroperoxy-eicosatetraenoic acid (12-HPETE) and 
leukotriene B4 (LTB4) being the most potent ones (Hwang et al, 2000). These agents 
are more potent than anandamide but less efficacious than capsaicin (Hwang et al, 
2000). Three-dimensional structural analysis revealed that the spatial arrangement of 
12-HPETE overlaps precisely with capsaicin, rendering it all the more likely to be 
the "endovanilloid" (Hwang et al., 2000). Furthermore, activation of TRPVl 
channels by 12-HPETE was blocked in the presence of capsazepine (Hwang et aL, 
2000). On the basis of these observations, a novel model of vanilloid receptor 
17 
Chapter 1 - Introduction 
activation was hypothesized (Piomelli, 2001), proposing that pro-inflammatory 
mediators like bradykinin mobilize AA during inflammation to generate 12-HPETE 
to recruit TRPVl participation during inflammation. Indeed, lipoxygenase inhibitors 
were found to reduce bradykinin stimulation of TRPVl (Carr et al., 2002). 
1.3 The Variegated Vanilloid Receptor: Multiple Actions of TRPVl 
1.3.1 Vanilloid-induced Hypothermia: some like it cold 
Vanilloids have contributed immensely to the understanding of pain signaling 
mechanisms and have thus achieved much recognition and attention within this field. 
Nevertheless, the actions of vanilloids are far from being confined within the realm 
. of pain signaling. Following the visualization of TRPVl in the brain, vanilloids have 
proved to be far more versatile molecules than ones merely able to elicit pain. 
Hypothermia is also a wellcharacterized action of vanilloids; capsaicin-induced 
hypothermia has been documented in the early works by Jancso-Gabor (Jancso-
Gabor et al, 1970a; Jancso-Gabor et al, 1970b). One can easily recall a culinary 
experience after enjoying, say, a Szechuan cuisine: ingesting spicy foods produces 
profuse perspiration. This gustatory sweating aids in heat dissipation and may 
explain to some extent why hot peppers are met with popularity predominantly in 
countries with tropical climates (Szallasi & Blumberg, 1999). 
The hypothalamus, particularly the preoptic region, is well known to be 
responsible for thermoregulation (Boulant, 2000). Documented reports of vanilloid-
induced hypothermia combined with the discovery of high TRPVl expression in the 
preoptic area (Szabo et al, 2002) led to the conceivable speculation that TRPVl is 
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implicated in temperature control mechanisms (Figure 1.4). Peripheral 
thermoreceptors input to the preoptic area, which integrates such information and 
elicits the appropriate thermoregulatory responses via pathways often involving 
neighbouring hypothalamic nuclei (Nagashima et al, 2000). The preoptic area 
contains warm-sensitive neurons that detect temperature fluctuations by altering the 
frequency of their basal spontaneous firing rate (Boulant, 2000). Upon preoptic 
warming, warm-sensitive neurons increase their firing rate and activate heat loss 
mechanisms by sending excitatory efferent signals to the periaqueductal grey and 
reticular formation to elicit cutaneous vasodilation (Nagashima et al, 2000), as well 
as to the rostral hypothalamus to produce sweating (Kanosue et al, 1998). Most 
animals lack the surplus of sweat glands humans possess and therefore dissipate heat 
by spreading saliva on their flir (Kanosue et al, 1998). Preoptic warming instead 
- induces salivary secretion via the anterior hypothalamus (Nagashima et al., 2000). 
Cold-sensitive neurons also exist, but they only comprise a small population (<5%) 
of the preoptic neurons (Boulant, 2000). No consensus has yet been reached 
regarding the function of these cold-sensitive neurons and how heat production 
mechanisms are initiated. According to Boulant (2000), cold-sensitive neurons are 
under the inhibitory control of warm-sensitive neurons. Upon preoptic cooling, 
warm-sensitive neurons reduce their firing rate, and hence their inhibition on cold-
sensitive neurons, allowing them to activate efferent pathways for heat production 
(Boulant, 2000). Heat-producing responses include shivering, nonshivering 
thermogenesis, and heat-retention processes like cutaneous vasoconstriction 
(Boulant, 2000; Nagashima et al, 2000). The posterior hypothalamus is a key 
structure involved in shivering while the ventral medial hypothalamus, along with 
other hypothalamic nuclei，is responsible for stimulating thermogenesis through 
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Figure 1.4 Anatomical diagram of the hypothalamus illustrating the putative nuclei 
responsible for controlling the functions involved in thermoregulation, grooming, 
and sexual behaviour. Areas shaded in grey represent the presence of TRPVl-
immimopositivity. Heat loss responses are mediated by the PO, which elicits 
salivation and sweating and sends signals to PAG/RF to induce vasodilatation. Heat 
retention responses include thermogenesis, controlled by the VMN, and shivering, 
controlled by the PH. The PO, AH, and PVN are implicated in sexual behaviour and 
the induction of grooming. PO, pre-optic nucleus; MPO, medial pre-optic nucleus; 
AH，anterior hypothalamic area; PVN, paraventricular nucleus; SON, supra-optic 
nucleus; DH, dorsal hypothalamic area; DMN, dorsomedial nucleus; VMN, 
ventromedial nucleus; PH, posterior hypothalamic area; LA, lateral hypothalamic 
area; PAG, periaqueductal grey; RF, reticular formation. Adapted from Pinel (2000). 
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increasing metabolic activity in brown adipose tissue (Nagashima et al., 2000). 
Cutaneous vasoconstriction appears to be under the control of the ventral tegmental 
area (Nagashima et al, 2000). It is worth noting that the warm-sensitive neurons 
work separately and independently to regulate these two opposing responses. 
The hypothermic actions of capsaicin and resiniferatoxin have been 
demonstrated in the mouse (de Vries & Blumberg，1989)，the rat (Szikszay et al, 
1982; Woods et al, 1994)，and the ferret (Andrews & Bhandari，1993). A substantial 
drop of 8 °C in body temperature was produced by resiniferatoxin in the mouse (de 
Vries & Blumberg, 1989), though the magnitude of hypothermia elicited is generally 
around 3 - 4 � C (Andrews & Bhandari，1993; Woods et al, 1994). Hypothermia 
typically lasts for several hours before returning to baseline values (de Vries & 
Blumberg, 1989). Consistent with the prominent desensitization of TRPVl, the 
' hypothermia response rapidly desensitizes, such that repeated administration evokes 
diminished responses or fails to evoke further temperature changes (Jancso-Gabor et 
al, 1970a; Woods et al, 1994). This effect persisted for weeks (Szallasi et al, 1989) 
or even appeared permanent (Jancso-Gabor et al, 1970a). Animals desensitized with 
capsaicin or resiniferatoxin subsequently exhibit impaired tolerance to heat. Placing 
these animals at high ambient temperatures led to drastic rises in body temperature, 
eventually ending in "collapse (Jancso-Gabor et al, 1970a; Szallasi & Blumberg, 
1989; Szikszay et al, 1982). This inability to adapt to heat stress is believed to 
reflect an impairment in heat dissipation mechanisms that result from desensitization 
and/or destruction of hypothalamic warm thermoreceptors; regulation against cold 
stress however remains unaffected (Jancso-Gabor et al, 1970a). 
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1.3.2 Three 's a crowd: Vanilloids, Substance P, and the Emetic Reflex 
Resiniferatoxin (RTX) was first discovered to have anti-emetic properties in 
the ferret (Andrews & Bhandari, 1993). However, the use of vanilloids for anti-
emetic therapy dates back since ancient times. Ginger {Zingiber officinale) is a 
traditional Chinese medicine used for the treatment of nausea and headaches (Dedov 
et al, 2002). It is customary for traditional Chinese to suck a piece of processed 
ginger when feeling queasy. Gingerols，the constituents in ginger, and zingerone, a 
degradation product of gingerol，were identified vanilloid agonists (Dedov et al., 
2002). Long before the connection between ginger, vanilloids, and the emetic reflex 
had been established, a group of researchers in Japan scientized the folklore by 
demonstrating that ginger extracts were orally active to prevent cyclophosphamide-
„ induced emesis (Yamahara et al, 1989b). They further suggested an anti-
serotonergic action of gingerols (Yamahara et al., 1989a). 
Recent investigations were mostly carried out with resiniferatoxin. 
Resiniferatoxin is a potent broad-spectrum anti-emetic, effective against emesis 
induced by copper sulphate, loperamide, radiation, cisplatin, apomorphine, and 
motion (Andrews & Bhandari, 1993; Andrews et al, 2000; Yamakuni et al., 2002). 
The efficacy of resiniferatoxin against nicotine-induced emesis, however, remains 
inconsistent (Andrews et al, 2000; Rudd & Naylor, 1995; Rudd & Wai，2001). 
Broad-spectrum anti-emetics are defined as agents capable of antagonizing emesis 
induced by centrally- or peripherally-acting stimuli, as well as treatments with mixed 
central/peripheral actions. They have sparked much interest among researchers since 
they appear beneficial in clinical situations where emesis such as post-operative 
vomiting is often multi-factorial (Gardner & Perren, 1998). Conventional anti-emetic 
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drugs commonly target single receptor systems and are usually more effective 
against a certain type of emesis (see Table 1.2). The 5 -HT3 receptor antagonists such 
as ondansetron effectively suppress the acute phase of cisplatin-induced emesis but 
leave the delayed phase unaffected (Singh et al., 1997). Novel broad-spectrum anti-
emetics such as resiniferatoxin (Yamakuni et al, 2002) and the NKi receptor 
antagonist CP-99,994 (Rudd et al., 1996) are effective against both phases. Other 
broad inhibitory anti-emetics include the ja-opioid receptor agonists (Rudd et al, 
1999a) and the 5-HTia receptor agonists (Wolff er al, 1997). 
Anti-Emetic Drug Example Type of Sickness 
Hi-receptor antagonists Diphenhydramine Motion Sickness 
Cyclizine Pregnancy Sickness 
.Muscarinic-receptor antagonists Scopolamine Motion Sickness 
D2-receptor antagonists Chlorpromazine Radiation Sickness 
Domperidone Gastrointestinal Irritation 
5-HT3-receptor antagonists Ondansetron Chemotherapy-induced Emesis 
Glucocorticoids Dexamethasone Chemotherapy-induced Emesis 
Table 1.2 Examples of some commonly used anti-emetic drugs and the clinical 
indications for their usage. 
The emetic response is a complicated defense mechanism requiring the 
highly coordinated and sequential participation of a variety of motor systems, 
culminating in the forceful expulsion of gastric contents through the mouth 
(Andrews, 1992). Believed to have evolved to rid the body of ingested toxins, emesis 
is regarded as appropriate when it improves survival, but creates an unpleasant 
problem when occurring as a side effect of cancer chemotherapy (Tortorice & 
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O'Connell, 1990) or after seemingly innocuous stimuli such as motion (Yates et al., 
1998). The integration of the motor outputs of vomiting takes place at the "vomiting 
center" in the brain, the existence and location of which are still disputed. The 
vomiting center was first conceptualized by Borison and Wang (1949), who 
demonstrated that electrical stimulation of a region of the brainstem could produce 
vomiting in the decerebrate cat. They localized this center to be in the dorsal portion 
of the lateral reticular formation (Borison & Wang，1949). The concept of a separate, 
chemoreceptive brainstem region, the area postrema, responsible for the detection of 
emetic agents was also based heavily on their work (Borison & Wang，1953). 
Several lines of evidence identified the nucleus tractus solitarius (NTS) or the 
Botzinger complex (Fukuda & Koga, 1991) as structures capable of fulfilling the role 
as the vomiting center. The NTS is located lateral to the dorsal nucleus of the vagus 
„ in the superior part of the medulla and is the main recipient of vagal afferents from 
the gastrointestinal tract (Leslie & Reynolds，1993). Its function is to integrate 
visceral information with signals from the area postrema and the vestibular system 
and to impinge upon more rostral brain areas. The Botzinger complex, also referred 
to as the "central pattern generator", is situated in the reticular area dorsomedial to 
the retrofacial nucleus and receives input from vagal afferents and projections from 
NTS (Fukuda et al, 1999). 
There are three major pathways by which emesis could be triggered (see 
Figure 1.5). Firstly, vagal afferents from the abdomen project to the area postrema, 
the NTS, and the dorsal motor nucleus of the vagus (Andrews et al, 1990). These 
afferent fibers, sensitive to mechanical distension and chemical irritants, are 
particularly important in the genesis of emesis by radiation and cytotoxic drugs, 
which involves 5-HT release from enterochromaffm cells (Reynolds, 1995). 
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Figure 1.5 Major pathways for the induction of emesis. (1) Irritation of 
gastrointestinal fibres initiates signals via vagal afferents to the area postrema (AP), 
nucleus tractus solitarius (NTS), and the central pattern generator (CPG). (2) Toxins 
present in the systemic circulation are detected by the AP, which has reciprocal 
projections' with the NTS. (3) The vestibular system, upon detecting a sensory 
conflict between spatial and visual information, inputs to the NTS. (4) The forebrain 
can also exert some control over emesis induction. The NTS integrates these 
information and projects to the CPG for the generation of vomiting. 
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Secondly, the vestibular system, critical for motion-induced emesis, inputs to the 
NTS upon detecting a sensory conflict between spatial and visual information (Yates 
et al., 1998). Histaminic and cholinergic receptors partake in this transmission 
pathway (Yates et al, 1998). Lastly, the area postrema, a highly vascularized, 
bilateral structure located in the caudal portion of the 4出 ventricle, has numerous 
reciprocal projections with the NTS (Miller & Leslie，1994). Also known as the 
"chemoreceptor trigger zone", this area is endowed with high chemosensitivity by 
the presence of a leaky blood brain barrier and an abundance of receptors (Miller & 
Leslie，1994). In species that do not vomit, such as rodents, the area postrema is a 
single structure instead (Matsuki et al, 1992). Interestingly, Suncus murinus, a 
species capable of vomiting, also has a single-structured area postrema (Matsuki et 
al, 1992). The area postrema screens the blood and the cerebrospinal fluid and 
-detects both endogenous and exogenous toxins. Many centrally acting emetic agents 
act via this structure, one example being the dopamine D2 agonist apomorphine. 
The mechanism underlying the anti-emetic action of resiniferatoxin is largely 
unknown and speculations have largely been based on indirect evidence. In Suncus 
murinus, resiniferatoxin and capsaicin induced transient emesis prior to conferring 
anti-emetic protection (Andrews et aL, 2000; Rudd & Wai，2001). The emetic 
mechanism for capsaicin was capsazepine- and ruthenium red-sensitive but 
resiniferatoxin-induced emesis was resistant to capsazepine (Rudd & Wai, 2001). 
This emetic effect is not seen in other species although it was reported that 
resiniferatoxin evoked fictive retching in the decerebrate dog (Shiroshita et al, 
1997). It is believed that resiniferatoxin suppresses transmission across the emetic 
pathway by desensitizing afferent terminals, possibly via depletion of substance P in 
the nucleus tractus solitarius (Andrews & Bhandari, 1993; Andrews et al., 2000). 
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Initial emesis observed in Suncus murinus could reflect the preceding activation of 
the area postrema and/or the nucleus tractus solitarius by the released substance P 
(Andrews et al.’ 2000; Shiroshita et al., 1997). This speculation, which embraces 
substance P into the vanilloid story, awaits further corroborative evidence. 
Substance P is a peptide belonging to the tachykinin family and exerts its 
actions primarily through the NKi receptor. This receptor is present along the emetic 
reflex. Autoradiographic studies revealed dense substance P binding in the area 
postrema, nucleus tractus solitarius, and the dorsal motor nucleus of the vagus, with 
the NTS having denser binding than the area postrema (Ariumui et al., 2000; Watson 
et al•，1995). C-fos expression was demonstrated in the area postrema and the 
nucleus tractus solitarius following NKi receptor activation (Yip & Chahl, 1999). 
The NKi receptor antagonists are a newly discovered class of broad-spectrum 
.anti-emetics. The non-peptide NKi receptor antagonist CP-99,994 reduced emesis to 
cisplatin, cyclophosphamide, radiation, morphine, ipecacuanha, copper sulphate, 
loperamide, apomorphine, and nicotine (Bountra et al, 1993; Tattersall et al, 1993; 
Tattersall et al, 1995; Watson et aL, 1995). The site of action of NKi antagonists 
remains unidentified but was quickly recognized to locate centrally, as brain 
penetration was a crucial determinant of anti-emetic efficacy (Tattersall et al, 1996). 
The quatemized NKi receptor antagonist L-743，310 failed to inhibit cisplatin-
induced emesis in the ferret (Tattersall et al, 1996). Studies employing 
microinjection ofNKi antagonists into the brain provided further support (Ariumui et 
al, 2000; Saito et al, 1998). The NTS and the dorsal motor nucleus of the vagus 
(DMNV) were implicated to partake in the anti-emetic action of NKi antagonists 
(Ariumui et cd., 2000; Watson et aL, 1995), as substance P and NKi agonists evoked 
depolarizations in these neurons (Maubach & Jones, 1997). However, some authors, 
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based on electrophysiological studies performed on the decerebrate dog, reasoned 
that substance P does not contribute to signal transmission between vagal afferents 
and the NTS (Fukuda et al., 1999; Fukuda et al, 1998). Instead, the central pattern 
generator, or connections between the NTS and the central pattern generator, is the 
site of action for NKi receptor antagonists (Fukuda et al, 1999; Fukuda et al, 1998). 
Despite the efficacy ofNKi antagonists in blocking emesis to a wide range of 
stimuli, they are much less effective in the treatment of nausea (Reid et al., 2000). 
Nausea, being a subjective sensation, is much harder to assess and quantify than 
vomiting, which is discrete and observable. Current animal models of nausea include 
conditioned taste aversion, pica behaviour, and autonomic changes (Fox, 1992). NKi 
antagonists, at significantly anti-emetic doses, failed to block behaviours associated 
with vomiting that were indicative of nausea (Gonsalves et al., 1996; Lucot et al., 
-1997)，although the NKi antagonist GR205171 did reduce the incidence of nausea-
like behaviours in the piglet (Grelot et aL, 1998). NKi antagonists also do not have a 
clear action to delay the onset of emesis (Gonsalves et al, 1996)，while ondansetron, 
which has been clinically demonstrated to be effective for the treatment of 
chemotherapy-induced nausea (McCune et al., 2001), significantly increased the 
latency to cisplatin-induced emesis in the ferret (Tattersall et al., 2000). It was 
hypothesized that NKi-receptors are either not involved in the nuclei responsible for 
mediating nausea, or that they exert their anti-emetic actions at terminal synapses in 
the emetic pathway which allows them to block the generation of vomiting from the 
brainstem but not the generation of nausea from the forebrain, purportedly (Lucot et 
al., 1997; Tattersall et al, 2000). It has been shown that GR205171 abolished fictive 
retching elicited by electrical stimulation of the vagus but did not affect neuronal 
firing in the nucleus tractus solitarius (Fukuda et al, 1998). 
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Although research has focused heavily on a central site of action, 
contributions of peripheral mechanisms cannot be overlooked. Sendide, a peptide 
tachykinin NKi receptor antagonist that is not brain penetrable, antagonized 
cisplatin-induced emesis in the ferret (Minami et al., 1998). CP-99,994 reduced both 
substance P- and 5-HT-induced vagal activation, implying a peripheral component 
for its anti-emetic action (Minami et al, 2001). The precise role and site of action of 
the NKi receptor in the emetic circuitry remain to be elucidated, but with the 
approval of MK 869 for use in man (Olver, 2004)，the NKi receptor antagonists 
certainly mark a whole new generation of anti-emetics. 
1-S.3 Grooming Behavior and Locomotor Changes: Further Involvement of 
Neurokinins? 
In addition to its unique emetic action in Suncus murinus, resiniferatoxin also 
produces unique genital grooming in this species (Rudd & Wai, 2001). Genital 
grooming consists of intense biting and/or licking of the ano-genital region and was 
elicited by both peripheral (Andrews et al, 2000) and central (Rudd & Wai，2001) 
administrations. Capsaicin was inactive to produce genital grooming; however, 
pretreatment with capsaicin was able to reduce subsequent genital grooming to 
resiniferatoxin (Rudd & Wai, 2001). Resiniferatoxin-induced genital grooming was 
antagonized by both capsazepine and ruthenium red (Rudd & Wai，2001). 
Furthermore, capsaicin was reported to inhibit locomotion in the rat (Di Marzo et al., 
2000; Di Marzo et al., 2001). These actions of vanilloids in altering grooming 
behaviour and locomotor activity are not at all understood. However, substance P 
and other neurokinins are known to induce behavioural changes. With the responses 
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of TRPVl activation suspected to occur from the release of substance P, these effects 
could perhaps be partially accounted for by the pharmacological actions of the 
neurokinin receptors. 
Neurokinin A (NKA) and neurokinin B (NKB), being also members of the 
tachykinin family, are somewhat selective for the NK2 and NK3 receptors 
respectively (Guard & Watson，1991). Together with substance P, they comprise the 
principal mammalian tachykinin peptides. Tachykinins are characterized by the 
presence of a conserved carboxy-terminal amino acid sequence. These peptides are 
coded for by two genes, termed TACl and TAC3. A third gene, termed TAC4, that 
codes for various previously unknown tachykinins (e.g. hemokinin 1, endokinin A 
and B) was recently discovered and welcomed into the tachykinin family (Patacchini 
et al, 2004). 
, Available evidence regarding neurokinin-induced behaviors has been largely 
inconclusive and difficult to interpret at times; nonetheless, some sweeping 
generalizations could still be inferred. In general, centrally administered substance P， 
NKA, and NKB evoke a profile of behaviors consisting of grooming, scratching, wet 
dog shakes, and increased locomotor activity (Culman et al, 1995; Elliott & Iversen, 
1986; Itoi et aL, 1992; Picard et al, 1994; Piot et aL, 1995; Yip & Chahl，1999). 
Grooming involves the "moving [of] the extremities over the body and mouthing [of] 
the body and the extremities" (Sachs, 1988). Scratching is defined as the "use of a 
hind limb to rhythmically scratch the body surface" while wet dog shakes consist of 
"brief, high-frequency shaking and axial rotation of the head and torso" (Bemtson et 
al, 1988). All of the tachykinins could elicit these behaviours, although they exhibit 
some selectivity over certain behaviors (Elliott & Iversen，1986; Picard et al., 1994). 
Generally speaking, substance P and NKA are more potent for inducing grooming 
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and increasing locomotor activity (Culman et al, 1995; Itoi et al, 1992; Yip & 
Chahl, 1999) while NKB is more potent for inducing wet dog shakes (Piot et al, 
1995). It is possible that inconsistencies in the literature arise from the low selectivity 
of neurokinins for their receptors. Despite being recognized as the preferential ligand 
for NKi, substance P could also activate NK2 and NK3 receptors. The rank orders of 
potency of the tachykinins for the three NK receptors are shown in Table 1.3. It is 
evident that all three neurokinins can activate all three NK receptors to a certain 
extent. The residual response to substance P observed in the presence of an NKi 
blocker reflects minor activation of NK2 receptors (Picard et al., 1994). Some reports 
implicated the involvement of uncharacterized neurokinin receptor subtypes in 
mediating these behavioral responses (Culman et al, 1993; Tschope et al, 1992), 
and studies performed with septide, a unique NKi agonist with a distinct profile of 
.action, suggested participation of the non-classical NKi receptor (Ravard et al, 
1994). 
Rank Order of Potency 
NKi receptor SP>NKA>NKB 
NK2 receptor NKA>NKB>SP 
NK3 receptor . NKB>NKA>SP 
Table 1.3 Rank order of potency of substance P (SP), neurokinin A (NKA), and 
neurokinin B (NKB) for the NKi, NK2, and NK3 receptors respectively. 
The brain circuitries involved in the mediation of tachykinin-induced 
behaviors are also poorly understood. What is known is the association of 
neurokinins with dopaminergic systems. Intranigral NK!-induced grooming was 
attenuated by dopamine Di antagonists (Stoessl et al., 1995; Van Wimersma 
Greidanus et al, 1989) and CP 99,994 antagonized behavioural stimulation by Di 
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agonists (Rupniak & Jackson, 1994). The substantia nigra, the ventral tegmental area, 
rostral hypothalamic areas, and the median raphe nucleus have all been proposed to 
play a part (Itoi et al, 1994; Mason & Elliott, 1992; Stoessl et al, 1991; Treptow et 
aL, 1983) although the relative participation of these brain areas in each of the 
behaviours is still unclear. C-fos expression following the administration of a 
substance P analogue was observed in the aforementioned brain areas as -well as in 
the frontal cortex, parts of the limbic system, the thalamus, the hypothalamus, and 
the periaqueductal gray (Yip & Chahl，1999). 
On the other hand, the hypolocomotor effect of capsaicin was again ascribed 
to cross talk between TRPVl and CBi. Hypokinesia is a known neurobehavioral 
effect of cannabinoids (Darmani, 2001b; Di Marzo et al., 2000). Capsaicin-induced 
reduction in locomotor activity was inhibited by capsazepine (Di Marzo et al, 2001). 
In a rat model of Huntington's disease, capsaicin reversed the hyperkinesia induced 
by intrastriatal lesions and rescued the diminutions in dopamine and GABA 
transmission (Lastres-Becker et al, 2003). Arvanil, also a CBi and TRPVl agonist, 
and anandamide both inhibited locomotor activity but their effects were blocked by 
neither capsazepine nor a CBi antagonist, suggesting a novel mechanism of action 
(Di Marzo et al., 2000; Di Marzo et al, 2001). Since the stimulation of capsaicin-
sensitive cells led to .anandamide formation, the authors believed that TRPVl 
activation suppressed motor activity via the intermediacy of anandamide (Di Marzo 
et a/., 2001). 
From cleansing the body and thermoregulation to social signaling and self-
stimulation, grooming serves diverse functions in animals (Sachs, 1988). Reports on 
neurokinin-induced grooming typically observed whole body grooming, failing 
either to observe genital grooming (Itoi et al, 1994) or to differentiate between the 
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types of grooming. Resiniferatoxin-induced grooming in Suncus murinus was 
specifically directed at the ano-genital region (Rudd & Wai, 2001). Male rats, 
especially prepubertal ones, self induce genital grooming to promote sexual maturity 
and reproductive readiness (Sachs, 1988). During mating, genital grooming is often 
observed after each intromission as well as after ejaculation (Sachs, 1988). Outside 
the context of copulation, genital grooming can also be provoked by afferent 
stimulation from the genitalia, the muscles for causing penile erection, or motor 
neurons activating the penile responses (Sachs, 1988). As intracerebral injection of 
substance P has been shown to facilitate copulatory behaviour (Argiolas, 1999), the 
involvement of substance P in resiniferatoxin-induced genital grooming remains 
possible but yet to be confirmed. 
1.4 Aims and Objectives of the Present Study 
The development of NKi antagonists as novel broad-inhibitory anti-emetics 
underscores the criticality of substance P in the genesis of emesis. Agents capable of 
modulating substance P functioning might therefore prove beneficial in preventing 
emesis, the vanilloids being possible candidates, as they are believed to exert anti-
emetic action via TRPVl-mediated substance P depletion in emetic circuitries. 
Vanilloids may even demonstrate superiority over the NKi antagonists by targeting 
multiple receptor systems, as evidence is amounting to suggest TRPVl modulation 
of other neurotransmitters such as CGRP and glutamate (Sasamura et al, 1998; 
Wardle et al, 1997). Glutamate receptor antagonists such as NBQX and 
dextrometorphan have also been demonstrated to possess anti-emetic efficacy against 
cisplatin-induced emesis in the ferret (Fink-Jensen et al., 1992; Lehmann & 
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Karrberg, 1996). Adding to its auspicious prospects, pre-clinical studies indicate a 
long lasting anti-emetic action of vanilloids, making them even more attractive 
(Andrews & Bhandari，1993; Rudd & Wai，2001). A better understanding of the 
underlying mechanisms and functioning of TRPVl will thus permit the exploitation 
of vanilloids to the full. 
The anti-emetic actions of resiniferatoxin and capsaicin have already been 
studied, but evidence for potential anti-emetic efficacy of non-pungent vanilloids is 
lacking. In Suncus murinus, pungent vanilloids have additional emetic effects. The 
hypothesis that this emetic action represents the prior activation of TRPVl leads to 
the speculation that a compound's pungency, which is also attributed to initial 
TRPVl excitation, could be related to its emetic ability. This putative relationship 
will provide insights into the mechanisms for pungency and emesis induction. 
“Pungency could then be used as a convenient indication of the compound's emetic 
ability. Vanilloid-induced emesis has not been observed in other species; whether 
this action is present in man is unknown. The recent developments of non-pungent 
vanilloid analgesics, such as SDZ 249,665 (Urban et al., 2000)，that are free from 
unwanted effects raise hopes for the discovery of non-pungent, non-emetic 
compounds that retain their anti-emetic efficacy. This study addresses this question 
by assessing the emetic/anti-emetic profiles of a range of pungent and non-pungent 
vanilloids in attempt to discover a dissociation of and/or a relationship between the 
two effects. 
The TRPVl receptor, widespread throughout the nervous system, exerts 
numerous other actions, some of them having already been discussed. Stand alone, 
these actions may have beneficial clinical contributions, but when occurring in 
combination, especially under circumstances in which only anti-emesis is desired, 
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they impose as side effects restricting therapeutic utility. The present study 
investigates the ability of different vanilloids in producing hypothermia, genital 
grooming, and locomotor activity changes and determines whether a dissociation of 
these effects is possible. Previous studies revealed a capsazepine-insensitive 
mechanism in resiniferatoxin-induced emesis (Rudd & Wai，2001), indicating the 
likelihood of TRPVl receptor subtypes and possible response dissociation. 
Nevertheless, these so-called side effects exploited individually could also have 
therapeutic values. Investigation into the mechanisms of TRPVl-induced 
hypothermia might reveal novel treatments for situations in which rapid hypothermia 
is desired, for example heat stroke, malignant hyperthermia, cerebral ischemia etc. 
(McGugan, 2001; Ooboshi et al, 2000). The ability of resiniferatoxin to induce 
genital grooming could indicate a potential to treat sexual disorders. Achieving 
dissociation therefore allows each distinct effect to be utilized therapeutically with 
minimal limitations and widens the promising prospects of the vanilloids. 
The prototypical TRPVl antagonists are capsazepine and ruthenium red 
(Dickenson & Dray，1991; Dray et al, 1990b). Their antagonism on TRPVl was 
noted following their ability to inhibit capsaicin-evoked responses such as 
nociception (Dickenson & D'ray，1991; Dray et al., 1990b), inward currents and 
calcium uptake (Bevan et aL, 1992), contraction of the urinary bladder (Maggi et al., 
1993)，CGRP release (Wardle et aL, 1997), and inhibition of electrically-evoked 
contractions of rat vas deferens (Maggi et al., 1993). Capsazepine is a synthetic 
analogue of capsaicin that exhibits competitive antagonism while ruthenium red is an 
inorganic dye that non-competitively inhibits TRPVl (Bevan et al., 1992). Yet, these 
two antagonists also have differential actions: capsazepine does not inhibit TRPVl 
activation by protons or heat in rat TRPVl (Bevan et al, 1992; Nagy & Rang，1999; 
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Savidge et al, 2001)， albeit being effective against proton- and heat-induced 
activation of the human and guinea pig TRPVl (Mclntyre et al, 2001; Savidge et cd., 
2002). Ruthenium red, on the other hand, can antagonize both heat and acid 
activation of rat TRPVl (Mclntyre et al, 2001; Savidge et al., 2001). Capsazepine is 
effective to block capsaicin-induced desensitizations while ruthenium red is not 
(Jung et ah, 1998; Sakurada et al, 2003) and ruthenium red could diminish capsaicin 
induced capsaicin-induced extravasation in rat bronchi while capsazepine could not 
(Auberson & Lundberg，1993). These provide evidence for the existence of TRPVl 
receptor subtypes, distinct binding domains, or different mechanisms of TRPVl 
inhibition. Yet, capsazepine is also found to inhibit voltage-gated calcium channels 
(Docherty et al., 1997) and nicotinic acetylcholine receptors (Liu & Simon, 1997), 
and ruthenium red non-selectively inhibits other types of ion channels (Maggi, 1991) 
and is also an antagonist for other TRPV channels e.g. TRPV2, TRPV4 (Gunthorpe 
et al, 2002). 
Rodents are the most widely used experimental animals in the laboratory; 
however, they do not possess the emetic reflex. Emesis research has therefore been 
mostly confined to using non-human primates and carnivores such as the dog, the 
cat, or the ferret. The insectivore Suncus murinus, otherwise known as the house 
musk shrew, is established as an animal model for emesis, since it responds to a wide 
range of emetic stimuli (Matsuki et al., 1992). Due to its small size, Suncus murinus 
is becoming increasingly popular as it is relatively easy to handle and requires 
smaller amounts of drug samples. However, there is great species dependent 
variation in emetic responses. Suncus murinus is not responsive to apomorphine but 
highly sensitive to motion (Matsuki et cd., 1992). Therefore, this species is useful for 
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the screening of anti-emetic drugs before proceeding to more human-like animal 
models. 
The work described in this thesis employed the intracerebroventricular (i.c.v.) 
injection technique to permit direct application of drugs into the central nervous 
system of Suncus murinus. This approach allowed us to look into the brain 
mechanisms for vanilloid-induced responses. The pungent vanilloids resiniferatoxin 
and capsaicin and their respective non-pungent analogues phorbol 12-phenylacetate 
13-acetate 20-homovanillate (PPAHV) and olvanil were used (Figure 1.6). The 
studies investigated the action of these compounds to evoke emesis, hypothermia, 
genital grooming, and locomotor activity changes and their ability to protect the 
animals against emesis by intragastric copper sulphate. The profiles of actions 
generated will then allow us to determine how these parameters interrelate, including 
”the relationship between pungency and induction of emesis. To elucidate the 
participation of the vanilloid receptor, the effect of capsazepine on the responses to 
vanilloids was investigated. To complement the central injection studies, separate 
sets of experiments employing peripheral injections of vanilloids were also carried 
out. The potential of peripherally administered resiniferatoxin to induce emesis, 
hypothermia, genital grooming, and locomotor activity changes were measured and 
the effect of capsazepine and ruthenium red on these effects was determined. The 
data generated from these studies may have relevance to the classification of 
vanilloid receptor subtypes. 
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Figure 1.6 Structures of the vanilloids used in the present studies. PPAHV is the 
structural analogue of resiniferatoxin while olvanil is the structural analogue of 
capsaicin. 
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Chapter 2 Methods 
Our complicated experiments have no longer anything to do with nature in her own 
right, but with nature charged and transformed by our own cognitive activity. 
——Werner Heisenberg (1901-1976) 
German physicist 
2.1 Animals 
Male (40-70 g) Suncus murinus were used in the central studies and female 
(25-40 g) Suncus murinus were used in the peripheral studies. Male animals were 
used in the central studies as they are larger in size and are more suited for 
stereotaxic surgery. Animals were bred at the Laboratory Animal Services Centre, 
Chinese University of Hong Kong. They were housed in a temperature-controlled 
"room (24 土 1 °C) with artificial lighting between 0600 to 1800 hr. Humidity was 
maintained at 50 土 5 %. Water and cat chow pellets (Feline Diet 5003, PMI® Feeds, 
USA) were provided ad libitum. All experiments were conducted under license from 
the Government of Hong Kong and in accordance with the Animal Experimentation 
Ethics Committee, Chinese University of Hong Kong (AEEC Ref: 03/002/ERG). 
Animals were not used more than once. 
2.2 Stereotaxic Surgery and Transmitter Implantation 
Male Suncus murinus were anaesthetized with sodium pentobarbitone (50 
mg/kg, i.p.) and placed onto a stereotaxic frame equipped with custom-made ear bars 
and mouthpieces (David Kopf Instruments, Tujunga, USA). The fur on the top of the 
head was shaved and the surrounding area was sterilized with hibitane solution 
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(Zeneca, UK) containing 5% (v/v) chlorhexidine gluconate made up in distilled 
water and 95% ethanol (Merck, Daimstadt, Germany) in the ratio of 2:3:15 
(hibitane:water: ethanol). An incision was made in the skin from behind the nose to 
the back of the head. The temporalis muscles on the sides of the sagittal crest were 
displaced and the skull areas were cleared of connective tissue. A hole was drilled in 
the skull according to the following coordinates: 8.2 mm rostral to the cross-suture 
and -0.9 mm lateral to the midline. A brass screw was anchored to the crest. A guide 
cannula (23 gauge) was then inserted through the hole to a depth of 11 mm below 
the surface of the brain and fixed in place with dental cement to the previously 
anchored screw (see Figure 2.1). After the cement had dried, the operative area was 
sutured with a number of interrupted stitches around the guide cannula. Next, the fur 
on the skin on the dorsal surface of the animals was shaved and a second incision 
-was made. The skin was then displaced from connective tissues using blunt 
dissection. A transmitter for measuring body temperature (PhysioTel® TA10TA-F20, 
Data Sciences International) was implanted under the skin and the wound was 
sutured with a few interrupted stitches. Buprenorphine (0.5 mg/kg, i.m.) was given as 
the post-operative analgesic. Animals were allowed at least 72 hours for recovery 
from surgery prior to the commencement of experiments. 
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Figure 2.1 Custom-made guide cannula, anchor screw, and injection unit for 
intracerebroventricular injections in Suncus murinus. 
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2.3 Measurement of Emesis and Genital Grooming 
Animals were placed in clear Perspex observation chambers (20 x 30 x 30 cm) 
during the experiments. Emesis was characterized by rhythmic contractions of the 
abdomen that may (vomiting) or may not (retching) be accompanied by oral 
expulsion of gastric contents. The total number of vomiting and/or retching episodes 
and the latency to first episode were manually recorded. Genital grooming was 
characterized as an intense, active licking and/or biting of the ano-genital region (see 
Figure 2.2). The total number of grooming episodes and the latency to first episode 
were manually recorded. Episodes were considered complete and separate when the 
interval between episodes exceeded 2 s. 
“2.4 Measurement of Locomotor Activity and Body Temperature 
Spontaneous locomotor activity of the animals was monitored by the 
EthoVision Color Pro system (Version 2.3, Noldus Information Technology, The 
Netherlands). The image of the animal was captured by a video camera (Sony DCR 
TRV240E, Japan) positioned vertically above the experimental chamber. Video 
signals were conveyed to a video recorder (Panasonic NV-FU620 model, Japan), 
which was connected to the computer (Dell Dimension 4100，Operating System: 
Microsoft Windows 2000) in which the EthoVision software was installed. The 
signals were then received and processed by the software and a constructed image 
was projected on the computer screen. The EthoVision Color Pro system required 
prior calibration of the system: calibration was achieved by defining absolute 
measurements for objects projected on the computer screen. Locomotor activity, 
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Figure 2.2 A picture showing genital grooming exhibited by Suncus murinus. During 
the grooming process, the animal bended ventrally towards its caudal end and licked 
and/or bit its ano-genital region. Grooming episodes were considered complete and 
separate when the interval between episodes exceeded 2 s. 
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quantified as the distance travelled by the animals within the observation chamber 
during the course of the experiments, was automatically sampled and recorded by the 
software (see Figure 2.3). 
Body temperature was measured at ambient temperature (20-22 °C) by the 
implanted PhysioTel® transmitter (Data Sciences International, Minnesota, USA). 
Wireless radio signals were transmitted to a PhysioTel® receiver (model: RPC-1) 
situated underneath the observation chamber. The receiver was connected to a 
custom matrix interface (Data Exchange Matrix™, Data Sciences International, USA) 
coupled to a computer (Dell OptiPlex GXllO, Operating System: Windows NT 
Workstation 4.0). Data from the transmitter was acquired and recorded at 5 min 
intervals by the computer program DataQuest ART Gold Software (Version 2.2, 
Data Sciences International, Minnesota, USA). This telemetry system allowed 
.’ monitoring of the time course of temperature change over long periods of time, 
precluding the need to use a rectal probe every 5 min (see Figure 2.3). 
A simple set of experiments was performed to determine the accuracy of the 
radio transmitters for measuring temperatures. The transmitters and a mercury 
thermometer were placed in a water bath with temperature that ranged from 22-44�C. 
Temperature readings detected by the transmitters and the thermometer were 
analyzed using linear regression. The two types of readings showed good correlation 
(r^=0.9988; see Figure 2.4). 
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Figure 2.3 A simplified diagram portraying the procedures for the acquisition of 
body temperature and locomotor activity data. Activity of the animal was captured 
by an overhead video camera and transmitted to a computer. The implanted 
transmitter detected body temperature and sent radio signals to a receiver coupled 
to a matrix that was connected to another computer. Separate computer 
programmes automatically analyzed and recorded the acquired data. 
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Figure 2.4 Plot of the linear regression of the temperature readings obtained from the 
telemetry transmitters and a mercury thermometer. 
2.5 Experimental Procedures for Central Injection Studies 
At the commencement of experiments, a habituation period of 30 min was 
“allowed prior to drug administration for the animals to familiarize with the novel 
environment and to generate baseline activity values. Intracerebroventricular 
injections were then accomplished by the insertion of a 30-gauge injection needle 
(Hamilton Company, USA; see Figure 2.1), attached to the end of a syringe, via the 
previously implanted guide cannula into the lateral ventricle. The needle tip extended 
0.5 mm below the tip of the guide cannula. Resiniferatoxin (RTX; 0.1-10 nmol), 
capsaicin (1-100 nmol), olvanil (10-600 nmol), PPAHV (0.1-10 nmol), and their 
respective vehicles were injected i.c.v. in a dosing volume of 5 |iL over a period of 3 
s. The doses of resiniferatoxin and capsaicin were based on published data generated 
from our laboratory (Rudd & Wai, 2001). Doses of olvanil and PPAHV were chosen 
after performing pilot studies. The doses for the pilot studies were based on 
publications by Appendino et al. (1996) on PPAHV and studies with intrathecal 
olvanil injections by Dickenson et al (1990) (Appendino et al., 1996; Dickenson et 
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al., 1990). The needle was removed and the animals were monitored for the next 3 
hours for episodes of emesis and grooming as well as locomotor activity and 
temperature changes. Copper sulphate (120 mg/kg, intragastric) was administered 2.5 
hours post vanilloid injection to assess potential anti-emetic action. The animals were 
watched for a further 30 min. Treatment groups were randomized according to the 
Latin square design and the observer was blinded to the treatments whenever 
possible. In later experiments, capsazepine (300 nmol) was injected (dosing volume 
5 laL, i.c.v.) 15 min prior to i.c.v. injection of vanilloids. The general protocol is 
summarized below in Figure 2.5. At the end of the experiments, animals were killed 
using sodium pentobarbitone (60 mg in 0.3mL, i.p.). Evans blue dye (5 jiL，i.c.v.) 
was then infused and after euthanasia, the brains were removed to confirm the site of 
injection. Data generated from animals with misplaced cannulae was discarded. 
I 
(a) 
habituation emetic, grooming, locomotion, anti-emetic 
period hypothermia data generated data generated 
t=-30mm t=Omin t=150min t=180min 
I 1 1 r - ^ 
animals in inject vanilloid administer end of 
observation agonist or vehicle CuSO* experiment 
chamber i.c.v. ‘ intragastric 
(b) . 
habituation pretreatment emetic, grooming, locomotion, anti-emetic 
period period hypothermia data generated data generated 
t=-45mm - t=-15mm t=Omin t=150min t=180min 
I 1 i 1 1 • 
animals in inject inject vanilloid administer end of 
observation antagonist or agonist or vehicle CUSO4 experiment 
chamber vehicle i.c.v. i.c.v. intragastric 
Figure 2.5 Schematic illustration of the experimental protocol for central studies of (a) 
the actions of vanilloids and (b) the effect of capsazepine on vanilloid-induced 
responses. 
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2.6 Experimental Procedures for Peripheral Injection Studies 
To complement the central injection studies mentioned above, a set of 
experiments employing peripheral injection of RTX was performed. Measurements 
of emesis, grooming, locomotor activity, and body temperature were made following 
identical methods (see Sections 2.3 and 2.4). Briefly, the total number of emetic and 
grooming episodes and the latencies to first episodes were manually recorded. 
Episodes were considered complete and separate when the interval between episodes 
exceeded 2 s. Body temperature and locomotor activity were automatically sampled 
and recorded by the DataQuest ART Gold Software and EthoVision Color Pro 
system respectively. Female Suncus murinus were anaesthetized with sodium 
pentobarbitone (50 mg/kg, i.p.) and the fur on the skin on the dorsal surface was 
-shaved. An incision was then made and the skin displaced from connective tissues 
using blunt dissection. The transmitter was inserted under the skin and the incision 
was closed with interrupted stitches. Animals were allowed 3 days for recovery. 
On the day of the experiments, animals were allowed 30 min for habituation 
in the observation chamber. RTX (100 nmol/kg) or its vehicle was administered 
subcutaneously. The animals were then observed for 3 hours for emesis, grooming, 
locomotor activity, and body temperature changes. For the general protocol, see 
Figure 2.6. The action of RTX against copper sulphate-induced emesis was not 
assessed. In antagonist studies, capsazepine (30-300 |j.mol/kg, s.c.), ruthenium red 
(0.3-3 i^mol/kg, S.C.), and their vehicle were administered 30 min before RTX 
injection. The doses of RTX, capsazepine, and ruthenium red were selected based on 
previous results generated from our laboratory. At the end of the experiment, 
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animals were sacrificed with an overdose of sodium pentobarbitone (60 mg in 0.3ml， 
i.p.). 
(a) 
habituation emetic, grooming, locomotion 
period hypothermia data generated 
t=-30min t=Omin t=180min 
I 1 — 1 • 
animals in inject RTX or end of 
observation vehicle s.c. experiment 
chamber 
(b) 
habituation pretreatment emetic, grooming, locomotion 
period period hypothermia data generated 
t=-60min t=-30min t=Omin t=180min 
I I 1 
animals in inject antagonist inject RTX or end of 
observation or vehicle s.c. vehicle s.c. experiment 
.chamber 
Figure 2.6 Schematic illustration of the general experimental protocol for peripheral 
studies of (a) the actions of RTX and (b) the effect of capsazepine and ruthenium red 
on RTX-induced responses. 
2.7 Drug Formulation . 
Resiniferatoxin (Sigma-Aldrich, USA), capsaicin (Tocris, UK), and phorbol 
12-phenylacetate 13-acetate 20-homovanillate (PPAHV; Sigma-Aldrich, USA) were 
dissolved in Tween 80 (Sigma-Aldrich, USA) /ethanol/saline (ratio of 1:1:8). Olvanil 
(Sigma-Aldrich, USA) was dissolved in dimethylsulfoxide (DMSO; Sigma-Aldrich, 
USA). Capsazepine (Research Biochemicals International, USA) and ruthenium red 
(Sigma-Aldrich, USA) were dissolved in 50% (v/v) DMSO made up in distilled 
water. Copper sulphate (British Drug Houses, UK) was dissolved in distilled water. 
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All central injections were administered in a volume of 5 jiL. Peripheral injections of 
resiniferatoxin and copper sulphate were administered in a dosing volume of 2 ml/kg 
while capsazepine and ruthenium red were administered in a dosing volume of 4 
ml/kg. 
2.8 Statistical Analysis 
The total number of emetic and genital grooming episodes were recorded 
from each animal. The significance of difference between treatment groups was 
analyzed using one-way analysis of variance (ANOVA) followed by Dunnett's 
Multiple Comparison Test or Bonferroni's Multiple Comparison Test (GraphPad 
Prism version 4.0，GraphPad Software, USA) as appropriate. The latencies to first 
episode were also recorded. Latency values were analyzed using Kruskal-Wallis test 
followed by Dunn's Multiple Comparison Test (GraphPad Prism version 4.0, 
GraphPad Software, USA). Hypothermia was quantified as the maximum decrease in 
body temperature observed within a defined time frame e.g. 30 min. This time frame 
was selected based on the temporal profiles of individual drugs. The results were 
analyzed by one-way ANOVA followed by Dunnett's Multiple Comparison Test. 
Body temperatures of and distance travelled by each animal were sampled for 3 
hours and temporal profiles were generated. Data from temporal profiles were 
analyzed using repeated measures two-factor ANOVA followed by pre-planned 
contrasts of specified means (SuperANOVA® version 1.11, Abacus Concepts, USA). 
All results were expressed as the mean 土 S.E.M. Differences were considered 
significant when p<0.05. Statistical analyses of the data from peripheral studies were 
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analyzed similarly, except, where appropriate, an unpaired t-test (GraphPad Prism 
version 4.0，GraphPad Software, USA) was used in lieu of ANOVA. 
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Chapter 3 Results 
If your experiment needs statistics, you ought to have done a better experiment. 
Lord Ernest Rutherford (1871-1937) 
British physicist 
3.1 Actions of Intracerebroventricularly Administered Vanilloid Agonists 
3.1.1 General Behaviour 
Upon removal from their home cages and first introduction to the observation 
chambers, the animals tended to explore the novel environment and had starting body 
temperatures of 34.7 土 0.1 °C (n=129, pooled data). Towards the end of the 30 min 
habituation time, exploration was reduced and body temperature rose to 36.4 土 0.1 
°C (n=140, pooled data). The total distance traveled by the animals during the 
habituation period was 3510 土 130 cm (n=143, pooled data). After drug injections, 
control animals continued to explore the chambers for a short while and then 
remained relatively quiescent for the rest of the experiment. Shortly after receiving 
olvanil, its vehicle, or high dose of RTX, the animals sometimes exhibited spasm of 
the limbs and twitching of the body that lasted for no more than five minutes. 
Vehicle-treated animals gradually lowered their body temperatures, such that at the 
end of the experiment, body temperatures were at 34.0 土 0.2 °C (n=18, pooled data). 
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3.1.2 Emetic Action of Vanilloids 
The vanilloid agonists RTX (0.1-10 nmol), capsaicin (1-100 nmol), PPAHV 
(0.1-10 nmol), olvanil (10-600 nmol), and their respective vehicles were 
administered intracerebrally into the lateral ventricle of Suncus murinus. None of the 
animals injected with the vehicle (TweenSO/ethanol/saline) experienced emesis. RTX 
(0.1-3 nmol), capsaicin (30-100 nmol), and PPAHV (10 nmol) induced significant 
emesis (Figure 3.1A-C). RTX produced a maximum number of 11.0 土 1.3 episodes 
at 0.3 nmol (p<0.01), capsaicin produced 6.0 土 1.0 episodes at 100 nmol (p<0.01), 
and PPAHV produced 5.7 土 1.9 episodes at 10 nmol (p<0.01). Emesis occurred 
shortly after drug injections; at these doses, latencies to first episode for RTX, 
capsaicin, and PPAHV were 2.7 土 1.6，4.3 土 1.4，and 2.0 土 0.7 min respectively 
(Figure 3.2A-C). Emesis generally lasted no more than 15 min. Both capsaicin- and 
PPAHV-induced emesis were dose-dependent while RTX-induced emesis exhibited 
a bell-shaped relationship, with the highest dose (10 nmol) failing to evoke a 
significant response (3.8 土 1.0 episodes; p>0.05). 
Olvanil (10-600 nmol) also caused vomiting, but the emesis observed was not 
significantly different from vehicle-treated animals (Figure 3.ID). The vehicle, 
DMSO, was weakly emetic, producing 1.8 土 1.1 episodes with a mean latency of 
21.31 土 12.76 min (Figure 3.2D). Olvanil, at 30 nmol, induced the most intense 
vomiting (6.3 土 2.9 episodes; p>0.05) and had the fastest onset (latency 5.2 土 1.8 
min). The latencies for olvanil-induced emesis were generally longer and more 
scattered than those for RTX, capsaicin, and PPAHV. 
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Figure 3.1 The emetic potential of (A) resiniferatoxin (0.1-10 nmol), (B) capsaicin 
(1-100 nmol), (C) PPAHV (0.1-10 nmol), and (D) olvanil (10-600 nmol) 
administered i.c.v. in Suncus murinus. Results are expressed as meanis.e.m., n=6. 
Significant differences from vehicle-treated animals are indicated as *p<0.05, 
**p<0.01 (one-way ANOVA followed by Dunnett's Multiple Comparison Test). 
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Figure 3.2 The latencies to first emetic episode induced by (A) resiniferatoxin (0.1-
10 nmol), (B) capsaicin (1-100 nmol), (C) PPAHV (0.1-10 nmol), and (D) olvanil 
(10-600 nmol) administered i.c.v. in Suncus murinus. Open circles represent 
individual latencies. Horizontal lines represent the mean latencies of each treatment 
group, n=6. 
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3.1,3 Anti-Emetic Action of Vanilloids against Copper Sulphate 
Copper sulphate acts peripherally and evokes emesis via gastric irritation and 
stimulation of vagal afferents (Wang & Borison，1952). In the present studies, the 
sensitivity of the animals to intragastric copper sulphate (120 mg/kg) was rather 
variable. In control animals, the number of emetic episodes produced by copper 
sulphate in individual experiments ranged from 3.8 土 1.6 to 10.8 土 2.0 episodes, with 
a mean latency between 3.0 土 0.3 and 10.67 土 6.5 min (Figures 3.3 and 3.4); 21 out 
of 24 animals, or 87.5%, responded (n=24, pooled data). RTX (0.3-10 nmol), 
capsaicin (30-100 nmol), PPAHV (10 nmol), and olvanil (10-600 nmol) significantly 
reduced this response. RTX (0.3-10 nmol) was capable of completely abolishing 
emesis (pO.Ol). At the most effective dose, capsaicin (100 nmol; p<0.05) and 
„ PPAHV (10 nmol; p<0.05) produced only partial blockade, achieving 87% and 88% 
reduction in emesis respectively. Olvanil effectively attenuated copper sulphate-
induced emesis by 72% at 300 nmol (p<0.05) and 100% at 10 nmol (p<0.01). The 
latencies to copper sulphate-induced emesis were not affected by RTX, capsaicin, or 
olvanil (p>0.05). On the other hand, PPAHV (10 nmol) increased the latency from 
3.0 土 0.4 to 15.8 土 5.4 min (p<0.05). In sum, RTX and olvanil were highly 
efficacious in suppressing copper sulphate-induced emesis, being effective across the 
tested dose range and were capable of achieving complete antagonism. 
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Figure 3.3 The anti-emetic potential of (A) resiniferatoxin (0.1-10 nmol), (B) 
capsaicin (1-100 nmol), (C) PPAHV (0.1-10 nmol), and (D) olvanil (10-600 nmol) to 
antagonize emesis induced by intragastric copper sulphate (120 mg/kg) in Suncus 
murinus. Results are expressed as meanis.e.m.，n=6. Significant differences from 
vehicle-treated animals are indicated as *p<0.05, **p<0.01 (one-way ANOVA 
followed by Dunnett's Multiple Comparison Test). 
56 
Chapter 3 - Results 
(A) (B) 
35-] 35-| 
30- o 30- o o 
；c 25- s 25- • 
旦 20- — 20-
^ ^ o 
§ 15- i 15- —— 
3 10-——oo 3 10- ° —— o n 
O ^ 亡 O On ^ ^ 
5- o 5- ^ ^ ^ o o 
OO ^ o ^ OO 
0-"—I 1 1 1 1 1— O-"—I 1 1 1 1 1— 
0 0.1 0.3 1 3 10 0 1 3 10 30 100 
Resiniferatoxin (nmol, i.e.v.) Capsaicin (nmol, i.e.v.) 
(C) (D) 
35n 35n 
30- 30- o 
25- � 25-
. t ^ O - o o 畏 20- —— 
1 15- — I 15-
3 10- 。。 3 10- + 
o OO —o— ^ “ o o 
5- rf^ A 。 。 o o 5- { ^ 
oO OQO 0。 O O 
—I 1 1 1 1 1~ O-'—I 1 1 1 I I 
0 0.1 0.3 1 3 10 0 10 30 100 300 600 
PPAHV (nmol, i.e.v.) Olvanil (nmol, i.c.v.) 
Figure 3.4 The latencies to first episode of copper sulphate-induced emesis for (A) 
resiniferatoxin (0.1-10 nmol), (B) capsaicin (1-100 nmol), (C) PPAHV (0.1-10 
nmol), and (D) olvanil (10-600 nmol) administered i.c.v. in Suncus murinus. Open 
circles represent individual latencies. Horizontal lines represent the mean latencies 
of each treatment group, n=6. Significant differences from vehicle-treated animals 
are indicated as *p<0.05 (Kruskal-Wallis test followed by Dunn's Multiple 
Comparison test). 
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3.1.4 Vanilloid-induced Hypothermia 
For RTX, PPAHV, and capsaicin, all of which shared the same vehicle, 
vehicle-treated animals had a slight temperature decrease of 0.4 土 0.3 to 1.0 土 0.2 °C. 
RTX (0.3-10 nmol), capsaicin (10-100 nmol), and PPAHV (3-10 nmol) produced 
dose-dependent reductions in body temperature. Hypothermia was observed shortly 
after drug injection. RTX- and PPAHV-induced hypothermia displayed similar time 
profiles (Figures 3.5 and 3.6), reaching a maximum low in body temperature at 30 
min and returning back to normal between 60-90 min. Capsaicin had a much shorter 
duration of action (Figure 3.7), with temperature decreasing and returning to normal 
within 20 min. This short time course could perhaps be due to its smaller magnitude 
of temperature fall. Olvanil-treated animals had significantly lower body 
temperatures around 20-30 min post injection, with the exception of the 300 nmol 
group (Figure 3.8). 
It is evident from the time profiles that temperature decrease reached a 
maximum within 20 min after injection of capsaicin and within 30 min after 
injections of RTX, PPAHV, and olvanil. Therefore, the maximum temperature 
reductions obtained within these time periods were calculated and analyzed (Figure 
3.9). RTX elicited the most substantial hypothermia, inducing a temperature drop of 
4.8 土 0.2。C at 3 nmol (pO.Ol). Capsaicin (100 nmol) and PPAHV (10 nmol) 
produced maximum decreases of 1.7 土 0.1。C (p<0.01) and 2.3 土 0.3。C (p<0.01) 
respectively. The vehicle of olvanil, DMSO，decreased body temperature by 2.5 ± 
0.1 。C (Figure 3.9D). Olvanil (10-600 nmol) failed to produce significant 
temperature reductions. At 600 nmol, olvanil only decreased temperature by 2.4 土 
0.3 °C，which was not statistically different from vehicle (p>0.05). Due to the 
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confounding effect of DMSO, the potential hypothermic effect of olvanil could not 
be clearly demonstrated in this study. 
Following hypothermia, a subsequent rebound effect was commonly seen for 
RTX and capsaicin (Figures 3.5 and 3.7). During this period, body temperatures of 
the animals were consistently 1-2 °C higher than those of control animals. This 
rebound effect was only apparent for RTX and capsaicin and was less evident with 
PPAHV or olvanil. 
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Figure 3.5 Time course of the hypothermic action of resiniferatoxin (0.1-10 nmol) 
administered i.c.v. in Suncus murinus. Circles represent mean body 
temperature土s.e.m. Open circles represent the control group while filled circles 
represent the respective treatment groups. Vertical dotted lines represent the time of 
resiniferatoxin injection. Significant differences from vehicle-treated group are 
indicated as *p<0.05, **p<0.01, ***p<0.001, n=6 (Repeated measures two-factor 
ANOVA followed by pre-planned contrasts of specified means). 
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Figure 3.6 Time course of the hypothermic action of PPAHV (0.1-10 nmol) 
administered i.c.v. in Suncus murinus. Circles represent mean body 
temperature土s.e.m. Open circles represent the control group while filled circles 
represent the respective treatment groups. Vertical dotted lines represent the time of 
PPAHV injection. Significant differences from vehicle-treated group are indicated as 
*p<0.05，**p<0.01，***p<0.001, n=6 (Repeated measures two-factor ANOVA 
followed by pre-planned contrasts of specified means). 
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Figure 3.7 Time course of the hypothermic action of capsaicin (1-100 nmol) 
administered i.c.v. in Suncus murinus. Circles represent mean body 
temperature土s.e.m. Open circles represent the control group while filled circles 
represent the respective treatment groups. Vertical dotted lines represent the time of 
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Figure 3.8 Time course of the hypothermic action of olvanil (10-600 nmol) 
administered i.c.v. in Suncus murinus. Circles represent mean body 
temperaturedrs.e.m. Open circles represent the control group while filled circles 
represent the respective treatment groups. Vertical dotted lines represent the time of 
olvanil injection. Significant differences from vehicle-treated group are indicated as 
*P<0.05, **p<0.01, ***p<0.001, n=6 (Repeated measures two-factor ANOVA 
followed by pre-planned contrasts of specified means). 
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Figure 3.9 The hypothermic action of (A) resiniferatoxin (0.1-10 nmol), (B) 
capsaicin (1-100 nmol), (C) PPAHV (0.1-10 nmol), (D) olvanil (10-600 nmol) 
administered i.c.v. in Suncus murinus. Individual bars represent the maximum 
decrease in temperature recorded within 30 min after injection of resiniferatoxin, 
PPAHV, and olvanil, and within 20 min after injection of capsaicin. Results are 
• expressed as mean+s.e.m., n=6. Significant differences from vehicle-treated group 
are indicated as *p<0.05, **p<0.01 (one-way ANOVA followed by Dunnett's 
Multiple Comparison Test). 
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3.1.5 RTX-induced Genital Grooming 
RTX (1-3 - nmol)-induced genital grooming had a bell-shaped dose-
relationship, with a maximum number of 46.7 土 8.8 grooming episodes occurring at 
1 nmol (p<0.01; Figure 3.1 OA). Compared to its emetic effect, RTX-induced genital 
grooming required much longer to occur. At 1 nmol, the latency to first grooming 
episode was 26.43 土 3.1 min (Figure 3.10B). Grooming generally subsided after 60-
90 min. Capsaicin (1-100 nmol), PPAHV (0.1-10 nmol), and olvanil (10-600 nmol) 
were inactive to induce grooming. 
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Figure 3.10 (A) The potential of resiniferatoxin (0.1-10 nmol) administered i.c.v. to 
induce genital grooming in Suncus murinus. Results are expressed as meanis.e.m., 
n=6. Significant differences from vehicle-treated animals are indicated as *p<0.05, 
**p<0.01 (one-way ANOVA followed by Dunnett's Multiple Comparison Test). (B) 
Latencies to first grooming episode. Open circles represent individual latencies. 
Horizontal lines represent the mean latencies of each treatment group. 
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3.1.6 Effects of Vanilloid on Locomotor Activity 
During the 30 min habituation period, the animals had a baseline activity of 
traveling 2700 土 380 to 4800 土 860 cm (Figure 3.11). Baseline locomotor activity of 
the animals did not differ between treatment groups for individual drugs (p>0.05). 
There was also no difference in baseline locomotor activity between the drug groups 
(p>0.05; Figure 3.12), allowing direct comparison of drug effects. 
The temporal profiles of locomotor activity, measured as cumulative distance 
travelled at 30 min intervals, were shown for each drug (Figures 3.13-3.16). Neither 
RTX (0.1-10 nmol) nor capsaicin (1-100 nmol) had apparent effects on locomotor 
activity (p>0.05; Figures 3.13 and 3.14). On the other hand, PPAHV (0.1, 1，and 10 
nmol) increased locomotor activity at 90 min post-injection onwards (p<0.05; Figure 
3.15), and all doses of olvanil, except 100 nmol, enhanced locomotor activity at 120 
min post-injection onwards (p<0.05; Figure 3.16). 
Since vanilloid-induced emesis occurred around 10 min post injection and 
hypothermia peaked at around 30 min, the distances travelled by the animals at these 
time points were further assessed for dose-relationship using one-way ANOVA 
(Figures 3.17 and 3.18). Only olvanil at 300 nmol significantly enhanced locomotor 
activity 10 min post injection (p<0.05; Figure 3.17). 
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Figure 3.11 Distance' travelled during the 30 min habituation period by animals 
receiving (A) resiniferatoxin (0.1-10 nmol), (B) capsaicin (1-100 nmol) (C) PPAHV 
(0.1-10 nmol), (D) olvanil (10-600 nmol), or their vehicle i.c.v. Results are expressed 
as mean±s.e.m., n=6. There are no significant differences from control animals 
(p>0.05，one-way ANOVA followed by Durmetfs Multiple Comparison Test). 
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Figure 3.12 Distance travelled during the 30 min habituation period by animals 
receiving resiniferatoxin (RTX; 0-10 nmol, i.c.v.), capsaicin (CAP; 0-100 nmol, 
i.c.v.)，PPAHV (0-10 nmol, i.c.v.), or olvanil (OLV; 0-600 nmol, i.c.v.). Results are 
expressed as mean土s.e.m.，n=36. There are no significant differences between 




Chapter 3 - Results 
_ 25000-1 
1" 0.1 nmol 
^ 20000-"O 
S» 15000- 了 
^ 10000- T T r ^ M n • 
崖 H n _ h i n i H I I I I 
30 60 90 120 150 
Time (min) 
_ 25000-1 
E 0.3 nmol ** . 
20000- 丁 
"a 
1 15000- T _ 
2 T ^ X • 
:10000- T ^ rh • n • 
^ H n i rti Ml I I I I I I 
30 60 90 120 150 
Time (min) 
_ 250001 





2 工 r ^ 
« 10000- T rS p ] _ 
i H 鬥 . H i n _ I I I I I I 
30 60 90 120 150 
Time (min) 
_ 25000"] 
'E 3 nmol 
20000-
I 15000-
卜 ^ f ] m rtl 
30 60 90 120 150 
Time (min) 
_ 25000- . 
I 1 0 nmol 
20000-
T3 
1 15000- _ 丁 
2 T T i • o 10000- T rn m • 
^ 5。。:lrin 鬥 _ n _ I l l J i i 
30 60 90 120 150 
Time (min) 
Figure 3.13 Time course of the effect on spontaneous locomotor activity of 
resiniferatoxin (0.1-10 nmol) administered i.c.v. in Suncus murinus. Open bars 
represent vehicle-treated animals. Filled bars represent respective treatment groups. 
Results are expressed as mean±s.e.m., n=6. Significant differences from vehicle-
treated group are indicated as *p<0.05, **p<0.01 (Repeated measures two-factor 
ANOVA followed by pre-planned contrasts of specified means). 
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Figure 3.14 Time course of the effect on spontaneous locomotor activity of capsaicin 
(1-100 nmol) administered i.c.v. in Suncus murinus. Open bars represent vehicle-
treated animals. Filled bars represent respective treatment groups. Results are 
expressed as mean±s.e.m., n=6. Significant differences from vehicle-treated group 
are indicated as *p<0.05 (Repeated measures two-factor ANOVA followed by pre-
planned contrasts of specified means). 
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Figure 3.15 Time course of the effect on spontaneous locomotor activity of PPAHV 
(0.1-10 nmol) administered i.c.v. in Suncus murinus. Open bars represent vehicle-
treated animals. Filled bars represent respective treatment groups. Results are 
expressed as mean土s.e.m.，n=6. Significant differences from vehicle-treated group 
are indicated as *p<0.05, **p<0.01, ***p<0.001 (Repeated measures two-factor 
ANOVA followed by pre-planned contrasts of specified means). 
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Figure 3.16 Time course of the effect on spontaneous locomotor activity of olvanil 
(10-600 nmol) administered i.c.v. in Suncus murinus. Open bars represent vehicle-
treated animals. Filled bars represent respective treatment groups. Results are 
expressed as meanis.e.m.，n=6. Significant differences from vehicle-treated group 
are indicated as *p<0.05, **p<0.01, ***p<0.001 (Repeated measures two-factor 
ANOVA followed by pre-planned contrasts of specified means). 
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Figure 3.17 The effect on spontaneous locomotor activity, recorded at 10 min post 
Z ' l J r w V f (A) resiniferatoxin (0.1-10 nmol), (B) capsaicin (1-100 nmol), (C) 
PPAHV (0.1-10 nmol), and (D) olvanil (10-600 nmol) administered i.c.v in Suncus 
細Results are expressed as meanis.e.m., n=6. Significant differences from 
vehicle-treated animals are indicated as *p<0.05 (one-way ANOVA followed bv 
Dunnett's Multiple Comparison Test). 
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Figure 3.18 The effect on spontaneous locomotor activity, recorded at 30 min post 
injection, of (A) resiniferatoxin (0.1-10 nmol), (B) capsaicin (1-100 nmol), (C) 
PPAHV (0.1-10 nmol), and (D) olvanil (10-600 nmol) administered i.c.v. in Suncus 
murinus. Results are expressed as mean士s.e.m.，n=6. There are no significant 
differences relative to vehicle-treated animals (p>0.05, one-way ANOVA followed 
by Dunnett's Multiple Comparison Test). 
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丄 1.7 Summary of Central Agonist Studies 
In conclusion, RTX, capsaicin, PPAHV, and olvanil all conferred anti-emetic 
protection against intragastric copper sulphate in Suncus murinus. Except for olvanil, 
all vanilloids were emetic and hypothermic. RTX induced the most intense emesis as 
well as the most substantial decrease in body temperature. Capsaicin and PPAHV 
were similar in efficacy. RTX was the sole agent capable of eliciting genital 
grooming. Only PPAHV and olvanil appeared to have enhancing effects on 
locomotor activity. The effective dose range of these vanilloids to produce emesis, 
anti-emesis, and hypothermia overlap one another (see Table 3.1)，such that no 
apparent dissociation of effects could be observed (Figure 3.19). 
Responses RTX Capsaicin PPAHV 
Emesis 0.1-3 nmol 30-100 nmol 10 nmol 
Anti-Emesis 0.3-10 nmol 30-100 nmol 10 nmol 
Hypothermia 0.3-10 nmol 10-100 nmol 3-10 nmol 
Genital Grooming 1-3 nmol — … 
Table 3.1 The effective dose ranges of RTX, capsaicin, and PPAHV to produce 
significant vomiting, reduction in emesis to copper sulphate, hypothermia, and 
genital grooming. ， 
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Figure 3.19 A summary of the emetic, anti-emetic, and hypothermic actions of (A) 
resiniferatoxin (0.1-10 nmol), (B) capsaicin (1-100 nmol), (C) PPAHV (0.1-10 
nmol), and (D) olvanil (10-600 nmol) administered i.c.v. in Suncus murinus. Results 
are expressed as mean+s.e.m., n=6. Significant differences from vehicle-treated 
animals are indicated as *p<0.05, **p<0.01 (one-way ANOVA followed by Dunnett's 
Multiple Comparison Test). 
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3.2 Effects of Intracerebroventricularly Administered Capsazepine on 
Vanilloid-induced Responses 
Animals were administered capsazepine (300 nmol, i.c.v.) or its vehicle 15 
min prior to the injection of RTX (3 nmol), capsaicin (100 nmol), PPAHV (10 nmol), 
or their vehicle. The dose of capsazepine was selected based upon previously 
published data generated from our laboratory (Rudd & Wai，2001). The doses of 
vanilloids were selected based upon agonist smdies reported earlier. These doses 
possessed all of the emetic, anti-emetic, and hypothermic action of vanilloids. For 
RTX, the dose selected was also capable of eliciting genital grooming. Olvanil was 
excluded from this part of study since it was not found to produce significant emesis 
or hypothermia. Time constraints were also a contributing factor. Results were 
obtained and analyzed in an analogous fashion as the agonist studies, employing one-
way ANOVA followed by Bonferroni's Multiple Comparison Test. 
3.2.1 Effect of Capsazepine on Vanilloid-induced Emesis 
Capsazepine was dissolved in 50% DMSO made up in distilled water. 
Administration of capsazepine and its vehicle produced a weak emetic response 
consisting of 1.1 土 1.0 to 3.6 ± 1.6 episodes during the 15 min pretreatment time 
(Figure 3.20A). The pretreatment vomiting data was pooled for further examination 
(Figure 3.20B). Vehicle- and capsazepine-treated animals had an average of 1.9 土 0.8 
and 2.5 土 0.8 episodes of vomiting respectively. The groups were not significantly 
different from each other (jp>0.05). Therefore, vomiting observed during the 
pretreatment period could be attributed to the application of DMSO. Capsazepine by 
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itself had no emetic action. Fortunately, this emetic response often subsided after the 
second injection of drugs i.e. after 15 min. Emesis was not observed in the vehicle-
vehicle treated group during the observation period, although weak emesis was 
observed in the capsazepine-vehicle treated group (1.1 土 0.8 episodes; Figure 3.21). 
For analysis purposes, only the vomiting data obtained during the observation 
period was included (Figure 3.21). Although all vehicle-vanilloid treatment groups 
produced emesis, only the vehicle-RTX treatment group was significantly emetic. 
RTX (3 nmol) evoked 7.9 土 2.1 episodes (p<0.05) with a latency of 5.5 土 1.8 min 
while PPAHV (10 nmol) and capsaicin (100 nmol) produced 4.1 ± 1.8 and 4.4 土 1.7 
episodes respectively (p>0.05), with latencies of 3.4 ± 1.4 and 3.5 土 1.2 min. 
Therefore，in this set of experiments, capsaicin and PPAHV were not found to be 
significantly emetic. Thus, it was not possible to determine the potential antagonistic 
action of capsazepine on capsaicin- and PPAHV-induced emesis. Nonetheless, 
pretreatment with capsazepine (300 nmol) did not reduce subsequent emesis to RTX 
(p>0.05). Capsazepine-RTX treated animals had 8.0 土 3.2 episodes of vomiting, 
which was significantly different from capsazepine-vehicle animals (p<0.05) but did 
not differ from vehicle-RTX treated ones (p>0.05). Latency (3.0 土 1.4 min) was also 
unaffected (p>0.05). . 
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Figure 3.20 (A) Vomiting observed during the 15 min pretreatment with capsazepine 
(300 nmol, i.c.v.) or its vehicle in Suncus murinus receiving resiniferatoxin (RTX; 3 
nmol)，capsaicin (CAP; 100 nmol), PPAHV (10 nmol), or their vehicle (Veh) 
administered i.c.v. Open bars represent vehicle-pretreated groups. Filled bars 
represent capsazepine-pretreated groups. Results are expressed as meanis.e.m.，n=7. 
There are no significant differences (p>0.05, one-way ANOVA followed by 
Bonferroni's Multiple Comparison Test). (B) Vomiting observed during the 15 min 
pretreatment time with capsazepine (300 nmol, i.c.v.) or its vehicle administered 
i.c.v. in Suncus murinus. Results are expressed as mean±s.e.m., n=28 (pooled data). 
There are no significant differences (p>0.05, unpaired t-test). 
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Figure 3.21 (A) The potential of resiniferatoxin (RTX; 3 nmol), capsaicin (CAP; 100 
nmol), PPAHV (10 nmol), and their vehicle (Veh) administered i.c.v. to induce 
emesis after pretreatment with capsazepine (300 nmol; i.c.v.) or its vehicle. Open 
bars represent vehicle-pretreated groups. Filled bars represent capsazepine-pretreated 
groups. Results are expressed as mean+s.e.m., n=7. Significant differences are 
indicated as *p<0.05 (one-way ANOVA followed by Bonferroni's Multiple 
Comparison Test). (B) The latencies to first emetic episode. Circles represent 
individual latencies. Open circles represent vehicle-pretreated groups while filled 
circles represent capsazepine-pretreated groups. Horizontal lines represent mean 
latencies of each treatment group. There are no significant differences between 
capsazepine-pretreated groups relative to their respective control groups (p>0.05, 
Kruskal-Wallis test followed by Dunn's Multiple Comparison Test). 
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2.2 Effect of Capsazepine on the Anti-Emetic Actions of Vanilloids 
Intragastric'copper sulphate (120 mg/kg) induced 12.6 土 4.0 emetic episodes 
(latency 3.3 土 0.4 min) in vehicle-vehicle treated animals and 9.0 土 2.7 emetic 
episodes (latency 2.8 土 0.8 min) in capsazepine-vehicle treated animals (Figure 3.22). 
Capsazepine administered alone had no anti-emetic action (p>0.05). The emetic 
response to copper sulphate was completely abolished by the administration of RTX 
(3 nmol; p<0.001). The anti-emetic action of RTX was preserved in the presence of 
capsazepine (300 nmol; p<0.05). In vehicle-capsaicin and vehicle-PPAHV treated 
groups, copper sulphate induced 5.6 ± 1.8 and 4.7 土 2.3 episodes respectively 
(latencies 7.0 土 0.9 and 4.1 土 0.8 min respectively). These responses were not 
statistically significant from the control group (p>0.05). Therefore, no significant 
anti-emetic action could be detected for capsaicin and PPAHV in this experiment. 
The effect of capsazepine on capsaicin and PPAHV thus could not be determined. 
Capsazepine was also inactive to affect the latency to copper sulphate-induced 
emesis (p>0.05; Figure 3.22B). 
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Figure 3.22 (A) The potential of resiniferatoxin (RTX; 3 nmol), capsaicin (CAP; 100 
nmol), PPAHV (10 nmol), and their vehicle (Veh) administered i.c.v. to antagonize 
emesis induced by intragastric copper sulphate (120 mg/kg) after pretreatment with 
capsazepine (300 nmol, i.c.v.) or its vehicle in Suncus murinus. Open bars represent 
vehicle-pretreated groups. Filled bars represent capsazepine-pretreated groups. 
Results are expressed as mea吐s.e.m.’ n=7. Significant differences are indicated as 
*p<0.05, **p<0.01, ***p<0.001 (one-way ANOVA followed by Bonferroni's 
Multiple Comparison Test). (B) The latencies to first emetic episode. Circles 
represent individual latencies. Open circles represent vehicle-pretreated groups while 
filled circles represent capsazepine-pretreated groups. Horizontal lines represent 
mean latencies of each treatment group. There are no significant differences between 
capsazepine-pretreated groups relative to their respective control groups (p>0.05, 
Kruskal-Wallis test followed by Dunn's Multiple Comparison Test). 
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3.2.3 Effect of Capsazepine on Vanilloid-induced Hypothermia 
During the 15 min pretreatment period, administration of capsazepine's 
vehicle produced a drop in body temperature of 1.2 土 0.2。C (n=28, pooled data). 
This decrease tended to plateau off after 15 min and returned to normal shortly 
afterwards. Administration of capsazepine decreased body temperature by 2.1 土 0.3 
°C (p<0.05; n=28, pooled data), suggesting an intrinsic hypothermic effect of 
capsazepine. 
The vehicle-vehicle treated group had a temperature decrease of 0.3 土 0.2。C. 
Vehicle-RTX, vehicle-capsaicin, and vehicle-PPAHV treated groups had maximum 
temperature reductions of 3.7 土 0.5，0.9 土 0.2，and 1.3 土 0.3。C respectively (Figure 
3.24). Only RTX (3 nmol) was found to be statistically significant from control 
(pO.OOl). A hypothermic action could not be demonstrated for capsaicin and 
PPAHV. RTX-induced hypothermia was not reversed by pretreatment with 
capsazepine (3.2 土 0.3 °C; p>0.05). 
The time profiles of body temperature decrease are shown in Figure 3.23. 
Capsazepine was found to prolong the action of RTX (Figure 3.23B). For vehicle-
RTX treated animals, body temperature returned to normal after 60 min while for 
capsazepine-RTX-treated animals, body temperature did not return to normal until 
after 120 min. A short period of elevated body temperature was seen for the vehicle-
RTX treated group following the hypothermia response. No changes in body 
temperature were evident for animals administered capsaicin (100 nmol) (Figure 
3.23C). As for PPAHV (10 nmol), there was a gradual decrease in body temperature 
which peaked at 20 min after injection and remained so for the whole of the 
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experiment, failing to ever return to normal (Figure 3.23D). Capsazepine (300 n m o l ) . 
shortened the duration of this response. 
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Figure 3.23 Time course of the hypothermic action of (B) resiniferatoxin (RTX 3 nmol), 
(C) capsaicin (CAP 100 nmol), (D) PPAHV (10 nmol), or (A) their vehicle (Veh) 
administered i.c.v. after pretreatment with capsazepine (CZP 300 nmol, i.c.v.) or its 
vehicle (Veh) in Suncus murinus. Symbols represent mean body temperature土s.e.m.， 
n=7. The first vertical dotted line represents injection of capsazepine or its vehicle and 
the second vertical dotted line represents injection of vanilloids or their vehicle. 
Significant differences of vehicle-vanilloid treated groups from vehicle-vehicle treated 
group are indicated as *p<0.05, **p<0.01, ***p<0.001. Significant differences of 
capsazepine-vanilloid groups relative to their respective vehicle-vanilloid groups are 
indicated as 卞p<0.05，竹pO.Ol,付卞pO.OOl (Repeated measures two-factor ANOVA 
followed by pre-planned contrasts of specified means). 
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Figure 3.24 Maximum temperature decrease recorded within 30 min after i.c.v.. 
administration of resiniferatoxin (RTX; 3 nmol), capsaicin (CAP; 100 nmol), 
PPAHV (10 nmol), or their vehicle (Veh) in Suncus murinus after pretreatment with 
capsazepine (300 nmol, i.c.v.) or its vehicle. Open bars represent vehicle-pretreated 
groups. Filled bars represent capsazepine-pretreated groups. Results are expressed as 
mean士s.e.m.’ n=7: Significant differences are indicated as *p<0.05, **p<0.01, 
***p<0 001 (one-way ANOVA followed by Bonferroni's Multiple Comparison Test). 
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3.2.4 Effect of Capsazepine on RTX-induced Genital Grooming 
RTX (3 nmpl) elicited 29.7 土 8.2 episodes of genital grooming (p<0.05) with 
a latency of 30.1 土 7.1 min (Figure 3.25). Genital grooming was not observed in 
control animals. Capsazepine (300 nmol) reduced this grooming response to 18.3 土 
11.4 episodes (38% reduction; latency 49.3 土 10.0 min), but this reduction did not 
reach statistical significance (p=0.2617). 
f 
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Figure 3.25 (A) The potential of resiniferatoxin (RTX; 3 nmol) or its vehicle (Veh) 
administered i.c.v to induce genital grooming after pretreatment with capsazepine 
(300 nmol, i.c.v.) or its vehicle in Suncus murinus. Open bars represent vehicle-
pretreated groups. Filled bars represent capsazepine-pretreated groups. Results are 
expressed as mean±s.e.m., n=7. Significant differences are indicated as *p<0.05 
(one-way ANOVA followed by Bonferroni's Multiple Comparison Test). (B) The 
latencies to first grooming episode. Circles represent individual latencies. Open 
circles represent vehicle-treated groups while filled circles represent capsazepine-
pretreated groups. Horizontal lines represent mean latencies of each treatment group. 
There are no significant differences between capsazepine-pretreated and vehicle-
pretreated groups (p>0.05, Kruskal-Wallis Test followed by Dunn's Multiple 
Comparison Test). 
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3.2.5 Effect of Capsazepine on Locomotor Activity of Vanilloid-treated Animals 
The animals travelled a distance of 3200 土 600 to 4400 土 600 cm during the 
30 min habituation period; baseline activity did not differ between groups (p>0.05; 
Figure 3.26A). Animals assigned to receive RTX, capsaicin, PPAHV, or vehicle did 
not differ in their baseline locomotor activity (p>0.05; Figure 3.26B). There was also 
no difference between animals assigned to receive capsazepine or its vehicle (p>0.05; 
Figure 3.26C). 
Administration of capsazepine alone did not affect locomotor activity 
(p>0.05). RTX (3 nmol) did not elicit locomotor activity changes (p>0.05; Figure 
3.27A). Capsaicin (100 nmol) increased the distance travelled at 60 min post-
injection onwards (p<0.05; Figure 3.27B). This enhancement was abolished in the 
presence of capsazepine (p<0.05). PPAHV (10 nmol) increased distance travelled 
only at 90 min post injection (p<0.05; Figure 3.27C). This effect was not blocked by 
capsazepine (p>0.05). Nonetheless, capsazepine-PPAHV treated animals exhibited 
reduced locomotor activity at 120 and 150 min post injection compared to vehicle-
PPAHV treated animals (p<0.05). 
90 
Chapter 3 - Results 
(A) 
5000] 丁 
+ � � � - “ r S i U i 工 i 
- - I i n i n l 
2。。。- I I I I 
• 1 1 1 1 
Veh RTX CAP PPAHV 
Treatment 
(B) 
SOOOn E 丁 丁 S 4000- ~~I~~ ^ 
J r — ^ r ^ 0) 3000-> ro 
^ 2000-
I 1000-
o U — — I — — — — — — I — — — — — — I — — — — — — I 




S 4000- I 
1 ~ I ~ ~ 




0-1 1 , 
Vehicle Capsazepine 
“ Treatment 
Figure 3.26 Distance travelled during the 30 min habituation period by (Fig A) animals 
receiving capsazepine (300 nmol, i.c.v.) or its vehicle followed by resiniferatoxin 
(RTX; 3 nmol), capsaicin (CAP; 100 nmol), PPAHV (10 nmol), or their vehicle (Veh) 
administered i.c.v. Open bars represent vehicle-pretreated groups. Filled bars represent 
capsazepine-pretreated groups. Results are expressed as mean±s.e.m.，n=7; (Fig B) 
animals receiving resiniferatoxin (RTX; 3 nmol), capsaicin (100 nmol), PPAHV (10 
nmol), or their vehicle administered i.c.v. Results are expressed as mean+s.e.m., n=14 
(pooled data); (Fig C) animals receiving capsazepine (300 nmol, i.c.v.) or its vehicle. 
Results are expressed as mean±s.e.m., n=28 (pooled data). There are no significant 
differences between treatment groups (p>0.05, one-way ANOVA followed by 
Bonferroni's Multiple Comparison Test or unpaired t-test as appropriate). 
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Figure 3.27 Time course of the effect on spontaneous locomotor activity of (A) 
resiniferatoxin (RTX; 3 nmol), (B) capsaicin (CAP; 100 nmol), (C) PPAHV (10 
nmol), and their vehicle (Veh) administered i.c.v. after pretreatment with capsazepine 
(CZP; 300 nmol, i.c.v.) or its vehicle (Veh) in Suncus murinus. Results are expressed 
as mean土s.e.m.，n=7. Significant differences are indicated as *p<0.05, **p<0.01, 
***p<0.001 (Repeated measures two-factor ANOVA followed by pre-planned 
contrasts of specified means). 
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3.3 Peripheral Studies with RTX, Capsazepine, and Ruthenium Red 
3.3.1 Experiment 1: Actions of Resiniferatoxin 
Vehicle-treated animals did not exhibit emesis or genital grooming. RTX 
(100 nmol/kg, s.c.) elicited 9.5 土 1.9 episodes of vomiting (p<0.01; Figure 3.28A) 
and 31.5 土 7.5 episodes of genital grooming (p<0.01; Figure 3.28C). Latencies for 
these responses were 6.6 土 1.4 and 56.4 土 4.3 min respectively (Figures 3.28B and 
3.28D). The body temperature of RTX-treated animals decreased to a maximum low 
at 35 min and returned to normal around 120 min (Figure 3.29). The time course of 
hypothermia was of much longer duration than that obtained for central injection 
studies (c.f. Figure 3.5). A maximum reduction of 6.3 土 0.2 °C in temperature was 
produced, as compared to a 0.7 土 0.2 °C decrease in control animals (pO.OOl; 
Figure 3.30A). The baseline activity of the animals did not differ between the two 
groups (p>0.05; Figure 3.30B). RTX did not produce significant alterations in 
distance travelled (p>0.05; Figure 3.31). At 10 and 30 min post injection, the time 
points which coincided with emesis and maximum hypothermia, no dose-related 
changes in locomotor activity were observed (p>0.05; Figure 3.32). 
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Figure 3.28 The potential of RTX (100 nmol/kg, s.c.) to induce (A) emesis and (C) 
genital grooming in Suncus murinus. Results are expressed as mean±s.e.m., n=4. 
Significant differences from vehicle-treated animals are indicated as *p<0.05, 
**p<0.01 (Unpaired t-test). Respective latencies to first emetic (B) or grooming (D) 
episode are also shown. Open circles represent individual latencies. Horizontal lines 
represent the mean latencies of each treatment group. 
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Figure 3.29 Time course of the hypothermic action of resiniferatoxin (100 nmol/kg) 
administered subcutaneously in Suncus murinus. Circles represent mean body 
temperature土s.e.m., n=4： Open circles represent the vehicle-treated group while 
filled circles represent the resiniferatoxin-treated group. 
95 
Chapter 3 - Results 
⑷ 
O 8 i 
0 
V 7- * * * 




0) 9 CO 乙-(0 
- 1- , 
o ‘ 
0) n 















RTX (nmol/kg, s.c.) 
Figure 3.30 (A) Maxiumum temperature decrease recorded within 60 min after 
‘subcutaneous injection of RTX (100 nmol/kg) or its vehicle in Suncus murinus. (B) 
Distance travelled by animals administered RTX (100 nmol/kg, s.c.) or its vehicle 
during the 30 min habituation period. Results are expressed as mean土s.e.m., n=4. 
Significant differences from vehicle-treated animals are indicated as *p<0 05 
**P<0.01, ***p<0.001 (Unpaired t-test). • ， 
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Figure 3.31 Time course of the effect on spontaneous locomotor activity, recorded at 
30 min intervals, of resiniferatoxin (100 nmol/kg) administered subcutaneously in 
Suncus murinus. Open bars represent the vehicle-treated group. Filled bars represent 
the resiniferatoxin-treated group. Results are expressed as mean±s.e.m., n=4. There 
are no significant differences from vehicle-treated groups (p>0.05, Repeated 
measures two-factor ANOVA followed by pre-planned contrasts of specified means). 
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Figure 3.32 The effect on spontaneous locomotor activity, recorded at (A) 10 min 
‘and (B) 30 min post injection of resiniferatoxin (100 nmol/kg) administered 
subcutaneously in Suncus murinus. Results are expressed as mean±s.e.m., n=4. 
There are no significant differences between treatment groups (p>0.05, unpaired t-
test). 
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I 
3.3.2 Experiment 2: Effects of Capsazepine and Ruthenium Red Administered 
Alone 
Control animals treated with 50% DMSO had 4.2 土 1.8 emetic episodes 
(Figure 3.33A). The emetic effect was slightly reduced in the presence of 
capsazepine (30-100 |amol/kg) or ruthenium red (0.3-3 |imol/kg). Animals that were 
treated with 100 ^mol/kg capsazepine did not exhibit emesis (p<0.05), perhaps 
reflecting an anti-emetic action of capsazepine against DMSO. Neither capsazepine 
nor ruthenium red had added actions to cause vomiting. DMSO-induced emesis had 
latencies between 32.9 土 3.13 to 60.2 土 25.0 min (Figure 3.33B). Most of the animals 
exhibited a gradual decrease in body temperature of 1-2 °C throughout the course of 
the experiment (Figure 3.34). Capsazepine (30 ^imol/kg) had slight hypothermic 
, effects (Figure 3.34A). Between 50-70 min and 120-150 min post injection, 
temperature was lowered by approximately 1 °C (p<0.05). Ruthenium red was 
inactive to alter body temperature (p>0.05; Figure 3.34B). Animals used in this 
experiment travelled an average distance of 2200 土 220 to 3900 土 140 cm during the 
habituation period (Figure 3.35). Baseline activity did not differ between groups 
(p>0.05). A high dose of capsazepine (100 |amol/kg) and low dose of ruthenium red 
(0.3 |imol/kg) enh^ced locomotor activity (p<0.05; Figure 3.36). The effect of 
capsazepine became apparent at 90 min onwards while that of ruthenium red was 
notable between 60-150 min post injection. 
99 
Chapter 3 - Results 
(A) 
_. 6n 丁 
I 5-
0 
W A- ~ ~~ 
• q . ^ 
山 
^ 3- 丁 T 
1 2- ^ 
E . 
i 1-
qII II r^ __二 
0 0.3 3 30 100 
RR OTP 





I 8 0 - 。 
S O 
I 6 0 : 丄 一 一 
. ^ 40- 。 。 
J - oO o 
20- 。 
0 
0 0.3 3 30 100 
RR CZP 
Treatment ( i^mol/kg, s.c.) 
Figure 3.33 (A) The emetic potential of ruthenium red (RR; 0.3-3 |j.mol/kg), 
‘capsazepine (CZP; 30-100 |imol/kg), or their vehicle administered subcutaneously 
in Suncus murinus. Results are expressed as mean±s.e.m., n=5. Significant 
differences from vehicle-treated animals are indicated as *p<0.05 (one-way ANOVA 
followed by Dunnett's Multiple Comparison Test). (B) Latencies to first emetic 
episode. Open circles represent individual latencies. Horizontal lines represent the 
mean latencies of each treatment group. 
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Figure 3.34 Time course of the effect on body temperature, measured at 5 min 
intervals, of (A) capsazepine (30-100 |imol/kg) and (B) ruthenium red (0.3-3 
^imol/kg) administered subcutaneously in Suncus murinus. Symbols represent mean 
body temperaturedrs.e.m., n=5. Open circles represent the control group. Filled 
circles or squares represent the treatment groups. Vertical dotted lines represent time 
of injection. Significant differences from vehicle-treated animals are indicated as 
*p<0.05, **p<0.01 (Repeated measures two-factor ANOVA followed by pre-planned 
contrasts of specified means). 
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Figure 3.35 Distance travelled during the 30 min habituation period by Suncus 
murinus receiving ruthenium red (RR; 0.3-3 |amol/kg), capsazepine (CZP; 30-100 
|imol/kg), or their vehicle administered subcutaneously. Results are expressed as 
meanis.e.m., n=5. There are no significant differences between treatment groups 
(p>0.05, one-way ANOVA followed by Bonferroni's Multiple Comparison Test). 
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Figure 3.36 Time course of the effect on spontaneous locomotor activity, measured at 
30 min intervals, of (A) capsazepine (30-100 |imol/kg) and (B) ruthenium red (0.3-3 
}imol/kg) administered subcutaneously in Suncus murinus. Results are expressed as 
meardbs.e.m., n=5. Significant differences from vehicle-treated animals are indicated 
as *p<0.05, **p<0.01, ***p<0.001 (Repeated measures two-factor ANOVA followed 
by pre-planned contrasts of specified means). 
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3,3.3 Experiment 3: Effects of Capsazepine and Ruthenium Red on RTX-induced 
Responses 
Capsazepine (30-100 )imol/kg), ruthenium red (0.3-3 |imol/kg), and their 
vehicle were given 30 min prior to the injection of RTX. During this pretreatment 
period, emesis was sometimes produced. A total of 0.2 土 0.2 to 2.7 土 2.3 episodes 
were observed (Figure 3.37A). 
RTX (100 nmol/kg) induced 6.5 土 3.1 episodes of vomiting in vehicle-treated 
animals (Figure 3.38A). Neither capsazepine (30-100 }j.mol/kg) nor ruthenium red 
(0.3-3 |Amol/kg) could significantly affect this response (p>0.05). However, there 
was a trend for ruthenium red to delay the onset of emesis (Figure 3.38B). At 3 
|amol/kg, ruthenium red was able to significantly prolong latency from 5.4 土 2.5 to 
.’ 32.3 ±5.3 min (p<0.05). 
There was also a non-significant trend for capsazepine and ruthenium red to 
antagonize RTX-induced genital grooming (Figure 3.38C). RTX elicited 14.3 土 9.1 
episodes of genital grooming in vehicle-pretreated animals. Ruthenium red- (3 
}imol/kg) and capsazepine- (30 |Limol/kg) pretreated animals had 0.3 土 0.3 and 0.5 土 
0.5 grooming episodes respectively (p>0.05). At 100 |j.mol/kg capsazepine, RTX did 
not elicit genital •grooming at all. However, statistical significance could not be 
reached (p>0.05), probably due to the reduced intensity of RTX-induced grooming in 
the control group. In Experiment 1，subcutaneous administration of RTX elicited a 
mean number of 31.5 土 7.5 grooming episodes in all animals (4 out of 4) (see Figure 
3.28C) while in this set of experiments, only 14.3 土 9.1 episodes were seen in 4 out 
of 6 animals. Latency was also delayed, being 96.9 土 23.8 min for the vehicle-RTX 
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group, as compared to 56.4 土 4.3 min in Experiment 1 (see Figure 3.28D). These 
differences, however, were not statistically significant (p>0.05). 
RTX produced a fall of 6.6 土 1.3 °C in body temperature that was not 
reversed by either capsazepine or ruthenium red (Figure 3.40). At 100 |imol/kg 
capsazepine and 3 |amol/kg ruthenium red, temperature decreases of 5.7 土 0.9°C and 
5.7 土 1.1。C were recorded (p>0.05). They were also inactive to alter the time course 
of body temperature change (Figure 3.39), except for 0.3 )j.mol/kg ruthenium red, 
which prolonged the hypothermia during the final stages of the observation period 
(p<0.05). It appeared that co-administration of RTX with the antagonists or vehicle 
extended the hypothermic response, as opposed to results obtained in earlier 
experiments. Body temperatures of the animals only partially recovered at the end of 
the experiment. 
• Animals used in this set of experiments exhibited different baseline 
locomotor activities (Figure 3.41 A). The vehicle-treated group travelled a distance of 
5800 土 700 cm during the habituation period while animals in the groups assigned to 
receive ruthenium red (3 ^imol/kg) and capsazepine (100 )j.mol/kg) travelled a 
distance of 3200 土 400 cm (p<0.05) and 2600 土 500 cm (p<0.01) respectively. 
Overall, for all three sets of experiments, pooled habituation data revealed that 
baseline activity differed between Experiment 1 and Experiment 3 (p<0.05; Figure 
3.41B). 
It is appropriate to recapitulate that from Experiment 1，RTX did not alter 
locomotor activity (see Figure 3.31) and from Experiment 2, capsazepine (100 
|amol/kg) and ruthenium red (0.3 fimol/kg) had an enhancing effect on spontaneous 
locomotor activity (see Figure 3.36). In the current set of experiments, capsazepine 
(30-100 }imol/kg) did not modify locomotor activity (p>0.05; Figure 3.42A). The 
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locomotor enhancing effect of 0.3 |amol/kg ruthenium red manifested at 150 and 180 • 
min post injection (p<0.05; Figure 3.42B). 
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Figure 3.37 Emesis observed during the 30 min pretreatment period with 
subcutaneously administered ruthenium red (RR; 0.3-3 |imol/kg), capsazepine (CZP; 
30-100 p-mol/kg), or their vehicle in Suncus murinus. Results are expressed as 
meardis.e.m., n=6. There are no significant differences between treatment groups 
(p>0.05, one-way ANOVA followed by Dunnett's Multiple Comparison Test). 
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Figure 3.38 The. effect of ruthenium red (RR; 0.3-3 |amol/kg, s.c.), capsazepine 
(CZP; 30-100 lamol/kg，s.c.), or their vehicle on resiniferatoxin (100 nmol/kg, s.c.)-
induced (A) emesis and (C) genital grooming. Results are expressed as mean+s.e.m., 
n=6. There are no significant differences between treatment groups (p>0.05, one-way 
ANOVA followed by Dunnett's Multiple Comparison Test). Respective latencies to 
first (B) emetic or (D) grooming episode are also shown. Open circles represent 
individual latencies. Horizontal lines represent the mean latencies of each treatment 
group. Significant differences are indicated as *p<0.05 (Kruskal-Wallis Test 
followed by Dunn's Multiple Comparison test). 
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Figure 3.39 Time course of the effect of resiniferatoxin (100 nmol/kg, s.c.) on body 
temperature, measured at 5 min intervals, after pretreatment with (A) capsazepine 
(30-100 jimol/kg，s.c.) and (B) ruthenium red (0.3-3 fxmol/kg, s.c.) in Suncus 
murinus. Symbols represent meanis.e.m., n=6. Open circles represent the control 
group. Filled circles or squares represent the respective treatment groups. The first 
vertical dotted line represents injection of capsazepine, ruthenium red, or their 
vehicle. The second vertical dotted line represents injection of resiniferatoxin. 
Significant differences from vehicle-treated animals are indicated as *p<0.05, 
**p<0.01, ***p<0.001 (Repeated measures two-factor ANOVA followed by pre-
planned contrasts of specified means). 
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Figure 3.40 Maximum temperature decrease within 60 min induced by 
subcutaneously administered RTX (100 nmol/kg) after pretreatment with ruthenium 
red (RR; 0.3-3 jiimol/kg，s.c.), capsazepine (CZP; 30-100 ^imol/kg, s.c.), or their 
vehicle in Suncus murinus. Results are expressed as mean+s.e.m., n=6. There are no 
significant differences between treatment groups (p>0.05, one-way ANOVA 
followed by Dunnett's Multiple Comparison Test). 
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Figure 3.41 Distance travelled during the 30 min habituation period by (A) Suncus 
‘murinus receiving resiniferatoxin (100 nmol/kg, s.c.) after pretreatment with 
ruthenium red (RR; 0.3-3 nmol/kg, s.c.), capsazepine (CZP; 30-100 fimol/kg, s.c.), 
or their vehicle, and (B) all the animals within each experiment. Results are 
expressed as mean土s.e.m.，n=6-30 (pooled data). Significant differences between 
‘ treatment groups are indicated as *p<0.05, **p<0.01 (one-way ANOVA followed by 
Bonferroni's Multiple Comparison Test). 
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Figure 3.42 Time course of the effect of resiniferatoxin (100 nmol/kg, s.c.) on 
spontaneous locomotor activity, measured at 30 min intervals, after pretreatment 
with (A) capsazepine (30-100 |amol/kg) and (B) ruthenium red (0.3-3 nmol/kg) 
administered subcutaneously in Suncus murinus. Results are expressed as 
mean±s.e.m., n=6. Significant differences from vehicle-treated animals are indicated 
as *p<0.05, **p<0.01, ***p<0.001 (Repeated measures two-factor ANOVA 
followed by pre-planned contrasts of specified means). 
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Chapter 4 Discussion 
In all experimental knowledge there are three phases: an observation is made, a 
comparison is established, and a judgement is rendered. 
----Claude Bernard (1813-1878) 
French physiologist 
4.1 General Considerations 
The logical approach to investigate the basic mechanisms of the emetic reflex 
is to identify key neurotransmitters involved in mediating emesis and the importance 
of their roles within the reflex. This also applies to the understanding of mechanisms 
for mediating hypothermia and grooming behaviour. The present studies used a 
neuropharmacological approach with surgical intervention to investigate the role of 
TRPVl in these pathways. It is undoubtedly desirable to use animal models that have 
a similar responsiveness to man. The present studies utilized the insectivore Suncus 
murinus, a species which responds to many drug treatments that are emetic in man, 
but which is also insensitive to stimuli such as apomorphine and ipecacuanha (Ueno 
et al, 1987). The failure of Suncus murinus to respond to treatments emetic in man 
may impact on the usefulness of this species in emetic research. Nevertheless, data 
obtained'from Suncus murinus may still reveal valuable information regarding drug 
mechanisms. In addition, Suncus murinus is smaller in size and relatively 
inexpensive. Experiments can be performed on this species before proceeding to 
more expensive ones, e.g. the ferret (Rupniak et al., 1997)，that are more human-like 
in emetic responsiveness. 
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There are two important considerations pertaining to the present studies. The 
first one is that the vanilloid receptor in Suncus murinus has not been systematically 
characterized. Knowledge of the potency and pungency of the vanilloids used in this 
study is based almost entirely on work done on rodents. It is possible that these 
compounds have a different profile of binding affinity and potency for the vanilloid 
receptor in Suncus murinus. The Suncus murinus has already been shown to possess 
pharmacologically distinct NKi receptors (Rudd et al., 1999b) and the vanilloid 
receptor is known to vary extensively from species to species (Szallasi, 1994). For 
example, PPAHV is an agonist in rat TRPVl but not human TRPVl (Mclntyre et al‘, 
2001); hamsters and rabbits are known for their insensitivity to vanilloids while 
guinea pigs display marked sensitivity to capsaicin (Szallasi, 1994); and olvanil is 
more potent than RTX to activate the guinea pig TRPVl (Savidge et al., 2002) where 
in other species RTX is invariably the more potent one (Jerman et al, 2000; 
Mclntyre et al, 2001; Smart et al, 2001). Secondly, the pharmacokinetic properties 
of the vanilloids in Suncus murinus are not known. There is no available data 
regarding tissue penetration, distribution, and metabolism of these compounds 
following i.c.v. administration in Suncus murinus. This lack of knowledge may 
somewhat undermine valid interpretations of the data. 
Relative potencies are conventionally determined by comparing EC50 values. 
Unfortunately, EC50 values in the present studies could not be easily estimated, since 
resiniferatoxin sometimes produced bell-shaped curves and maximal responses had 
‘ not always been determined. Therefore, in order to give an approximate idea of the 
relative potencies between the drugs, threshold doses were compared instead. This 
approach gives only approximations and should not be viewed as absolute figures. 
However, it is sufficient to generate rank orders of potency for the vanilloids. 
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Determining rank orders of potency of agonists is one method of classifying receptor 
subtypes in the absence of selective antagonists. Historically, it has led to the 
successful identification of a- and P-adrenoceptors (Rang et al., 1999). An alternative 
method is to examine the differential actions of various antagonists. This is a more 
popular and reliable method to classify receptors than using rank orders of potency. 
Since no subtypes of vanilloid receptors have yet been identified, the information 
that has been generated could potentially aid in the classification of vanilloid 
receptors. 
Throughout the present studies, variability in the emetic sensitivities of 
Suncus murinus was observed. Copper sulphate was previously shown to produce 
consistent emesis (Rudd et al,, 1999a) and subsequently became the choice as the 
reference emetogen for this study. However, the response to copper sulphate 
obtained in the present studies was less consistent than previously reported and 
varied from experiment to experiment. Moreover, the emetic sensitivity to vanilloid 
agonists may have somewhat shifted, such that later experiments failed to replicate 
the results obtained in earlier experiments. The reason behind this is unknown but 
may reflect a seasonal variation, as the work done in this thesis was performed over a 
two-year period. • 
As the central and peripheral studies in this work were performed in male and 
_ female animals respectively, the issue of a fundamental sex difference in emetic 
sensitivity and physiology arises when comparisons of results obtained from the 
different sexes were made. Information from the literature regarding the regulation of 
body temperature and locomotor activity of Suncus murinus was unfortunately only 
available for adult males (Ishii et al, 2002). A sex difference in emetic 
responsiveness, however, had been previously investigated (Matsuki et al, 1997). 
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Briefly, male and female Suncus murinus showed no significant differences in the 
emetic response to cisplatin，copper sulphate, and nicotine. Male animals are more 
sensitive to serotonin and more susceptible to motion than females, and tropisetron, a 
5-HT3 receptor antagonist, was less effective against cisplatin-induced emesis in 
females than in males. It should also be noted that female Suncus murinus are 
induced ovulators and do not exhibit an ovarian cycle (Matsuki et al., 1997). 
4.2 Emetic Action of Vanilloids 
Resiniferatoxin, capsaicin, and PPAHV were emetic when administered into 
the ventricular system of Suncus murinus. Resiniferatoxin produced emesis in a bell-
shaped manner while capsaicin and PPAHV exhibited linear dose-dependency within 
the dose ranges used. It remains possible that the linearity observed for the drugs 
r 
represented the left half of an otherwise bell-shaped curve. Bell-shaped responses 
may reflect neuropeptide depletion and/or receptor desensitization. At high 
concentrations of agonists, stimulation of TRPVl progresses at a very rapid speed, 
such that the receptor gets desensitized before its activation can be transduced to a 
full-blown response. Alternatively, capsaicin has been shown to evoke anandamide 
production via a capsazepine-sensitive mechanism in primary sensory neurons 
..(Ahluwalia et al., 2003b). Anandamide, in turn, can activate the CBi receptor to 
produce inhibition of neuropeptide release (Ahluwalia et al, 2003a). Therefore, it is 
possible that bell-shaped curves reflect increased anandamide production, hence 
increased CBi-mediated inhibition, evoked by high doses of vanilloids. This assumes 
that the CBi receptor and TRPVl are analogously coexpressed in the brain. Whether 
such a parallel mechanism as observed in sensory neurons exists in the emetic 
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circuitry is unknown but could be determined by measuring possible anandamide 
release following vanilloid application to brain stem slices. 
Olvanil was the only agent that did not elicit significant emesis. Nonetheless, 
upon inspection of the data generated, it is tempting to believe that olvanil was, in the 
least, weakly emetic. The dose-response curve for olvanil appeared to be smoothly 
bell-shaped. The intrinsic emetic effect of DMSO might have complicated the 
interpretation of results. DMSO-induced emesis generally had longer, more scattered, 
and less consistent latencies. In humans, systemic side effects of DMSO include 
headaches, dizziness, and nausea (Swanson, 1985). The choice of DMSO as the 
vehicle for olvanil was unfortunate but unavoidable, since central injections employ 
minute injection volumes (5 |iL), which translates into very concentrated drug 
solutions. The common vehicle tween/ethanol/saline could not solubilize olvanil at 
the required concentrations. Geraghty and Mazzone (2002) used 25-35% ethanol in 
saline as their vehicle for olvanil injections into the NTS, but their stock 
concentration was still six times more dilute than the one used in the present 
experiment. Moreover, high concentrations of ethanol should be avoided since it is 
also emetic (Chen et al, 1997). It remains to be determined whether a more suitable 
vehicle exists. Nevertheless, it might be too early to conclude that olvanil is non-
emetic, as emesis had been observed. It is perhaps justified to say that the emetic 
potential of olvanil awaits further confirmation. 
Resiniferatoxin is known to be the ultrapotent analogue of capsaicin, its 
relative potency being dependent on the response system measured. It is 10,000 
times more potent than capsaicin to inhibit electrically-evoked twitching in rat vas 
deferens (Maggi et al, 1990) and 300 times more so to induce neurogenic 
inflammation (Szallasi & Blumberg，1989). In the present experiment, the threshold 
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dose for resiniferatoxin-induced emesis following i.c.v. administration was below 0.1 
nmol while that for PPAHV was 10 nmol. Therefore, resiniferatoxin was at least 100 
times more potent than PPAHV. The threshold dose for capsaicin was 30 nmol, 
indicating that resiniferatoxin was at least 300 times more potent than capsaicin. 
Thus, the rank order of potency is resiniferatoxin > PPAHV > capsaicin » > olvanil. 
A full dose-response curve was not constructed for peripherally injected 
resiniferatoxin. At 100 nmol/kg s.c., resiniferatoxin elicited emesis with an intensity 
similar to that elicited by central administration. Latency to emesis was not 
substantially affected by the route of administration; animals receiving subcutaneous 
injections of resiniferatoxin had latencies that were only two to three minutes longer 
than those receiving the drug centrally. In general, the latencies to vanilloid-induced 
emesis are comparable with the latencies to fast-acting emetic treatments such as 
copper sulphate and nicotine. In Suncus murinus, nicotine and copper sulphate had 
latencies of less than 5 min (Rudd et al., 1999b). Agents with relatively quick onset 
of action generally induce emesis via direct mechanisms. Nicotine is believed to act 
via nicotinic receptors in the area postrema (Beleslin & Krstic，1987) and the 
mechanism for copper sulphate-induced emesis is thought to involve gastric irritation 
and vagal stimulation (Wang & Borison, 1952). Emetogens acting via multiple or 
indirect pathways such as cisplatin, which is putatively metabolised to generate a 
reactive species that induces 5-HT release from enterochromaffm cells (Chen et aL, 
1997)，have substantially longer latencies. In the ferret, cisplatin-induced emesis had 
a latency of 1.7 hours (Rudd et al, 1996). Therefore, it is conceivable that emesis to 
vanilloids is mediated via straightforward and direct mechanisms. 
The exact mechanism of vanilloid-induced emesis has not yet been fully 
elucidated, but it is commonly believed to involve a release of substance P in the 
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nucleus tractus solitarius (Andrews et al, 2000; Shiroshita et al, 1997). 
Resiniferatoxin induced c-fos expression in the area postrema, nucleus tractus 
solitarius, and the dorsal motor nucleus of the vagus in Suncus murinus (Andrews et 
a/.，2000). The presence of substance P immimoreactivity in these brain areas 
provides circumstantial evidence (Ariumui et al., 2000; Watson et al, 1995). In vitro, 
resiniferatoxin induced a release of immunoreactive substance P from the dorsal 
vagal complex (Toyoda et al., personal communication). In the dog, substance P 
elicited emesis when given intravenously (Carpenter et al., 1984) although Wu et al 
(1985) failed to observe emesis when substance P was administered into the fourth 
ventricle. Substance P also excited 48% of the neurons of the area postrema (AP), as 
opposed to 86% by apomorphine and 66% by 5-HT (Carpenter et al., 1984). 
Glutamate, on the other hand, produced excitation in 99% of the AP neurons 
(Carpenter et al, 1984). Application of glutamate on AP neurons resulted in a dose-
dependent increase in intracellular calcium (Hay & Lindsley，1999). Both NMDA 
and non-NMDA glutamate receptors have been shown to take part in the 
transmission pathway between the area postrema and the nucleus tractus solitarius 
(Aylwin et aL, 1998) and capsaicin has been shown to elicit glutamate release 
(Morgado-Valle & Feldman, 2004). Therefore, a possible involvement of glutamate, 
in addition to substance P, in vanilloid-induced vomiting should not be neglected. It 
was demonstrated that capsaicin application could lead to parallel increases in 
glutamate and substance P release from dorsal horn slices of the rat (Ueda et al., 
1994). The role of CGRP in the emetic reflex has not been firmly established, but 
CGRP immunoreactivity identified in the nucleus tractus solitarius has led to it being 
proposed as a neurotransmitter in vagal afferents (Andrews & Bhandari，1993). 
CGRP is known to partake in the extracranial vasodilatation event in migraine and 
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nausea and vomiting can occur during migraine attacks (Dahlof & Hargreaves, 1998). 
Capsaicin increased blood flow in the dura mater via CGRP release (Dux et al, 2003) 
and TRPVl on-trigeminal sensory nerves plays a role, albeit minor, in neurogenic 
vasodilatation, which is the trigger for migraine attacks (Akerman et al., 2003). To 
firmly establish the participation of glutamate, substance P，and CGRP in vanilloid-
induced emesis, it is necessary to determine whether the antagonists for the receptors 
of these transmitters could inhibit emesis, and whether administration of these 
substances or their receptor agonists can mimic vanilloid-induced emesis (see Figure 
4.1 for summary). 
In the present experiment, subcutaneously injected resiniferatoxin (100 
nmol/kg) induced an approximate of 9 vomiting episodes with a latency of 6.5 min. 
The i.c.v. dose of resiniferatoxin required to produce emesis of similar intensity was 
0.1 nmol (approximately 8 episodes; latency 4.5 min), or 2 nmol/kg, assuming that 
the animals weighed 50 g on average. Therefore, there was a 50 times difference 
between the i.c.v. and subcutaneous doses of resiniferatoxin. Apomorphine, an 
emetic agent known to act centrally, was reported to have a difference of 30-50 times 
in threshold emetic doses when administered centrally as compared to peripherally in 
the dog (Harding et al, 1987). The rapid action of subcutaneous resiniferatoxin 
might have indicated a peripheral mechanism for emesis, but the relative difference 
between i.c.v. and s.c. doses lends support for a central mechanism instead. Latencies 
might be a better reflection of pharmacokinetic properties rather than the site of 
action. If the receptor is located in deeper brain areas, then the drug would take more 
time to penetrate from the ventricular system to the required site; but if peripheral 
sites are easily accessible, then peripheral injections could still have a rapid onset. So 
far, although evidence tends to point to a central site of action, a peripheral 
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component cannot be definitively excluded. Vagotomy could produce a reduction in 
the number of emetic episodes (Andrews et al, 2000). To ascertain the mechanism 
and site of action of resiniferatoxin, it would be necessary to do precise intracerebral 
injections into specific brain areas e.g. the nucleus tractus solitarius. 
The reason underlying the unique emetic action of vanilloids in Suncus 
murinus remains unknown. Resiniferatoxin did not induce observable emesis in 
species such as the ferret (Andrews & Bhandari，1993) or the dog (Yamakuni et al., 
2002), although in these studies, a full dose-response curve was not constructed. In 
the ferret, only a dose of 100 fig/kg, s.c. resiniferatoxin was tested (Andrews & 
Bhandari, 1993) while 10 |ig/kg, s.c. was administered to the dog (Yamakuni et cd., 
2002). It is possible that higher or lower doses might elicit emesis in these species, 
since resiniferatoxin induces emesis in a bell-shaped manner. However, these doses 
(10 and 100 )ig/kg) were sufficient to produce significant emesis in Suncus murinus 
(Andrews et al, 2000). Species differences may also contribute to this discrepancy. 
The NKi receptor in Suncus murinus was discovered to be pharmacologically unique 
(Rudd et al, 1999b). It is equally likely that the vanilloid receptor in this species is 
also unique, as the vanilloid receptor is known to exhibit species variation (Szallasi, 
1994). Emesis to resiniferatoxin was previously found to be inhibited by the broad 
inhibitory anti-emetics 8-OH-DPAT, CP-99,994, and morphine, as well as by 
-ruthenium red and resiniferatoxin itself (Andrews et al, 2000; Rudd & Wai，2001). It 
was insensitive to capsazepine, the 5-HT3 receptor antagonist tropisetron, and 
capsaicin (Andrews et al., 2000; Rudd & Wai, 2001). Although CP-99,994 
antagonized emesis to resiniferatoxin, due to its broad inhibitory nature, the blockade 
could only be considered as limited support for the proposal that central release of 
substance P mediates resiniferatoxin-induced emesis. 
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A primary aim of the present study was to determine the relationship between 
pungency and emetic ability. PPAHV, the non-pungent analogue of resiniferatoxin, 
evoked significant emesis, although the emetic potential of the non-pungent 
capsaicin analogue olvanil was ambiguous. Thus, a clear relationship between 
pungency and emetic ability cannot be readily delineated. The present studies do not 
support the notion that a compound's known pungency is a direct index of its emetic 
ability. The mechanism behind pungency/non-pungency is still unresolved, although 
a popular belief is that non-pungent compounds have slower channel activation 
kinetics (Liu & Simon, 1997). Conversely, lida et al (2003) demonstrated that the 
non-pungent capsaicin analogue, capsiate, induced nociceptive responses in mice 
when injected subcutaneously into their hindpaws. This led them to postulate that the 
lack of pungency of capsiate is due to its inaccessibility to free nerve endings rather 
than its inability to activate them (lida et al., 2003). The route of administration, 
therefore, accounts for the outcome of studies investigating potential pungency. 
However, intradermal injection of olvanil did not evoke C-fibre activation 
(Dickenson et al, 1990) but this may be due to the extensive metabolism olvanil 
undergoes in the rat skin (Kasting et al, 1997). According to previous studies, 
capsaicin analogues required a carbon side chain of a certain length for them to be 
pungent; longer or shorter chains rendered them less pungent (Szolcsanyi & Jancso-
.Gabor, 1975). Therefore, the correct degree of lipophilicity is critical. In the present 
studies； administration of vanilloids into the cerebral ventricle exposed them directly 
to vanilloid receptors located in the vicinity of the ventricular system. It is necessary 
to determine whether the emetic potential of the non-pungent PPAHV is also 
dependent on route of administration in order to provide support for the lipophilicity-
pungency hypothesis. 
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The TRPVl antagonist capsazepine (i.c.v. or s.c.) did not significantly reduce 
the number of emetic episodes evoked by resiniferatoxin (i.c.v. or s.c.). Ruthenium 
red (s.c.) also did not inhibit resiniferatoxin-induced emesis, which contrasts with our 
previous results (Rudd & Wai，2001). This discrepancy could be due to differences in 
routes of administration, as previous studies employed i.c.v. injection of 
resiniferatoxin and ruthenium red while the present studies examined the effects of 
the drugs administered subcutaneously. However, ruthenium red did significantly 
delay the onset of emesis. The pretreatment time for peripherally injected antagonists 
was longer (30 min) than the time allowed for central injections (15 min). If the 
action of ruthenium red is short lasting, then the increase in latency could represent a 
fading of the effect of ruthenium red and a return of the emetic response. Therefore, 
it can be inferred that emesis induced by resiniferatoxin is mediated via ruthenium 
red-sensitive mechanisms, which is consistent with our previous results. 
Unfortunately, the effect of capsazepine on capsaicin- and PPAHV-induced 
emesis could not be determined from the present studies. Capsaicin and PPAHV, at 
doses that were found to be emetic in the agonist studies, did not elicit significant 
emetic responses in subsequent antagonist studies. The reason for this is unclear but 
will be addressed in the following sections. Previously, capsaicin-induced emesis 
was antagonized by both capsazepine and ruthenium red (Rudd & Wai, 2001). This 
difference in pharmacological sensitivity to capsazepine may indicate that 
resiniferatoxin and capsaicin act on different domains on the vanilloid receptor or via 
different receptor subtypes to produce emesis. It was shown that point mutations 
could be introduced to the rat TRPVl to decrease capsaicin sensitivity while leaving 
sensitivity to resiniferatoxin unaffected (Gavva et al, 2004). 
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4.3 Anti-Emetic Action of Vanilloids 
The reference emetogen chosen was intragastrically administered copper 
sulphate. Emesis induced by copper sulphate results from gastric irritation and/or 
stimulation of osmoreceptors, involving the vagal and splanchnic nerves (Andrews et 
a l , 1990; Wang & Borison, 1952). It is a commonly used emetic agent in the ferret 
(Saito et aL, 1998) and Suncus murinus (Rudd et al., 1999a). This model of emesis 
may be useful to mimic clinical situations where disturbance of the gastrointestinal 
tract contributes to the generation of emesis. Copper sulphate induced dose-
dependent emesis in Suncus murinus with 100% of the animals responding (Rudd et 
a l , 1999a). The dose of 120 mg/kg was selected based upon this study. 
Despite the ambiguity over olvanil's emetic potential, its anti-emetic potential 
was quite evident. In fact, olvanil was the only agent that was anti-emetic across all 
the doses tested. In general, the anti-emetic action of vanilloids was dose-related. 
Resiniferatoxin and olvanil were capable of achieving complete antagonism, while 
capsaicin and PPAHV only produced partial inhibition at their respective highest 
doses. There is, however, one caveat: emesis evoked by copper sulphate during 
experiments with resiniferatoxin was of reduced magnitude as compared to emesis 
evoked during experiments with other vanilloids. This might have rendered 
resiniferatoxin to appear more potent than other vanilloids, since there were fewer 
episodes that needed to be suppressed. Nevertheless, the high potency of 
resiniferatoxin was equally evident in later studies with capsazepine, where the 
sensitivity to copper sulphate was higher. Previous studies had also demonstrated 
complete antagonism of copper sulphate-induced emesis by resiniferatoxin and 
partial antagonism by capsaicin (Rudd & Wai, 2001). It has not been investigated 
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whether higher doses of capsaicin and PPAHV could also result in complete 
blockade. 
The NKi receptor antagonists similarly produced only partial antagonism 
against copper sulphate-induced emesis in Suncus murinus (Rudd et al, 1999b). The 
maximum reduction observed was about 80% by CP-122,721 (Rudd et al., 1999b). 
This extent of antagonism was slightly less, but comparable, to the anti-emetic 
efficacy of capsaicin and PPAHV, which produced maximum reductions of 87% and 
88% respectively. In the ferret, emesis to low dose of copper sulphate (12.5 mg/kg) 
was completely antagonized by CP-122,721 (Gonsalves et aL, 1996) but only partial 
inhibition was obtained with a higher dose (40 mg/kg) (Bountra et al., 1993). The 
similar extent of antagonism of copper sulphate-induced emesis by the NKi receptor 
antagonists and the vanilloids capsaicin and PPAHV provides some support for the 
sharing of parallel mechanisms between the two types of anti-emetics. Vanilloids 
could achieve "blockade" of the NKi receptor by depleting substance P and/or 
desensitizing the receptor. It was suggested that high dose of copper sulphate induces 
emesis with a small NKi receptor antagonist-resistant component (Rudd et al, 
1999b). This component, however, was completely antagonized by resiniferatoxin 
and olvanil, indicating .an advantage of these compounds over the NKi receptor 
antagonists. It is likely that resiniferatoxin and olvanil prevent emesis via additional 
pathways involving unidentified transmitter systems that account for the residual 
component. 
The threshold doses for the anti-emetic action of resiniferatoxin, PPAHV, and 
capsaicin were 0.3，10，and 30 nmol respectively. In other words, resiniferatoxin was 
33 times more potent than PPAHV and 100 times more so than capsaicin. Olvanil 
was highly anti-emetic at 10 nmol, the lowest dose tested, so its threshold dose 
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should lie substantially below 10 nmol. It is deemed inappropriate to make this 
estimation of relative potency since olvanil could either be less potent, equally potent, 
or even more potent than resiniferatoxin. Based on this, the rank order of anti-emetic 
potency is resiniferatoxin ~ olvanil > PPAHV > capsaicin. 
For resiniferatoxin, capsaicin, and PPAHV, the effective anti-emetic doses 
closely overlapped those that had produced significant emesis. Another objective of 
this study was to determine whether emesis and anti-emesis could be dissociated. It 
seemed that no such dissociation was possible, although only a limited range of 
compounds was being used. However, this conforms with the speculation that initial 
release of substance P in the nucleus tractus solitarius is the basis for the emetic 
action of vanilloids while subsequent substance P depletion underlies their anti-
emetic action (Andrews et al, 2000). In other words, anti-emesis may be a natural 
consequence of prior emesis. In the decerebrate dog, capsaicin and resiniferatoxin 
initially evoked firing of the medial solitary nucleus neurons before reducing 
neuronal firing induced by electrical stimulation of vagal afferents (Shiroshita et al., 
1997). Certainly, additional mechanisms such as the inhibition of voltage-gated 
calcium channels, desensitization of the NKi and/or vanilloid receptors, and receptor 
downregulation are also possible contributing factors (Andrews et al., 2000). 
In the present study, resiniferatoxin was given 2.5 hours prior to copper 
-sulphate. In the ferret, resiniferatoxin was given 30 min and 16 hours prior to 
cisplatin injection (Yamakuni et al, 2002) and 3 hours prior to radiation, copper 
sulphate, and loperamide challenge (Andrews & Bhandari，1993). Therefore, given 
prophylactically, resiniferatoxin was highly effective to inhibit emesis. Even when 
administered 3-5 min before radiation, resiniferatoxin was still effective to abolish 
emesis (Andrews & Bhandari，1993). However, when resiniferatoxin was given 1 
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min after the start of emesis to radiation or 6-10 min after the start of emesis to 
loperamide, the anti-emetic efficacy of resiniferatoxin became non-significant 
(Andrews & Bhandari, 1993). Thus, it appears that the timing of resiniferatoxin 
treatment is crucial in determining its anti-emetic efficacy. If resiniferatoxin needs to 
deplete substance P before it can exert anti-emetic actions, then the question arises as 
to how long does it take for the substance P stored in the emetic circuits to be 
depleted. When cisplatin was administered to Suncus murinus, the animals can vomit 
continually for 4-6 hours (Sam et al, 2001). Yet, resiniferatoxin can presumably 
deplete substance P within 3-5 minutes (Andrews & Bhandari，1993). Therefore, 
even though the NKi antagonists are broad inhibitory and the NKi receptor is located 
at a convergence point late in the emetic reflex, substance P alone is insufficient for 
the generation of emesis. The NKi-resistant component of copper sulphate-induced 
emesis (Rudd et al, 1999b) is a good illustration of the participation of other 
neurotransmitters. 
The added action of vanilloids on glutamatergic systems may enhance their 
broad-spectrum anti-emetic efficacy by additionally depleting glutamate. Vagal 
stimulation-evoked fictive retching in the dog was abolished in the presence of 
NBQX, a non-NMDA receptor antagonist (Furukawa et al, 1998). NBQX and the 
NMDA antagonist dextrometorphan both inhibited cisplatin-induced emesis in the 
,ferret (Fink-Jensen et al, 1992; Lehmann & Karrberg, 1996). It was proposed that 
glutamate acts as the excitatory neurotransmitter in the transmission of emetic signals 
from vagal afferents to the NTS while NKi receptors take part in the output pathway 
from the NTS to the central pattern generator (Furukawa et al., 1998). This is 
supported by the observation that an intact area postrema was not required for the 
anti-emetic action of CP-99,994 (Andrews et al, 2001). Therefore, the broad 
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Figure 4.1 A. diagram summarizing the putative sites of actions and 
neurotransmitters implicated in mediating the emetic and anti-emetic actions of 
vanilloids. Activation of TRPVl receptors in vagal terminals and AP releases and 
subsequently depletes substance P and glutamate. Only substance P is believed to 
partake in the transmission between the NTS and CPG. The CPG generates the 
motor components of vomiting while pathways responsible for mediating nausea 
are unknown. Glu, glutamate; GluR, glutamate receptors; SP, substance P; NTS, 
nucleus tractus solitarius; AP, area postrema; CPG, central pattern generator 
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inhibitory anti-emetic efficacy of vanilloids may reside in their ability to affect two 
sequential pathways along the same reflex (see Figure 4.1). 
Olvanil- presents a possible challenge to the hypothesis of substance P 
depletion as the basis for the anti-emetic action of vanilloids. Olvanil's emetic ability 
was not significant, but its antagonism of copper sulphate-induced emesis was highly 
potent. Should olvanil really possess dissociated emetic and anti-emetic ability, its 
slow activation kinetics could be the underlying mechanism for its anti-emetic action 
(Liu et al, 1997). This dissociation is desirable in making the vanilloids clinically 
useful as anti-emetic drugs. Since the lowest dose of olvanil (10 nmol) was only 
weakly emetic but highly anti-emetic, it is not unlikely that lower doses would cease 
to be emetic yet remain anti-emetic, although no conclusions can be drawn at this 
moment before its emetic potential can be firmly established and characterized. 
Among the vanilloids tested in the present studies, olvanil displayed the 
highest affinity for the CBi receptor - it only has a four times higher affinity for 
TRPVl than for the CBi receptor (Kj for TRPVl = 0.4 ^iM; for CBi = 1.6 |iM) (Di 
Marzo et cd., 1998; Szallasi et al., 1999b). At higher concentrations (Kj = 14.1 |aM), 
it can even potentiate the action of anandamide by inhibiting the anandamide 
membrane transporter (Beltramo & Piomelli, 1999). Therefore, it is conceivable that 
CBi stimulation could contribute to some extent to the effects of olvanil. Di Marzo et 
al. (1998) had previously speculated that the analgesic action of olvanil might be due 
in part to CBi stimulation. CBi receptor agonists, such as tetrahydrocannabinol 
(THC)，the active principle from marijuana, and nabilone, the synthetic cannabinoid, 
are anti-emetic agents (Mitchelson, 1992a). Nabilone prevented vomiting by 
apomorphine and several anti-cancer drugs (London et al, 1979) and THC inhibited 
cisplatin-induced emesis in the least shrew (Darmani, 2001b). CBi receptor 
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immunoreactivity is present in the dorsal motor nucleus of the vagus, the nucleus 
tractus solitarius, as well as the area postrema (Van Sickle et al, 2003). However, 
cannabinoids are rarely used as anti-emetic drugs since side effects are common 
(Mitchelson, 1992a). Concomitant activation of the CBi receptor by olvanil may 
therefore contribute to its unusually high anti-emetic potency. Although there have 
been no reports on the anti-emetic action of CBi receptor agonists against copper 
sulphate-induced emesis, THC was effective in inhibiting emesis induced by 
intragastric hypertonic saline, which, similar to copper sulphate, causes gastric 
irritation by the stimulation of osmoreceptors (Van Sickle et al, 2003). Experiments 
using a selective CBi receptor antagonist could help clarify the participation of CBi 
in the anti-emetic action of olvanil. 
It is important to note that CP-122,721 was ineffective to increase the latency 
to copper sulphate-induced emesis (Gonsalves et al, 1996). Capsaicin similarly had 
no effect on latency, but PPAHV at the highest dose significantly delayed the onset 
of emesis. Although resiniferatoxin and olvanil also did not have observable effects 
on latency, one needs to be cautious since 0.3-10 nmol resiniferatoxin and 10 nmol 
olvanil had no animals responding to copper sulphate and only one animal responded 
to each of 30 and 100. nmol olvanil. Since PPAHV is the structural analogue of 
resiniferatoxin, it is not unreasonable to expect that it might exhibit pharmacological 
resemblance to resiniferatoxin. The action of PPAHV to delay the onset of copper 
sulphafe-induced emesis might be a reflection of its similar ability as resiniferatoxin 
to antagonize the residual component, but with a reduced efficacy or shorter duration 
of action. 
Conventional anti-emetics act by blocking emetic input at afferent sites 
before they converge at the vomiting center, thereby inhibiting the generation of both 
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emesis and nausea (Mitchelson, 1992a; Mitchelson, 1992b). Broad-spectrum anti-
emetic drugs act at a central site to prevent the generation of emesis (Tattersall et al., 
1996). The mode of connectivity between pathways responsible for the generation of 
nausea and those for the generation of emesis is not known. The failure of broad-
inhibitory drugs to delay the onset of emesis (Gonsalves et a!., 1996) and to prevent 
nausea (Reid et al, 2000) indicates that although mechanisms for the motor output of 
emesis are being antagonized, pathways for inducing nausea are still being activated. 
In the clinic, the control of nausea is of no less importance than the control of 
vomiting (Morrow et al, 2002). Since the possible mechanism for the anti-emetic 
action of vanilloids does not lie simply in the disruption of substance P fiinctioning 
but also in the modulation of glutamate and CGRP release and/or other unknown 
neurotransmitters, they could be superior to NKi receptor antagonists in the 
treatment of nausea. Nevertheless, except for PPAHV, none of the other vanilloids 
could significantly delay the onset of copper sulphate-induced emesis. Therefore, 
despite the high efficacy of resiniferatoxin and olvanil to inhibit emesis, their ability 
to prevent nausea is still uncertain. Previous attempts have been made to measure 
nausea in Suncus murinus using the pica model. However, cisplatin (5-30 mg/kg) 
failed to induce pica behavior in Suncus murinus (J.A.Rudd, personal communication) 
while a dose of 3 mg/kg was sufficient to induce pica in rats (Rudd et al., 2002). 
Thus, measurements of nausea in Suncus murinus appear problematic. 
It is by no means a universal phenomenon for anti-emetic drugs to produce 
emesis prior to blocking emesis. Therefore, whether the reduced response to copper 
sulphate was due to the failure of the animals to respond specifically to copper 
sulphate or a refractory emetic reflex in general was uncertain. Control experiments 
to examine the interdependence of consecutive emetic challenges had not been 
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undertaken in the present studies but were performed by Andrews et al. (2000) in 
Suncus murinus. Two consecutive emetic challenges were given 60 min apart. Prior 
nicotine administration delayed the latency of a second nicotine challenge and the 
number of episodes was non-significantly reduced. The response to resiniferatoxin 
given 60 min after nicotine challenge had increased latencies and reduced number of 
episodes. Animals in which prior emesis was induced by motion responded to 
resiniferatoxin with reduced number of episodes and the latency was non-
significantly increased. Therefore, generally speaking, the second emetic response in 
a series of consecutive emetic challenges might have reduced intensity and delayed 
onset. If this were the case, then the anti-emetic potency of vanilloids could be 
exaggerated, since vehicle-treated animals did not experience emesis prior to the 
administration of copper sulphate and may thus retain a higher responsiveness to 
copper sulphate as compared to vanilloid-treated, and previously vomited, animals. It 
is important to bear these results in mind as they also have relevance to later 
experiments in the present studies. 
Capsazepine did not affect the anti-emetic action of resiniferatoxin against 
copper sulphate. Complete antagonism of copper sulphate-induced emesis was 
obtained with 3 nmol. resiniferatoxin in the presence of 300 nmol capsazepine. 
Capsazepine by itself had no anti-emetic action against copper sulphate. It was 
mentioned earlier that there was no dissociation between vanilloid-induced emesis 
and ariti-emesis. The speculation is that prior activation of TRPVl or NKi receptors 
(i.e. emesis) is needed for subsequent desensitization of receptors and/or depletion of 
neurotransmitters (i.e. anti-emesis). As capsazepine failed to prevent emesis to 
resiniferatoxin, it is consistent with this hypothesis that capsazepine will also fail to 
affect its anti-emetic action, as emesis had already occurred. Again it is unfortunate 
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that capsaicin and PPAHV failed to be anti-emetic in these antagonist studies and the 
effect of capsazepine on the actions of these drugs could not be determined. 
Serotonin and prostaglandins could, under pathological conditions, induce 
TRPVl activity (Kress et aL, 1997; Vyklicky et al., 1998). These substances are 
implicated in the genesis of chemotherapy-induced acute/delayed emesis, as 
exemplified by the effectiveness of 5 - H T 3 receptor antagonists and dexamethasone in 
preventing emesis to chemotherapeutic agents (Naylor & Rudd，1996). This raises 
the possibility that serotonin, prostaglandin, and other lipid metabolites of 
arachidonic acid partly contribute to the induction of chemotherapy-induced emesis 
by activating TRPVl. If so, then a TRPVl antagonist could potentially be effective 
to at least partially inhibit chemotherapy-induced emesis. In the rat, capsazepine 
could antagonize carrageenan- and formalin-induced hyperalgesia (Szallasi & 
Blumberg, 1999). The potential anti-emetic effect of ruthenium red is equally 
interesting. The ability of resiniferatoxin to desensitize TRPVl，thus precluding one 
pathway via which serotonin and prostaglandin induce emesis, could further enhance 
its efficacy in preventing chemotherapy-induced emesis. Nevertheless, the activation 
of 5 - H T 3 receptors is known to be a major contributor to chemotherapy-induced 
acute emesis (Naylor & Rudd, 1996); preventing TRPVl activation by serotonin 
could perhaps produce only a minor effect. 
4.4 Hypothermic Action of Vanilloids 
Suncus murinus is a nocturnal animal with unique physiological properties, 
especially in the regulation of body temperature. A 10-day monitoring of the 
physiology of male adult Suncus murinus revealed short-term periodicity as well as 
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daily fluctuation in body temperature (Ishii et al, 2002). Body temperature oscillates 
between 34-37 °C and, once daily, is lowered to approximately 30 °C or below (Ishii 
et al, 2002). The fact that the body temperature of Suncus murinus periodically 
drops from 37 °C to 34°C coincides with our observation that the body temperatures 
of control animals gradually decreased to 34 °C during the experiments. The daily 
lowering of body temperature down to 30 °C occurs mostly during the light period 
and progresses over a period of three to four hours (Ishii et al, 2002). This state of 
lowered body temperature, referred to as "daily torpor", presumably occurs to 
conserve energy expenditure (Ishii et al, 2002). There was no indication that "daily 
torpor" had occurred during our studies. 
The conventional method for measuring core body temperature is to insert a 
rectal probe into the animal. Measuring temperature by telemetry is a more 
convenient method when repeated measurements need to be made over long periods 
of time. The telemetry system also avoids creating stress to the animals during the 
insertion of the probe, which in turn might affect accurate temperature 
measurements. The telemetry transmitter is originally designed for implantation into 
the peritoneal cavity. However, carrying a transmitter in the abdomen impedes the 
animal's mobility, and -since it is also an objective of this study to determine 
locomotor activity changes, the transmitter was implanted subcutaneously on the 
back of the animals instead. The transmitter was implanted in such an orientation that 
the thermosensor faced the animal's body and away from the skin, so that it was 
more likely to detect gross body temperature changes more representative of core 
body temperature rather than changes in skin temperature that may be due to 
alterations in blood flow. Therefore, it is a limit of the present study that temperature 
134 
Chapter 4 - Discussion 
measurements may not reflect true core body temperature. Temperature 
measurements are therefore referred to only as "body temperature". 
Dose-dependent hypothermia was produced by resiniferatoxin, capsaicin, and 
PPAHV. Resiniferatoxin elicited the greatest temperature decrease, producing a 
reduction of � 5 °C in body temperature within 30 min of injection. The magnitudes 
of capsaicin- and PPAHV-induced hypothermia were in the ballpark of � 2 °C. The 
duration of PPAHV-induced hypothermia appeared to be longer than that of 
resiniferatoxin, as PPAHV required more time for body temperature to recover in 
spite of a smaller temperature reduction. Capsaicin had the shortest duration of action 
and the smallest magnitude of temperature decrease. When given subcutaneously, 
resiniferatoxin produced a greater hypothermic response that persisted for a much 
longer period of time. The maximum temperature drop recorded was more than 6 
and hypothermia lasted for about two hours, a duration that doubled the period 
observed for centrally injected resiniferatoxin. The rate of temperature decrease was, 
however, similar between the two routes of administration, both reaching a 
maximum low at or around 30 min post injection. The prolonged hypothermia seen 
with peripheral administration could be attributed to a slower recovery rate. This 
suggests that vanilloid-induced hypothermia could potentially have two components 
to it - a central component that has a fast onset but shorter duration and a longer 
lasting peripheral component that enters at a later time or that requires more time to 
manifest. The central component could reflect vanilloid-mediated stimulation of 
warm-sensitive neurons in the pre-optic area (Jancso-Gabor et al, 1970b) and the 
ensuing activation of heat regulation pathways. The peripheral component may 
consist of vanilloid-mediated vasodilatation or stimulation of peripheral 
thermoreceptors. Capsaicin and resiniferatoxin relax vascular preparations via CGRP 
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release (Andersson et al, 2002; Zygmunt et al, 1999) and intravenous capsaicin 
elicits bradycardia, hypotension, and apnea via excitation of the chemosensitive 
receptors in pulmonary vagal C-fibers (Szolcsanyi et al., 1990). Although one 
consequence of activating central heat loss pathways is cutaneous vasodilation 
(Kanosue et al., 1998)，the additional, direct vasodilator effect of vanilloids could 
further aid in heat dissipation. The duration of the hypothermic action of peripherally 
• • 
administered capsaicin had not been investigated in this study, but previous reports 
often observed its duration of action to be hours long (de Vries & Blumberg，1989; 
Szikszay et al, 1982). This further supports the existence of two mechanistic 
components in vanilloid-induced hypothermia. 
Unfortunately, the hypothermic effect of olvanil was confounded by the use 
of DMSO, which by itself produced long-lasting hypothermia. Yet, a detailed 
analysis of the time course of body temperature change revealed that olvanil 
significantly lowered body temperatures around 20 to 30 min post injection. 
Attempts to quantify hypothermia by calculating maximum temperature decreases, 
however, led to non-significance. DMSO-induced hypothermia had a similar time 
profile to olvanil, reaching a maximum low at 15 min and remained there. It is 
therefore desirable to re-characterize the hypothermic action of olvanil, preferably 
with a different vehicle. 
PPAHV was previously reported to lack the hypothermic response in the rat 
for up to two hours post injection (Appendino et aL, 1996). The discrepancy between 
the present results and their study could first of all be ascribed to differences in 
routes of administration. In their experiments, PPAHV was injected subcutaneously 
while in the present study, the i.c.v. injection technique was employed. As vanilloid-
induced hypothermia could be composed of two components, if PPAHV only 
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selectively activates the central component, then it would seem natural that 
peripheral administration of PPAHV will fail to produce hypothermia, assuming that 
it lacks substantial brain penetrance. There is evidence showing that PPAHV 
activates a capsazepine-insensitive subtype of vanilloid receptor in rat trigeminal 
ganglion neurons (Liu et al, 1998). In addition, PPAHV seems to have binding 
requirements distinct from other vanilloids. Whilst mutations which confer 
sensitivity to one vanilloid generally confer sensitivity to all vanilloids (Gawa et al, 
2004), specific mutations can be introduced to alter sensitivity to PPAHV without 
affecting sensitivity to other vanilloids (Phillips et al., 2004). Secondly, a species-
specific difference is equally possible, as PPAHV does not activate the human 
(Mclntyre et cd., 2001) or guinea pig (Savidge et al, 2002) TRPVl. Nevertheless, the 
logical step that follows would be to determine the potential hypothermic effect of 
subcutaneously administered PPAHV in Suncus murinus. 
The doses of resiniferatoxin, capsaicin, and PPAHV which produced 
hypothermia overlapped with those which elicited emesis and anti-emesis. There was 
no apparent dissociation of effects. Comparing threshold doses yielded relative 
potency values of PPAHV and capsaicin to resiniferatoxin of 10 and 33 respectively. 
The rank order of potency is thus resiniferatoxin > PPAHV > capsaicin » > olvanil. 
Since the proposed mechanism of vanilloids to induce emesis involves a 
release of substance P and/or other transmitters, whether this mechanism also 
accounts for the hypothermia observed is a key question. Unfortunately, there is a 
paucity of information regarding the effect of substance P on body temperature. 
Intrathecal injection or microdialysis of substance P into the preoptic anterior 
hypothalamus had no effect on body temperature in rats (Dib，1987; Xin et cd., 1997). 
In spite of this, animals administered substance P stimulated bar-pressing for cool air 
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(Dib, 1987). Both substance P and bombesin, a peptide known to lower body 
temperature, excited neurons of the preoptic anterior hypothalamus (Schmid et al., 
1993). However, bombesin increased the temperature coefficient of neurons, 
converting temperature-insensitive neurons to warm-sensitive ones, while substance 
P decreased the temperature coefficient, converting warm-sensitive neurons to 
temperature-insensitive ones (Schmid et al., 1993). These results suggest that despite 
having no direct effect on body temperature, substance P is capable of altering 
thermal responses and could be involved in thermoregulation. 
Microinjection of glutamate into the organum vasculosum laminae terminalis 
(OVLT) led to a rise in rectal temperature in rats (Huang et al, 2001). Systemic 
administration of the NMDA antagonist dextromethorphan resulted in dose-
dependent hypothermia (Rawls et al., 2002b) and attenuated morphine-induced 
^ hyperthermia (Rawls et al, 2003). CGRP has ambiguous effects on temperature: 
intrathecal injections led to prolonged hypothermia (Smith et aL, 1993) while a rise 
in body temperature was observed when CGRP was microinjected into the 
ventromedial and dorsomedial hypothalamus (Kobayashi et al, 1999). No changes in 
temperature were observed following CGRP injection into the preoptic area 
(Kobayashi et al, 199.9). Intravenous CGRP led to rises in skin temperature, possibly 
as a result of.vasodilatation (Noguchi et al., 2003). Which of these putative 
‘transmitters, or even other yet-to-be-identified substances, are responsible for the 
mediation of vanilloid-induced hypothermia awaits further confirmation. 
The CBi receptor is also known to cause hypothermia (Di Marzo et al., 2000). 
WIN 55212-2, a CBi agonist, induced dose-dependent reductions in body 
temperature (Rawls et al., 2002a). Indeed, the nature of the hypothermia induced by 
WIN 55212-2 most resembled that of resiniferatoxin-induced hypothermia. At 5 
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mg/kg, i.m.，WIN 55212-2 produced a drop of 3.4 土 0.4 °C at 90 min post injection 
and hypothermia lasted for 5 hours (Rawls et al, 2002a). When given intra-
preoptically, however, WIN 55212-2 decreased body temperature by 1.3 土 0.1 °C at 
around 30 min post injection and hypothermia lasted for 1 hour (Rawls et al, 2002a). 
Given that the time course of both cannabinoid- and vanilloid-induced hypothermia 
are sensitive to route of injection, it is possible that vanilloids elicit hypothermia via 
the intermediacy of anandamide and activation of CBi. However, olvanil was the 
vanilloid that had the highest affinity for the CBi receptor (Di Marzo et al, 1998; 
Szallasi et al, 1999b) but the hypothermia it elicited was not quite comparable to 
that elicited by CBi activation. The appropriate test for this hypothesis would be to 
examine the effect of a CBi antagonist on hypothermia produced by the vanilloids. 
It is not uncommon for anti-emetic drugs to have concomitant effects on body 
temperature. Scopolamine, an anti-muscarinic agent, elevates body temperature in 
rats (Gordon & Grantham，1999; Mallick & Joseph，1997), while chlorpheniramine, 
an anti-histamine, decreases body temperature (Karamanakos et al, 2004; Yeh, 
1999), possibly involving an anti-cholinergic action (Mukherjee & Poddar, 2001). 
Diphenhydramine, also an anti-histamine, does not affect body temperature (Yeh, 
1999). Chlorpromazirie, a D2 antagonist, produces hypothermia in the guinea pig, 
although an anti-cholinergic mechanism is possible (Adler et al, 1 9 9 1 ) . The 5 - H T I A 
agonist 8-OH-DPAT decreases body temperature (Patel & Hutson，1996; Wolff er al., 
1997)，with the 5-HT7 receptor also implied to play a part (Hedlund et al, 2003). 
Ondansetron does not cause temperature changes (Mazzola一Pomietto et al., 1995) 
but attenuated hypothermia induced by radiation (Kandasamy, 1997). Since, many of 
the neurotransmitter systems involved in emesis control are also involved in 
temperature regulation mechanisms, the question regarding whether hypothermia is a 
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necessary action common to the mechanism of anti-emetic drugs is raised. It is also 
an illustration of the ubiquitous nature of neurotransmitters and receptors in the brain 
and the difficulty of dissecting one effect from another. We have so far been unable 
to achieve dissociation of vanilloid-induced effects. 
Following hypothermia, a period of temperature rebound, where the body 
temperatures of vanilloid-treated animals were higher than those of control animals, 
was observed for resiniferatoxin and capsaicin. This rebound effect could represent 
an abrogation of the gradual temperature decrease seen in control animals or a 
compensatory response to prolonged hypothermia. The magnitude of temperature 
rebound was not proportional to the magnitude of prior hypothermia. Capsaicin, 
which elicited less intense hypothermia than resiniferatoxin, was equally effective in 
producing a temperature overshoot of similar magnitude as resiniferatoxin. Although 
the temperature rebound effect of capsaicin occurred at an earlier time than 
resiniferatoxin, this was probably because of its shorter duration of hypothermia. The 
temperature overshoot appeared shortly after recovery from hypothermia. This effect 
was not observed in peripheral studies with resiniferatoxin, perhaps because the 
observation period was not long enough. Interestingly, the temperature overshoot 
was only apparent for-resiniferatoxin and capsaicin. This effect was not clearly seen 
subsequent to PPAHV- and olvanil-induced hypothermia. Therefore, for this 
- t empera tu re rebound effect, the rank order of potency is resiniferatoxin ~ capsaicin 
» > ]^PAHV ~ olvanil. 
Observations of hyperthermia subsequent to capsaicin or resiniferatoxin 
treatment had been previously reported (de Vries & Blumberg，1989; Kobayashi et 
al, 1998; Osaka et al., 2000a; Osaka et al, 2000b; Szikszay et al.’ 1982; Woods et 
al, 1994). This hyperthermia could persist up to days (Jancso-Gabor et al, 1970b). 
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Capsaicin-treated animals subsequently exhibited permanent impariment in heat 
tolerance and this led to the postulation that the subsequent hyperthermia was a 
consequence "of desensitization and/or destruction of warm-sensitive neurons 
(Jancso-Gabor et al, 1970a; Szikszay et al, 1982). The duration of the rebound 
effect seen in our experiments was not determined, but persisted till the end of the 
experiment. 
Some authors reached a contrary conclusion, stating that capsaicin 
simultaneously activates brainstem-controlled heat production and forebrain-
controlled heat loss mechanisms (Kobayashi et al, 1998). Rather than observing a 
decrease in oxygen consumption, indicative of decreased thermogenesis (Woods et 
al-, 1994)，they observed an increase in oxygen consumption, indicative of increased 
thermogenesis (Kobayashi et al., 1998; Osaka et al, 2000b). This capsaicin-induced 
thermogenesis was a consequence of catecholamine secretion and was mediated in 
part by capsaicin-sensitive structures in the rostral ventrolateral medulla (Kobayashi 
et al., 1998; Osaka et aL, 2000b). Decerebration prevented capsaicin-induced 
hypothermia and enhanced capsaicin-induced heat production (Osaka et al., 2000a). 
They reasoned that capsaicin-induced heat loss predominated during the initial stages 
while the effect of heat production emerged later, giving rise to the period of 
hyperthermia (Kobayashi et al, 1998). Interestingly, the effect of capsaicin is 
dependent on the route of administration. As opposed to subcutaneous or 
intraperitoneal injections (de Vries & Blumberg，1989), oral administration of 
capsaicin resulted in increased body temperature without hypothermia (Ohnuki et al, 
2001). Therefore, hyperthermia is not a consequence of desensitization and/or 
destruction of warm receptors. Since the period of temperature overshoot was not 
observed for the non-pungent vanilloids, it is possible that pungency is correlated 
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with the compound's ability to activate capsaicin-sensitive heat production pathways. 
Non-pungent compounds may therefore only selectively activate heat loss pathways. 
Whether TRPVl involvement in heat loss and heat production mechanisms 
represents different receptor subtypes or the same receptor located in different 
situations is not known. If two distinct receptor subtypes separately mediate these 
responses, then the subtype that is responsible for heat production could be the very 
same one that is responsible for pungency. However, the non-pungent vanilloid 
capsiate was also found to produce increases in body temperature following oral 
dosing (Ohnuki et al. ,2001). 
If vanilloids initially induce emesis via neurotransmitter release and 
subsequently antagonize emesis via neurotransmitter depletion, then analogously, it 
is possible that hyperthermia following initial hypothermia is also a result of 
substance P，glutamate, and/or CGRP depletion. It is unfortunate that evidence for 
t* 
the effects on body temperature of these neurotransmitters and/or their antagonists is 
somewhat scant and inconclusive. There have been no reports of NKi antagonists on 
body temperature while NMDA antagonists caused hypothermia instead (Rawls et aL, 
2002b), suggesting that perhaps glutamate depletion is the basis of vanilloid-induced 
hypothermia. The proposed CGRP antagonist, CGRPg-sv, induced a small heat 
production response, but the authors ascribed this effect to a partial agonistic action 
at the CGRP receptor instead (Kobayashi et al, 1999). 
Resiniferatoxin-induced hypothermia was not antagonized by capsazepine or 
ruthenium red. Capsaicin and PPAHV failed to produce significant hypothermia in 
the antagonist studies and the effect of capsazepine again could not be examined. It 
was reported that capsazepine did not block hypothermia to capsaicin (Di Marzo et 
a/.，2000; Okane et al, 2001)，but resiniferatoxin-induced hypothermia was inhibited 
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by ruthenium red (Okane et al, 2001). Central administration of capsazepine or 
DMSO produced a drop in temperature, such that at the time of vanilloid injection 
animals had "lower starting body temperatures. This might explain the reduced 
hypothermia response, or the failure to observe hypothermia, to capsaicin and 
PPAHV, as body temperature was already lowered at the time of injection. It was 
still possible to demonstrate resiniferatoxin-induced hypothermia, probably because 
the magnitude of response to resiniferatoxin was large enough to overcome the small 
initial decrease. In the presence of capsazepine, the hypothermia response to 
resiniferatoxin was substantially prolonged, requiring nearly two hours for body 
temperature to return to normal. Although vanilloid-induced hypothermia is 
capsazepine-insensitive, TRPVl is ultimately responsible for mediating the 
hypothermic action of capsaicin, as capsaicin did not decrease body temperature in 
mice lacking TRPVl (Caterina et al, 2000). 
The intrinsic action of capsazepine to transiently lower body temperature and 
its prolongation of resiniferatoxin-induced hypothermia suggest a partial agonistic 
action. The prolonged hypothermia could reflect an additive or even synergistic 
action of resiniferatoxin and capsazepine in lowering body temperature. Capsazepine 
has been shown to behave as a weak agonist in other systems. It produced capsaicin-
like contractions of the rabbit iris sphincter muscle (Wang & Hakanson, 1993) and 
stimulated CGRP release from rat skin (Petho et aL, 2004). Alternatively, this may 
reflect a possible role of endogenous vanilloids in maintaining temperature 
homeostasis. Although TRPVl knockout mice had core body temperatures that were 
not significantly different from wild-type mice (Caterina et aL, 2000), the amplitudes 
of daily body temperature fluctuation were increased, such that daily temperature 
highs were greater than wild-type mice and daily temperature lows were lower 
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(Szelenyi et al., 2004). Since blockade of TRPVl in our experiments led to 
decreased body temperature, endogenous vanilloids could be responsible for 
maintaining heat production. It has been suggested that capsaicin activates both heat 
dissipation and heat production pathways (Kobayashi et al, 1998; Osaka et al., 
2000b). Szelenyi et al. (2004), on the basis of studies performed with TRPVl 
knockout mice, postulated that the vanilloid receptor has a "brake-like" modulatory 
role in homeothermic regulation that mitigates potentially large rises in core 
temperature. 
Intriguingly, the temperature rebound effect evident in the earlier agonist 
studies was no longer seen in capsazepine-pretreated animals. The temperature 
overshoot induced by resiniferatoxin and capsaicin was virtually abolished in the 
presence of capsazepine. As already suggested, the vanilloid receptor (subtype) 
responsible for eliciting heat production could also be responsible for mediating 
pungency. Pungency refers to the ability of the compounds to produce pain. 
Capsazepine effectively antagonizes nociceptive responses to capsaicin (Dickenson 
& Dray, 1991; Ferreira et al, 2004; Santos & Calixto, 1997). Therefore, the 
pharmacological sensitivity of this putative receptor subtype to capsazepine 
conforms to the original speculation. Capsazepine also inhibited the increase in body 
temperature elicited by oral administration of capsaicin and capsiate (Ohnuki et al., 
2001). Thus, vanilloids could activate heat loss via a capsazepine-insensitive 
pathway and heat production via a capsazepine-sensitive mechanism, both of which 
� are mediated by TRPVl. However, in the rat, the rise in body temperature was not 
blocked by either capsazepine or ruthenium red (Okane et al, 2001). (see Figure 4.2) 
In the present studies, resiniferatoxin elicited a drop of approximately 5 °C in 
body temperature. The largest magnitude of hypothermia reported was in the mouse, 
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Figure 4:2 A diagram illustrating the possible pathways for vanilloid-
induced temperature changes. TRPVl in the hypothalamus activates heat 
.loss mechanisms. This pathway is not antagonized by capsazepine. 
Vanilloid-induced CGRP release leads to peripheral vasodilatation and 
further enhances heat dissipation. TRPVl present in the brainstem activates 
heat production. This pathway is antagonized by capsazepine and is not 
activated by non-pungent vanilloids. 
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where resiniferatoxin decreased body temperature by 8 °C (de Vries & Blumberg, 
1989). Although there are many other agents with documented hypothermic actions, 
rarely can a "reduction of such a substantial magnitude be observed. The 5-HTIA 
agonist LY301317 reduced temperature by 4.5 °C (Wolff et al, 1997)，intravenous 
injection of histamine produced a 4 °C decrease (Makabe_Kobayashi et al., 2002), 
and the opioid ji-receptor agonist loperamide decreased temperature by 4.5 °C 
(Baker & Meert, 2002). Therefore, resiniferatoxin appears to be one of the most 
efficacious hypothermic agents available and this feature could be utilized in clinical 
situations where rapid hypothermia is desired. Malignant hyperthermia is a 
hypermetabolic condition characterized by hyperthermia, metabolic acidosis, and 
muscle rigidity that can be induced by agents used in general anesthesia such as 
halothane and succinylcholine (Gurrera, 2002). The first line treatment is dantrolene, 
” which is a muscle relaxant that impairs excitation-contraction coupling in skeletal 
muscles (Krause et al, 2004). However, dantrolene can have synergistic effects with 
neuromuscular blocking drugs and has poor water solubility (Krause et aL, 2004). 
Heat stroke is another emergency condition defined when body temperature reaches 
40.6 °C (Grogan & Hopkins, 2002). There are several types of heat stroke, each with 
different triggering and risk factors, but the classic type of heat stroke is thought to 
be a result of thermoregulation failure (Grogan & Hopkins, 2002). Management of 
heat stroke patients generally involves a variety of physical cooling techniques to 
promote heat loss (Grogan & Hopkins, 2002). Vanilloids could potentially contribute 
to these clinical situations. However, the subsequent hyperthermia observed after 
vanilloid administration also becomes a matter of concern. Therefore, a better 
understanding of the thermal regulation mechanisms of vanilloids is needed to help 
realize their therapeutic values. 
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4.5 Resiniferatoxin-induced Genital Grooming 
Only resiniferatoxin could induce genital grooming. PPAHV, which 
structurally most resembles resiniferatoxin (Appendino et al, 1996)，was inactive. 
Resiniferatoxin-induced genital grooming had a steep bell-shaped curve; choosing 
the right doses would therefore be critical. Since resiniferatoxin ranged from being 
10 to 100 times more potent than PPAHV and 33 to 300 times more so than 
capsaicin, genital grooming could perhaps still be induced by higher doses of these 
vanilloids. Capsaicin pretreatment was previously found to be capable of reducing 
genital grooming induced by subsequent resiniferatoxin (Rudd & Wai，2001). The 
latency to genital grooming was much longer than the latencies required for inducing 
emesis and hypothermia. Emesis and hypothermia were observed within minutes 
while genital grooming was typically not seen until 30 min post injection. The 
duration of grooming was also much longer than the duration of emesis, often lasting 
up to an hour. Subcutaneously administered resiniferatoxin also elicited genital 
grooming, though the intensity of grooming was somewhat weaker. The time taken 
for genital grooming to occur was even longer, requiring almost an hour for it to 
emerge. The reason for the longer latency for peripherally injected resiniferatoxin to 
induce genital grooming may reflect the additional time taken to access the central 
nervous system or even a sex difference in response. Whereas centrally injected 
resiniferatoxin induced genital grooming with a steep bell-shaped curve, peripherally 
injected resiniferatoxin appeared to induce grooming in a dose-dependent manner 
(Andrews et a/., 2000). 
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The long latency for the onset of genital grooming may indicate that 
resiniferatoxin needed more time to penetrate into deeper brain areas involved in the 
genesis of genital grooming, or that the mechanisms for this response were indirect 
and involved activation of multiple pathways or the generation of an active 
metabolite. Moreover, genital grooming could be a spinally mediated response in 
which case resiniferatoxin would have to travel from the lateral ventricle down 
through the spinal canal to the required site(s) of actions. Since resiniferatoxin-
treated animals exhibited two discrete, sequential responses, namely emesis and 
genital grooming, there is a possibility that the occurrence for genital grooming was 
delayed because vomiting was the dominant response that had priority. In other 
words, the animals "postponed" the genital grooming response because they were 
preoccupied with vomiting. The appropriate test for this speculation would be to 
block the emetic response with an anti-emetic drug known to be effective against 
resiniferatoxin e.g. morphine (Andrews et al, 2000) and determine whether the 
latency to genital grooming will be decreased. Nevertheless, there is a considerable 
time lag between the subsidence of emesis and the emergence of genital grooming. 
Emesis usually disappeared within 10 min (central) or 15 min (peripheral) after drug 
injection while genital grooming required at least 25 min (central) or 45 min 
(peripheral) to occur. 
Episodes of genital grooming were occasionally intermitted with episodes of 
hindquarter grooming. Salivation was reported with 100 jig/kg, s.c. resiniferatoxin 
(Andrews et al., 2000). Spreading saliva on the fur is one way of promoting heat 
dissipation in animals (Nagashima et al., 2000) and grooming may thus potentially 
contribute to hypothermia. However, overt salivation was not observed in the present 
studies and the contribution of grooming seemed insufficient to elicit a hypothermic 
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response of such a large magnitude. Furthermore, hypothermia was elicited by doses 
of resiniferatoxin (10 nmol) that failed to produce significant genital grooming. It is 
therefore unlikely that grooming is a major contributor to hypothermia. 
In the present studies, genital grooming was not significantly antagonized by 
capsazepine or ruthenium red. This is at variance with our previous results where 
genital grooming was antagonized by both compounds (Rudd & Wai, 2001), 
although there was a non-significant trend of antagonism in the present studies. 
Latencies were also unaffected. Centrally administered capsazepine reduced the 
intensity of genital grooming by 38% and the number of responding animals from 5 
out of 7 to 3 out of 7. In peripheral studies, none of the animals administered 100 
|j.mol/kg capsazepine exhibited genital grooming while the groups treated with 3 
|Limol/kg ruthenium red and 30 |imol/kg capsazepine had only one responding animal. 
The failure to reach statistical significance for the peripheral studies could be due to 
the large variations in response observed in control animals. Only four out of six 
control animals responded to resiniferatoxin. The standard error of mean for the 
control group was also quite large (mean+s.e.m. = 14.3 土 9.1). Inspection of the raw 
data revealed that among the four responding animals, one animal had only one 
episode of genital grooming. 
The precise function of genital grooming in Suncus murinus is not known. 
' However, the behaviour may be associated with sexual activity, given that in 
experiments with male animals, genital grooming was sometimes accompanied by 
penile erections. Nevertheless, such a function would require formal investigation 
using protocols for assessing sexual performance. TRPVl is present in brain areas 
that are involved with sexual behaviour (Mezey et al., 2000; Szabo et al., 2002). 
These areas include the hypothalamus, most importantly the medial preoptic area and 
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the paraventricular nucleus, as well as the limbostriatal system (Giuliano & Allard, 
2001). Erectile dysfunction is the inability to sustain erections sufficient for 
satisfactory sexual intercourse. Treatments with reasonable efficacy are readily 
available and often target at improving local blood flow to the penis. Existing 
pharmacological therapies include alprostadil (prostaglandin Ei), papaverine (a non-
specific phosphodiesterase inhibitor), phentolamine (an a-adrenoceptor blocker), 
apomorphine (a D2 agonist), and sildenafil (a selective inhibitor of cGMP specific 
phosphodiesterase type 5) (Thomas, 2002). Most of these agents act peripherally, 
except for apomorphine, which has a central site of action. Studies with apomorphine 
have revealed the importance of dopamine in the paraventricular nucleus in eliciting 
penile erection and the nucleus accumbens, the medial preoptic area, and the striatum 
in facilitating sexual performance (Giuliano & Allard, 2001). Whereas the brain is 
the major organ in sexual functioning, sexual response is ultimately controlled by 
spinal autonomic nuclei, located at the thoracolumbar and sacral levels. 
Apomorphine delivery at the lumbosacral level can also elicit erectile activity 
(Giuliano & Allard，2001). 
There are certain drawbacks with existing therapies for erectile dysfunction. 
Alprostadil and papaverine are not orally active and need to be self-injected 
intracavemosally (Thomas, 2002). Phentolamine can produce cardiovascular effects 
while apomorphine has a narrow therapeutic window and can cause nausea, emesis, 
and drowsiness (Thomas, 2002). Sildenafil, better known as Viagra, is marketed as 
the breakthrough drug for the treatment of erectile dysfunction. Nevertheless, post-
marketing surveillance revealed that headaches are common and cardiovascular side 
effects may occur (Thomas, 2002). Interestingly, ginger is being used in Arab 
medicine as an aphrodisiac and its extract was found to promote sperm fertility 
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(Qureshi et al, 1989). The potential of zingerone to induce genital grooming in 
Suncus murinus, however, has not been investigated, but this does not rule out the 
possibility that resiniferatoxin might prove beneficial in treating sexual disorders. 
Neuropeptides have been implicated in the control of sexual behaviour, 
although knowledge is far from being complete (Argiolas，1999). Substance P 
shortened the latency to initiate copulation in the male rat, while injections of a 
substance P antiserum markedly impaired copulatory behavior (Doman & Malsbury, 
1989). Substance P also facilitated female sexual receptivity when injected into the 
midbrain central gray (Doman et al, 1987). Microinjection of NMDA into the 
medial hypothalamus, paraventricular nucleus, and dorsal hypothalamic area evoked 
grooming in rats (Duva et al., 2002; Reeling et al., 1991). Grooming was also 
produced when CGRP was administered intracerebroventricularly (Kovacs et al, 
1995; Kovacs et al, 1999). However, there is no direct evidence to implicate CGRP 
tf 
and glutamate in the regulation of sexual behaviour. 
The dopaminergic system, on the other hand, is known to be involved in 
sexual functioning. Activation of dopamine receptors induces penile erection and 
enhances sexual performance (Hull et al, 1989; Markowski et al., 1994). Since there 
are reports that certain vanilloids can bind to dopamine receptors (Jonassohn et al.， 
1997) and some dopamine antagonists have an affinity for the vanilloid receptor (Acs 
et al., 1995; Szallasi et al, 1996b), dopamine receptors could potentially be involved 
in the genesis of resiniferatoxin-induced genital grooming. If this were the case, then 
only those vanilloids with D1/D2 binding properties would be able to induce genital 
grooming and could explain why this action is unique to resiniferatoxin. Certainly, it 
is necessary to determine whether resiniferatoxin has an affinity for dopamine 
receptors and whether dopamine antagonists can block resiniferatoxin-induced 
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genital grooming. Nevertheless, despite the speculative nature of the therapeutic 
potentials of resiniferatoxin in sexual dysfunction, the central site of action of 
resiniferatoxin in eliciting this behaviour could potentially aid in revealing novel 
mechanisms and transmitter systems involved with sexual functioning. 
4.6 Actions of Capsazepine and Ruthenium Red 
There have been some discrepancies between the results obtained from the 
antagonist studies in the present work and those that were, obtained previously from 
our laboratory. To recap, it was previously demonstrated that resiniferatoxin-induced 
emesis was antagonized by ruthenium red while resiniferatoxin-induced genital 
grooming was antagonized by both capsazepine and ruthenium red (Rudd & Wai， 
2001). In the present studies, only the onset of resiniferatoxin-induced emesis was 
delayed by ruthenium red and neither capsazepine nor ruthenium red could 
significantly antagonize resiniferatoxin-induced genital grooming. It is rather 
difficult to come up with a satisfactory explanation; however, some observations 
have been made and will be described here. 
During the pretreatment period with capsazepine or ruthenium red, both 
emesis and hypothermia were observed. For central studies, emesis during the 
‘ pretreatment period commonly subsided before the second injection of drugs. The 
vomiting data during the pretreatment period was separated from statistical analyses 
of the vomiting data obtained during the observation period. Pretreatment vomiting 
was observed in 17 out of 56 animals, which was about 30%. These 17 vomiting 
animals had an average of 7.1 土 1.1 vomiting episodes. When taking all 56 animals 
into account, the average was 2.2 土 0.6 episodes. There was no statistical 
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significance between animals administered capsazepine or its vehicle, 50% DMSO. 
Pretreatment vomiting is probably due to the action of DMSO; capsazepine was not 
found to have an intrinsic emetic effect. 
In the peripheral studies, the emetic potential of ruthenium red, capsazepine, 
and their vehicle were assessed over a period of 3 hours. Emesis was observed in 
most treatment groups and was again likely to be caused by DMSO rather than an 
intrinsic effect of the antagonists. However, high dose of capsazepine (100 |j.mol/kg) 
appeared to have an antagonistic action against DMSO-induced emesis. When the 
antagonists and vehicle were administered as a 30 min pretreatment, 6 out of 30 
animals (20%) vomited during the pretreatment period. Emesis of 0.8 土 0.5 episodes 
was observed among all animals; the six vomiting animals had an average of 4.2 土 
2.0 episodes. Pretreatment vomiting was also not seen in animals treated with 100 
)j.mol/kg capsazepine. Nonetheless, the possible anti-emetic action of capsazepine 
against DMSO-induced emesis was not replicated in central studies. 
The potential effect of a first emetic challenge on the response to a second 
emetic challenge has already been discussed. Briefly, Andrews et al. (2000) reported 
that consecutive emetic challenges may result in a reduced magnitude and delayed 
onset of the second emetic challenge. Pretreatment vomiting therefore could have led 
to reduced responses and consequently the failure of capsaicin and PPAHV to be 
significantly emetic and anti-emetic in the antagonist studies. Resiniferatoxin was 
perhaps potent enough to overcome this effect. As a matter of fact, resiniferatoxin 
was the only agent capable of producing significant responses in the presence of 
DMSO. The following table (Table 4.1) compares the responses produced by the 
same dose of capsaicin and PPAHV in earlier agonist studies and subsequent 
antagonist studies. Except for hypothermia, none of the other responses reached 
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statistical difference. The reduced hypothermia could be due to the already lowered 
body temperatures at the time of injection. Resiniferatoxin-induced genital grooming 
also had a reduction in intensity that was not statistically different. 
Agonist Studies Antagonist Studies p-value 
Emetic action of 
Capsaicin 6.0 土 1.0 episodes 4.1 ± 1.8 episodes 0.4014 
PPAHV 5.7 ± 1.9 episodes 4.4 土 1.7 episodes 0.6309 
Anti-emetic action of 
Capsaicin 1.2 土 0.4 episodes 5.6 土 1.8 episodes q 0529 
(87% reduction) (55% reduction) 
PPAHV 2.0 土 1.3 episodes 4.7 土 2.3 episodes q 3488 
(810/0 reduction) (63% reduction) ‘ 
Hypothermic action of 
Capsaicin 1.7 ± 0.1 °C 0.9 土 0.2 °C 0.0065** 
PPAHV 2.3±0.3°C 1.3 土 0.3 °C 0.0353* 
J^JJifgUced genital 39.8 土 3.7 episodes 29.7 土 8.2 episodes 0.3113 
Table 4.1 The magnitudes of responses produced by capsaicin (100 nmol), PPAHV 
(10 nmol), and resiniferatoxin (RTX 3 nmol) in the agonist studies and in control 
animals in the antagonist studies with capsazepine. * p<0.05, **p<0.01 (Unpaired t-
test). 
In peripheral studies, even resiniferatoxin was observed to produce attenuated 
responses in vehicle (DMSO)-pretreated animals (Experiment 3) as compared to un-
pretreated ones (Experiment 1). As evident from Table 4.2, except for the 
hypothermia response, both resiniferatoxin-induced emesis and genital grooming had 
diminished magnitudes and larger standard errors. Hypothermia, on the other hand, 
appeared to be potentiated. None of these differences, however, reached statistical 
significance. 
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Un-pretreated animals DMSO-pretreated animals p-value 
(Experiment 1) (Experiment 3) 
Emesis 9.5 土 1.9 episodes 6.5 ± 3.1 episodes 0.4864 
Hypothermia 6.3 土 0.2 °C 6.6 土 0.5 °C 0.7236 
GroomLg ^ [； 土 ， e p i s o d e s 14.3 土 9.1 episodes 0.2194 
Table 4.2 The magnitudes of responses produced by subcutaneous administration of 
resiniferatoxin (100 nmol/kg) obtained in the two different sets of experiments. 
There are no significant differences between the groups (p>0.05, Unpaired West). 
Animals administered DMSO sometimes displayed transient writhing of the 
body and/or twitching and spasm of the limbs. No animals, however, died from 
DMSO administration. Although unlikely that DMSO had specific interactions with 
the vanilloid receptor, it probably led to attenuated responses due to its generalized 
toxicity. A comprehensive review on DMSO documented that DMSO has 
anticholinesterase and CNS depressant activity and may enhance permeability of the 
blood brain barrier (Swanson, 1985). Sedation, headache, dizziness, hepatotoxicity, 
and skin reactions are frequent side effects (Swanson, 1985). DMSO-pretreatment 
resulted in prolonged hypothermia to resiniferatoxin. In central studies, 
resiniferatoxin-induced hypothermia lasted for 60 min in un-pretreated animals and 
90 min in DMSO-pretreated animals. In peripheral studies, resiniferatoxin-induced 
hypothermia in DMSO-pretreated animals only partially recovered at the end of the 
experiment. During the experiment, the body temperature of the animals even 
decreased to as low as 28 °C. In earlier studies, body temperatures were seldom seen 
to fall below 30 °C. It remains to be determined whether the problem with having to 
use DMSO as the choice of vehicle can be resolved. The ideal vehicle is of course 
one that does not exert any effects on its own. It had occurred repeatedly throughout 
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the present studies that a pharmacologically active vehicle could seriously 
complicate the interpretation of results. 
The pharmacological sensitivity of capsaicin and PPAHV to vanilloid 
antagonists could not be determined from the present studies. Yet, resiniferatoxin 
induces emesis, hypothermia, and genital grooming via a capsazepine-insensitive 
mechanism. Whether resiniferatoxin acts on a different subtype of vanilloid receptor 
or via the activation of other receptor systems is unclear. As discussed in detail in the 
preceding sections, participation of the cannabinoid or dopamine system could 
potentially contribute to the actions of resiniferatoxin. Emesis to resiniferatoxin 
appeared to be sensitive to ruthenium red, since latency was delayed although a 
significant reduction in number of emetic episodes was not reached. 
Studies with the vanilloid antagonists revealed the possible existence of three 
vanilloid receptor subtypes: (i) a capsazepine-insensitive but ruthenium red-sensitive 
f 
subtype for mediating emesis; (ii) a capsazepine-sensitive subtype that activates heat 
production; and (iii) a capsazepine- and ruthenium red-insensitive subtype 
responsible for mediating hypothermia. Genital grooming appeared to be mediated 
by the third subtype, although the inconsistencies in results and large variations in 
response prevented a conclusive argument, and the activation of other receptor 
systems, e.g. dopamine, also seems possible. The capsazepine-sensitive subtype is 
probably the same one that is responsible for causing pungency, as non-pungent 
compounds did not activate heat production. The sensitivity of this subtype to 
capsazepine also correlates with the known pharmacological sensitivity of pungency 
to capsazepine (Dickenson & Dray, 1991; Ferreira et al., 2004; Santos & Calixto, 
1997). Pungency could therefore be an indication of a compound's hyperthermic 
potential. 
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Although capsazepine was reckoned to be the prototype of vanilloid receptor 
antagonists (Bevan et al., 1992; Dickenson & Dray, 1991), newer vanilloid 
antagonists have been developed. lodo-resiniferatoxin, JYL1421, and KJM429 
(Wahl et al., 2001; Wang et al, 2002) are found to have greater potency and 
improved selectivity than capsazepine. SB-366791 was effective against acid-
induced TRPVl activation (Gunthorpe et al., 2004) and IBTU was found to exhibit 
selectivity between subpopulations of TRPVl, namely the plasma membrane 
population and the intracellular fraction (Toth et cd., 2004). It would be desirable to 
investigate the effects of these new antagonists on the actions of resiniferatoxin. 
4.7 Locomotor Activity 
The activity of Suncus murinus follows a clear nocturnal pattern: locomotor 
f 
activity is significantly higher during dark periods than light periods (Ishii et al., 
2002). Experiments in the present studies were all conducted during the day, when 
spontaneous locomotor activity of these animals was presumably to be at a low. 
Thus, it might have been difficult to detect locomotor activity differences, as most 
animals tended to curl up in a comer after brief exploration of the surroundings. 
To ensure that all animals exhibited similar baseline activity, locomotor 
- activity during the habituation period was included in the analyses. Sometimes the 
habituation data was pooled to allow a larger sample analysis. Throughout the central 
studies, analysis of the habituation data did not reveal major differences. However, 
animals began to exhibit varying baseline activities in Experiment 3 of the peripheral 
studies. Animals assigned to the group receiving resiniferatoxin following vehicle 
treatment had significantly higher baseline locomotor activity than the groups 
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receiving resiniferatoxin following 3 |amol/kg ruthenium red and 100 jamol/kg 
capsazepine. Pooling the habituation data across all three experiments revealed that 
animals in Experiment 3 overall exhibited increased activity compared to Experiment 
1. The experiments were conducted over an extended period of almost a year. 
Caution should therefore be taken when comparing results obtained from the 
different experiments. 
Resiniferatoxin (i.c.v. or s.c.) did not have any effects on locomotor activity. 
On the other hand, PPAHV and olvanil enhanced locomotor activity, with the effect 
commencing about mid-way through the experiments. However, this enhancement 
did not demonstrate clear dose-dependency. Furthermore, PPAHV failed to affect 
locomotor activity in subsequent antagonist studies, while capsaicin, which was 
inactive to alter locomotor activity in the earlier agonist studies, significantly 
enhanced locomotor activity in the later antagonist studies. Central injection of 
capsazepine did not modify locomotor activity but attenuated the enhancing effect of 
capsaicin. However, peripheral injection of high dose capsazepine and low dose 
ruthenium red alone significantly increased distance travelled. The locomotor 
enhancement of high dose capsazepine was abolished in the presence of 
resiniferatoxin, although it should be noted that animals in this treatment group 
exhibited significantly lower baseline activity during the habituation period. 
Resiniferatoxin delayed the onset of the locomotor enhancing effect of low dose 
ruthenium red. 
From our results, it is difficult to draw straightforward conclusions regarding 
the effect of vanilloids on locomotor activity. An inhibition in locomotor activity is 
often interpreted as a sign of sedation while a stimulation in locomotor activity is 
used as a measurement of psychostimulant properties (Halpert et al., 2003; 
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Karamanakos et al., 2004). Capsaicin was previously reported to inhibit locomotor 
activity (Di Marzo et al., 2000; Di Marzo et al, 2001), but the effects that we have 
observed, albeit inconsistent, were enhanced locomotion instead. In the agonist 
studies, since only the non-pungent PPAHV and olvanil could produce increases in 
locomotor activity, this locomotor enhancing effect could be related to 
pungency/non-pungency. Unfortunately, the antagonist studies could not confirm this 
hypothesis since PPAHV failed to reproduce the locomotor activity changes. The 
locomotor enhancing effects of PPAHV and olvanil did not become apparent until 90 
and 120 min onwards and this provoked one to speculate that hypothermia might 
have resulted in reduced activity in general, such that the locomotor enhancing 
effects of PPAHV and olvanil were suppressed until the animals had recovered from 
hypothermia. Consequently, in order to assess whether levels of locomotor activity 
differ during periods of emesis and hypothermia, the distance travelled at 10 and 30 
min, the times taken for emesis to be complete and hypothermia to be at a maximum, 
were analysed separately. No significant differences in locomotor activity could be 
observed at these time points. 
Many of the neurotransmitter systems involved in the emetic reflex are also 
involved in locomotor activity control mechanisms. Agents with anti-muscarinic 
actions such as scopolamine and diphenhydramine are known to stimulate locomotor 
activity (Halpert et al., 2003; Sipos et al., 1999). Oxotremorine, a muscarinic agonist, 
attenuates amphetamine-induced hyperlocomotion (Ichikawa et al., 2002) and 
haloperidol reverses scopolamine-induced hyperlocomotion (Mathur et al., 1997), 
illustrating that cholinergic systems inhibit dopaminergic systems in the nucleus 
accumbens. Apomorphine has a locomotor enhancing effect that is dependent upon 
an intact mesoaccumbens pathway (Mele et al., 1998). Intracerebroventricular 
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injection of histamine evokes initial hypoactivity, mediated by H3 receptors, and 
subsequent hyperactivity, mediated by Hi receptors (Chiavegatto et al., 1998). The 
hypoactivity - phase of histamine is correlated with a concomitant decrease in 
dopamine turnover in the striatum (Chiavegatto et al., 1998). Serotonergic pathways 
are also involved: stimulation of 5-HTIA receptors by 8-OH-DPAT can increase 
locomotor activity (Mignon & Wolf，2002). Hyperlocomotion can also be stimulated 
by pharmacological treatments that enhance brain serotonin release (Vanderwolf et 
al, 1997). 
The hypolocomotor effects of capsaicin has been attributed to anandamide 
release and activation of CBi receptor (Di Marzo et al, 2001). CBi receptor 
activation has been demonstrated to decrease spontaneous locomotor activity 
(Darmani, 2001a; Darmani, 2001b). Administration of a substance P analogue 
stimulated locomotor activity (Yip & Chahl, 1999), an effect antagonized by CP-
99,994 (Rupniak & Jackson，1994). Putative brain areas involved in NKi-mediated 
hyperlocomotion include the substantia nigra, the ventral tegmental area, rostral 
hypothalamic areas, and the median raphe nucleus (Itoi et al., 1994; Mason & Elliott, 
1992; Stoessl et al, 1991). Administration of the glutamate NMDA receptor 
antagonist MK-801 stimulated locomotor activity (Adriani et al., 1998; Mele et al, 
1996)，as did metabotropic glutamate agonists when injected into the nucleus 
- a c c u m b e n s and ventral tegmental are (Swanson & Kalivas, 2000). 
Intracerebroventricularly administered CGRP decreased ambulatory activity (Kovacs 
et al., 1995; Kovacs et al, 1999). Whether these putative neurotransmitters partake 
in the modulation of locomotor activity by vanilloids is not known. Our results did 
not demonstrate a straightforward effect on locomotor activity by vanilloids. The 
reason for the discrepancy between our results and previous publications is unknown 
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(Di Marzo et al, 2001), but Treptow et al. (1983) discovered that substance P 
stimulated locomotor activity during the light phase but produced inhibition during 
the dark phase in the rat. The authors suggested that substance P had a leveling, 
rather than a unidirectional, effect on locomotor activity instead (Treptow et al., 
1983). It has already been mentioned that the vanilloid receptor assumes a "brake-
like" role in modulating homeothermic regulation (Szelenyi et al, 2004). It is thus 
not too far-fetched to speculate that the vanilloid receptor exerts control over 
locomotor activity in an analogous manner. 
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Chapter 5 Summary 
If we knew what it was we were doing, it would not be called research, would it? 
----Albert Einstein (1879-1955) 
German physicist 
The present studies demonstrated that the pungent vanilloids resiniferatoxin 
and capsaicin and the non-pungent vanilloid PPAHV had the ability to rapidly induce 
emesis and hypothermia when administered into the lateral ventricle of Suncus 
murinus. Emesis was transient while hypothermia elicited by resiniferatoxin and 
PPAHV lasted for 60-90 min. The duration of hypothermia elicited by capsaicin was 
about 20 min. Following resiniferatoxin- and capsaicin-induced hypothermia, a 
. period of temperature rebound occurred, where the body temperatures of vanilloid-
treated animals were consistently higher than control animals. All three vanilloids 
were subsequently anti-emetic against copper sulphate-induced emesis. The non-
pungent olvanil was also an effective anti-emetic, but its emetic and hypothermic 
potentials could not be accurately determined, since its vehicle, DMSO, had intrinsic 
emetic and hypothermic effects which complicated the interpretation of the data. 
Only resiniferatoxin was capable of eliciting genital grooming. PPAHV and olvanil 
induced a non-dose-related enhancement of locomotor activity. 
The route of administration did not affect the action of resiniferatoxin. 
Subcutaneously injected resiniferatoxin also elicited emesis, hypothermia, and 
genital grooming. However, the hypothermia was of much longer duration than that 
observed for centrally administered resiniferatoxin. It is conceivable that there are 
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potentially two components, a central and a peripheral component, that mediate 
resiniferatoxin-induced hypothermia. 
The doses of resiniferatoxin, capsaicin, and PPAHV required to produce 
emesis, hypothermia, and anti-emesis overlapped one another. Therefore, no 
dissociation of these effects could be seen. By comparing threshold doses, 
resiniferatoxin ranges from being 10 to 100 times more potent than PPAHV and 33 
to 300 times more potent than capsaicin. For emesis and hypothermia, the rank order 
of potency is resiniferatoxin > PPAHV > capsaicin » > olvanil; for anti-emesis, the 
rank order of potency is resiniferatoxin ~ olvanil > PPAHV > capsaicin; for genital 
grooming, the order is resiniferatoxin » > PPAHV ~ capsaicin ~ olvanil; and for 
temperature rebound, the order is resiniferatoxin ~ capsaicin > » PPAHV ~ olvanil 
(see Table 5.1). From these studies alone, however, it is difficult to know if the 
differences in potencies relate to subtypes of vanilloid receptors, since the pungency, 
desensitization of responses, and rates of brain penetration have not been directly 
determined. Caution should also be taken when drawing inferences from studies with 
olvanil. Moreover, the participation of other neurotransmitter systems e.g. dopamine 
is possible and pathways for mediating the vanilloid-induced responses have not 
been fUlly elucidated. The postulation of the existence of receptor subtypes is 
therefore, at best, speculative. Nonetheless, electrophysiological studies with the rat 
- T R P V l found that the rank order of potency was resiniferatoxin > capsaicin > olvanil 
> PPAHV (Jerman et al, 2000) while those for human and guinea pig TRPVl were 
resiniferatoxin > olvanil > capsaicin » PPAHV (Smart et al., 2001) and olvanil > 
resiniferatoxin > capsaicin » PPAHV (Savidge et al, 2002) respectively. Suncus 
murinus, thus, appears to have a species-specific vanilloid receptor. 
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Studies with the vanilloid receptor antagonists may suggest the existence of 
three distinct receptor subtypes (based on resiniferatoxin as the agonist): (i) a 
capsazepine-insensitive but ruthenium red-sensitive subtype for mediating emesis; (ii) 
a capsazepine-sensitive subtype that activates heat production; and (iii) a 
capsazepine- and ruthenium red-insensitive subtype responsible for mediating 
hypothermia. The pharmacological sensitivity and rank orders of potency for each of 
the vanilloid-induced effect are tabulated in Table 5.1 below. Centrally administered 
capsazepine by itself caused transient hypothermia and prolonged the duration of 
resiniferatoxin-induced hypothermia, indicating a possible endogenous vanilloid tone 
in temperature homeostasis or a partial agonistic action of capsazepine. Peripherally 
administered capsazepine and ruthenium red increased locomotor activity and had a 
non-significant trend to antagonize resiniferatoxin-induced genital grooming. 
Capsazepine Ruthenium Rank order of potency 
sensitive? Red sensitive? 
Emesis X V RTX > PPAHV > CAP » > OLV 
Anti-Emesis X ？ RTX ~ OLV > PPAHV > CAP 
Hypothermia X X RTX > PPAHV > CAP » > OLV 
Temperature • V ？ RTX ~ CAP » > PPAHV ~ OLV 
Rebound 
Genital ‘ X(?) X(?) R T X � � C A P = PAHV = OLV 
“ Grooming 
Table 5.1 The sensitivity of vanilloid-induced emesis, anti-emesis, hypothermia, 
temperature rebound effect, and genital grooming to capsazepine and ruthenium red 
and the rank orders of potency of the agonists for mediating each response. RTX, 
resiniferatoxin; CAP, capsaicin; OLV, olvanil. 
The administration of capsazepine, ruthenium red, or their vehicle, 50% 
DMSO, appeared to have mild effects on the animals, resulting in large variations in 
164 
Chapter 5 - Summary 
responses. Pretreatment with these agents produced vomiting and hypothermia in the 
animals. Pretreatment vomiting could have altered the sensitivity or the 
responsiveness of the animals to subsequent vanilloid treatment. Therefore, the work 
presented in this thesis demonstrated that the use of DMSO as the drug vehicle 
should be avoided as much as possible. It is not clear why the use of DMSO in 
previous experiments did not pose as a major problem (Rudd & Wai’ 2001) whereas 
it affected the interpretation of the results in the present study. It is unfortunate that 
the mechanisms for capsaicin and PPAHV could not be determined. However, from 
the data that we have generated, it seemed as though the actions of both capsaicin 
and PPAHV were also insensitive to capsazepine. Nevertheless, further experiments 
are warranted. The poor solubility of capsazepine limits the available choices for its 
vehicle. It remains to be determined whether a more suitable vehicle than DMSO 
exists. 
The important finding of the present studies is the profiles of actions 
generated for the different vanilloids. We have also demonstrated a hypothermic 
action of PPAHV and a species variation between the rat, human, and Suncus 
murinus TRPVl. It is postulated that receptor subtypes exist for TRPVl in Suncus 
murinus. The question that is left unanswered pertains to the mechanism of action of 
these vanilloids. Whether a single neurotransmitter and/or receptor system is 
- responsible for mediating all the actions of the vanilloids or that different systems are 
responsible for the different effects is a key question. The logical step that follows 
would be to examine effects of other TRPVl antagonists, as well as NKi, glutamate, 
and CGRP receptor antagonists, on vanilloid-induced effects. It is also desirable to 
determine if their receptor agonists can mimic the actions of vanilloids. There is also 
a lack of available information regarding the pungency of these compounds and the 
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distribution and/or binding of these drugs to the vanilloid receptor in Suncus murinus. 
It is therefore important to determine the pungency of the vanilloids in this species 
using the eye-wiping assay as well as other assays for analgesia, and also to obtain 
data on drug distribution following various routes of injection. Furthermore, the 
extent of tissue penetration and lipophilicity of the drugs should also be determined. 
This information could help validate, or invalidate, the present findings. 
The ideal anti-emetic is one that is effective against a wide range of emetic 
stimuli, has a limited side effect profile, and has a large therapeutic window. 
Vanilloids are proved to be broad inhibitory, but they also produce unwanted effects 
such as hypothermia and emesis at their effective anti-emetic doses. The present 
studies did not demonstrate a dissociation between these effects and therefore 
provided restricted support regarding their therapeutic potential. The only possible 
candidate for the ideal anti-emetic is olvanil, which did not elicit hypothermia or 
emesis, but was highly anti-emetic. Olvanil is also non-pungent and does not evoke 
heat production. Therefore, it is desirable to carry on further investigations with 
olvanil. 
In summary, the present thesis generated profiles of actions for 
resiniferatoxin, capsaicin, PPAHV, and olvanil in Suncus murinus. The 
neurotransmitters and/or co-transmitter responsible for mediating these responses 
remain to be identified. There are auspicious therapeutic possibilities for vanilloids. 
A better understanding of the underlying mechanisms responsible for mediating the 
‘ effects of vanilloids will aid in the progression of these studies to other species and 
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